Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,chemokine activity (GO:0008009),0.7839427820363049,2.056715533875653,0.0,0.000979177841712586,0.001,3/31,0.31%,CCL3;CCL4;CCL2
prerank,chemokine receptor binding (GO:0042379),0.7535606770404892,2.0187343925339185,0.0,0.000979177841712586,0.002,3/35,0.31%,CCL3;CCL4;CCL2
prerank,CCR chemokine receptor binding (GO:0048020),0.7777125698459992,1.9913268694698645,0.0,0.0006527852278083907,0.002,3/28,0.31%,CCL3;CCL4;CCL2
prerank,hormone activity (GO:0005179),0.6937024942620753,1.9766925890613753,0.0,0.0012239723021407324,0.005,10/54,13.36%,NPY;NPPC;METRN;PENK;PPY;AGT;CHGB;METRNL;IGF1;CCL25
prerank,cytokine activity (GO:0005125),0.6297392224794693,1.9521888734177661,0.0,0.0033292046618227924,0.016,10/131,3.78%,CCL3;BMP5;OSM;CCL4;CCL2;CSF1;WNT5B;IL34;HMGB1;NDP
prerank,neuropeptide hormone activity (GO:0005184),0.7829092087672237,1.9312407428732437,0.0,0.004569496594658734,0.026,3/22,4.90%,NPY;PENK;PPY
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.7150880403923978,-1.9294427899151234,0.002857142857142857,0.12188420019627086,0.103,7/14,15.26%,SPOCK3;TIMP2;SPOCK2;SPOCK1;BST2;TIMP3;RECK
prerank,glycine binding (GO:0016594),-0.7726138797324131,-1.911858832252101,0.0,0.07948969578017664,0.13,8/11,16.44%,GRIN2B;GLRB;GRIN3A;GLRA1;GLRA2;GRIN1;SRR;GLRA3
prerank,neuropeptide receptor binding (GO:0071855),0.8500572497179021,1.898544297712082,0.0,0.00867271802659719,0.053,3/14,4.90%,NPY;SHANK1;PPY
prerank,receptor ligand activity (GO:0048018),0.5912485066316348,1.878903590764224,0.0,0.011994928560979176,0.081,32/245,10.68%,CCL3;GDNF;SEMA3G;NPY;BMP5;OSM;CCL4;CSF1;NPPC;METRN;SEMA4G;WNT5B;PDGFA;IL34;HMGB1;TNFSF13B;NDP;SEMA6D;PPY;PDGFB;AGT;SEMA6A;JAG1;CHGB;VEGFC;METRNL;IL1A;BMP6;ARTN;SEMA4C;BDNF;IL18
prerank,growth factor activity (GO:0008083),0.607167855146866,1.7885871830597064,0.0,0.05820668281291483,0.357,14/74,16.54%,GDNF;OSM;CSF1;PDGFA;PDGFB;AGT;JAG1;VEGFC;ARTN;BDNF;IL6;HGF;PGF;FGF9
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.6700777881119201,-1.7414304976913992,0.011527377521613832,0.3907360157016683,0.624,5/13,5.22%,PIP4K2A;PIK3C2A;PIP4K2B;PIK3C2B;PIP5K1B
prerank,chemoattractant activity (GO:0042056),0.6852268142836636,1.7253110054371772,0.002688172043010753,0.14080577363826988,0.683,5/26,7.83%,CCL3;GDNF;HMGB1;PDGFB;VEGFC
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.6530253988691118,-1.7220232906357085,0.008310249307479225,0.3500196270853778,0.681,9/13,20.05%,GLRB;GABRG3;GABRG2;GLRA1;GABRA5;GLRA2;GLRA3;GABRG1;GABRA1
prerank,phosphate ion binding (GO:0042301),0.812837929660969,1.7127771069449491,0.004975124378109453,0.15471009899058857,0.753,5/10,8.34%,ADSS2;RELA;PNP;RPH3A;MTHFD2
prerank,lipase activator activity (GO:0060229),0.8144195839359457,1.667682387470047,0.004934210526315789,0.26543879325758685,0.933,1/10,0.01%,CCL3
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.7412624784018712,1.650564125213536,0.010574018126888218,0.30482559426237194,0.957,5/13,6.44%,PDGFRB;IL1R1;PDGFA;ITGB3;PDGFB
prerank,platelet-derived growth factor binding (GO:0048407),0.7782919363230892,1.6457772375935693,0.011128775834658187,0.29885906554556285,0.966,5/11,6.44%,PDGFRB;PDGFA;COL1A2;COL1A1;PDGFB
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.7358234788200968,1.642813828266201,0.021244309559939303,0.29022831228361046,0.968,3/13,9.33%,BMP5;BMP6;PYCARD
prerank,phospholipase activator activity (GO:0016004),0.8093793322131371,1.6379777740527028,0.010135135135135136,0.28751109377285805,0.977,1/10,0.01%,CCL3
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.6862968907494724,-1.6233046894849161,0.00819672131147541,0.6717409224730129,0.932,5/10,14.81%,ADARB2;LACC1;CDADC1;APOBEC1;GDA
prerank,outward rectifier potassium channel activity (GO:0015271),-0.6607258345987308,-1.6116065632688386,0.015789473684210527,0.6178999018645732,0.946,4/11,15.05%,KCND2;KCND3;KCNK2;PKD2
prerank,R-SMAD binding (GO:0070412),0.6871290620303859,1.6083911822727293,0.02225519287833828,0.3798058051913407,0.993,7/18,18.20%,RANBP3;JUN;SMURF1;DDX5;DROSHA;SMAD3;LDLRAD4
prerank,ADP binding (GO:0043531),0.6282391128268732,1.601736159578591,0.013262599469496022,0.38742803270427983,0.995,12/25,22.61%,PGK1;MYH9;LONP1;GLUD1;PRKAG1;MYH10;MYO9B;ATP5F1D;PPP5C;MIEF1;GCLC;MYO18A
prerank,lipoprotein particle receptor binding (GO:0070325),0.6276422505120137,1.595977769832284,0.02204928664072633,0.3914134583056363,0.996,12/27,18.39%,PICALM;APOE;LANCL1;LRP1;AP2A1;DNAJA1;CLTC;CLU;APBB3;SYT1;AP2M1;HSP90B1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.5246893435039691,-1.5925799436749841,0.02857142857142857,0.6198682181410347,0.968,4/21,16.26%,GRM5;GRIA1;CHRFAM7A;CHRNA7
prerank,BMP receptor binding (GO:0070700),0.7358293278540398,1.5846378819155515,0.02875399361022364,0.42158501974935386,1.0,3/12,9.33%,BMP5;BMP6;PYCARD
prerank,transaminase activity (GO:0008483),0.7379252825234682,1.5803578794082727,0.020933977455716585,0.41988078402961126,1.0,5/11,14.48%,BCAT2;AGXT;GOT2;ABAT;GOT1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.49059612483205756,1.5780656651640923,0.0,0.4098304348404314,1.0,24/254,5.29%,ATF3;EGR2;MYC;NKX2-8;SOX10;EGR1;ZNF319;HOXD8;LITAF;STAT3;TFAP2B;NR4A1;HOXB7;CREB3L1;JUN;PRRX1;SOX9;KLF15;NFATC3;ATF4;RELA;CASZ1;CREB3;MDM4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.5063776712460559,1.5777997049710062,0.0,0.3933740546706215,1.0,57/188,18.36%,ATF3;EGR2;SOX10;EGR1;BASP1;STAT3;ZNF513;KCNH2;NFE2L2;CREB3L1;JUN;NFYA;HMGB1;KLF11;KLF15;ATF4;RELA;ZBTB48;ARID5A;XRCC5;TBP;DHX9;CRY2;TCF7L2;TBL1X;SPI1;GABPB1;GABPB2;HDAC5;SFPQ;SOX2;HNRNPL;FOXO3;KMT2D;JUND;NCOR1;POU2F2;ATF6;ARID5B;CTCF;RUNX1;FOXK2;PAX2;RXRA;NFKB1;PSPC1;NONO;PER1;TCF12;NFYC;SMAD3;ATMIN;ETS1;DDIT3;MEF2C;CEBPB;CEBPA
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5937215240849681,1.5758653508305358,0.02040816326530612,0.38567367240454475,1.0,13/35,12.03%,MYC;DRAP1;RELA;GTF2A1;TAF1;BAZ2A;FOXP1;TBP;KLF10;HDAC1;ZBTB17;DR1;SMARCB1
prerank,DNA polymerase binding (GO:0070182),0.6614383848196896,1.5722979236786159,0.0323943661971831,0.3821535280635881,1.0,7/18,8.27%,ACD;HSP90AB1;HMGB1;PCNA;LONP1;PTGES3;POLG2
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5468831087385325,1.565931896751486,0.010650887573964497,0.3915958153125949,1.0,15/55,16.54%,SLC7A5;SLC7A1;SLC16A3;SLC23A2;SLC23A1;SLC16A14;SLC22A4;SLC16A1;SLC6A11;SLC6A6;SLC36A1;SLC38A1;SLC16A6;SLC36A4;SLC16A7
prerank,G protein-coupled receptor binding (GO:0001664),0.5029486952005721,1.5430016262970687,0.002105263157894737,0.4717823904755197,1.0,25/132,14.96%,NPY;BAMBI;CALCA;REEP2;DVL2;PENK;WNT5B;C1QBP;NDP;PDCD6IP;PPY;GNAS;HSPA8;SDCBP;RYK;DNAJA1;ARRB1;GNAO1;RNF43;GNA15;STUB1;CCL25;ZNRF3;FLNA;S1PR1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.5110213572270689,-1.5350966418110619,0.03571428571428571,0.8342443572129539,0.992,11/21,29.94%,PDE7B;PDE1C;PDE8B;PDE1A;PDE4A;PDE10A;PDE4D;PDE5A;PDE7A;PDE1B;PDE9A
prerank,ephrin receptor binding (GO:0046875),-0.5099077024662968,-1.529248566215865,0.02768166089965398,0.7727576054955839,0.994,11/21,27.42%,ANKS1A;CBL;GRB2;CHN1;PTPN1;SRC;EFNB3;EFNA5;ABL1;EFNB2;ANKS1B
prerank,5'-3' exonuclease activity (GO:0008409),-0.5638963126477345,-1.528386627079153,0.042735042735042736,0.7005691854759569,0.994,8/14,25.05%,CPSF3;MRE11;DCLRE1C;FAN1;EXOG;DCLRE1A;DCLRE1B;DCP2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",-0.5398430015909523,-1.5231220477127343,0.043478260869565216,0.6598126505486662,0.994,7/17,15.02%,DPYD;BLVRA;PTGR2;BLVRB;PECR;LBR;DECR1
prerank,GABA receptor binding (GO:0050811),0.7085012601962515,1.5218559879600868,0.03599374021909233,0.5506826240517175,1.0,5/11,6.74%,AKAP5;GABARAP;GABARAPL1;ARFGEF2;TRAK1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.6164377021432519,-1.5184879332569474,0.039886039886039885,0.6252306182531895,0.995,5/12,7.28%,STAT1;TRAF5;BABAM2;TRAF6;TRAF2
prerank,frizzled binding (GO:0005109),0.5879578935543923,1.5147121281107119,0.026888604353393086,0.5668426760920998,1.0,8/34,13.44%,BAMBI;DVL2;WNT5B;NDP;SDCBP;RYK;RNF43;ZNRF3
prerank,phospholipase A2 activity (GO:0004623),0.6014600183956551,1.5139344460184174,0.026954177897574125,0.5518646315892134,1.0,2/26,4.37%,PLB1;PLA2G4A
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.6164921262731675,1.5133395500216607,0.040214477211796246,0.5361788342926176,1.0,11/22,18.39%,PICALM;APOE;LANCL1;AP2A1;DNAJA1;CLTC;CLU;APBB3;SYT1;AP2M1;HSP90B1
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.7347576370011437,1.4951484318963466,0.05401234567901234,0.5867352315765053,1.0,2/10,2.07%,DUSP5;DUSP16
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.7347576370011437,1.4951484318963466,0.05401234567901234,0.5867352315765053,1.0,2/10,2.07%,DUSP5;DUSP16
prerank,titin binding (GO:0031432),-0.5761621354247011,-1.4804938692226004,0.07909604519774012,0.7467955008681212,1.0,6/13,26.90%,CALM2;CALM1;CAPN3;CALM3;ACTN2;MYBPC1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7128898352373718,1.4804780587546167,0.05660377358490566,0.6400943149971746,1.0,2/11,2.29%,SLC23A2;SLC23A1
prerank,potassium ion leak channel activity (GO:0022841),0.647479499506864,1.4657727372528702,0.0527086383601757,0.69507638506712,1.0,2/15,5.23%,KCNK4;KCNK9
prerank,semaphorin receptor binding (GO:0030215),0.5979452667578491,1.460349014996501,0.06052269601100413,0.7041648651138094,1.0,6/23,9.93%,SEMA3G;SEMA4G;SEMA6D;SEMA6A;SH3BP1;SEMA4C
prerank,Tat protein binding (GO:0030957),0.7003303942097077,1.4580437124836974,0.07309486780715396,0.6973069446293223,1.0,6/10,18.15%,GABARAPL1;DNAJA1;CTDP1;SMARCB1;ACTB;MDFIC
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.6898645892095264,1.4570952018324619,0.07198748043818466,0.6843680078432781,1.0,3/12,4.67%,CBR1;AIFM2;DHRS4
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.5814817905509481,-1.4555233368262361,0.07238605898123325,0.811324828263003,1.0,7/11,33.76%,PPP1R14C;PPP1R2;PPP1R8;PPP1R11;PPP1R14A;PPP1R14B;PABIR1
prerank,pseudouridine synthase activity (GO:0009982),0.658572001516118,1.4552763491990852,0.06351791530944625,0.6761097461404674,1.0,1/13,0.08%,RPUSD2
prerank,adrenergic receptor binding (GO:0031690),0.6448332447445986,1.454667821981292,0.051319648093841645,0.6619731798897938,1.0,4/16,5.21%,C1QBP;AKAP5;UCHL1;GNAS
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.7076239300266929,1.4523689274628448,0.06951026856240126,0.6566223312206302,1.0,4/10,11.37%,CXADR;SIRPA;JUP;CD200
prerank,G protein-coupled receptor activity (GO:0004930),0.4595985405998433,1.450825193475804,0.0030272452068617556,0.64816910369746,1.0,19/239,8.68%,MC2R;NPY;LPAR3;NPFFR2;GPR135;PDGFRB;CXCR4;S1PR5;CELSR2;GPR85;GPR63;MTNR1A;ADGRG1;CMKLR1;ADGRL2;LANCL1;GPR183;P2RY1;TAPT1
prerank,WW domain binding (GO:0050699),0.5756696437961544,1.4463805794603164,0.07046070460704607,0.6544779150851496,1.0,4/26,8.69%,LITAF;ENAH;WBP1;TCEAL8
prerank,MAP kinase phosphatase activity (GO:0033549),0.6894856853409821,1.444545685417812,0.06069802731411229,0.6481712231300176,1.0,2/12,2.07%,DUSP5;DUSP16
prerank,chemorepellent activity (GO:0045499),0.5887129480323502,1.4431548754461807,0.05986394557823129,0.6402952704496567,1.0,5/25,9.93%,SEMA3G;SEMA4G;SEMA6D;SEMA6A;SEMA4C
prerank,transforming growth factor beta binding (GO:0050431),0.5877562518989692,1.4413195744628797,0.059639389736477116,0.6354651327966484,1.0,6/23,8.66%,LTBP4;TGFBR1;TGFBR2;NRROS;LTBP3;ENG
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",-0.43941090456728005,-1.4406255847013227,0.05058365758754864,0.8326280667320903,1.0,7/25,12.00%,FCHSD2;KIF16B;HIP1;DAPP1;SESTD1;ADAP2;MYO1G
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5884694310070467,1.4393903992556187,0.07250341997264022,0.6296530193633932,1.0,2/23,1.23%,PLCD4;PLCH1
prerank,ubiquitin protein ligase binding (GO:0031625),0.44851124052060026,1.4333655022306833,0.0010090817356205853,0.6437686318492872,1.0,81/254,16.98%,EGR2;BAG6;TRIOBP;KCNH2;JKAMP;LTBR;SQSTM1;CXCR4;CUL3;JUN;FZD5;USP2;GABARAP;HSP90AB1;FZD6;RNF20;GABARAPL1;UBE2T;ABI2;HDAC6;UCHL1;RELA;NEK6;TANK;PSMD1;HSPA8;RPS27A;UBC;RTN4;TRIB2;MAP1LC3A;GLMN;XRCC5;UBE2D1;HM13;TRIM28;UQCRC1;RALB;PCBP2;ACVR1B;MAP1LC3B;DNAJA1;TUBB;SUMO1;USP25;ACTG1;ARRB1;ATP6V0C;PA2G4;MID1;BAG1;NEDD8;RNF31;UBE2L3;UBXN1;HSPA5;SNCAIP;TMBIM6;MAGEC2;CLU;PRKAR2A;DERL1;SLC25A5;STUB1;HERC2;NAE1;TRAF3;CUL2;WFS1;IKBKE;EIF4E2;UBE2J1;TNFRSF1B;OTUB1;ARIH1;HSPD1;RNF34;CUL4A;APC;PER1;YWHAZ
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.6059163274809782,1.4306746980256546,0.07868383404864092,0.6423006977209376,1.0,6/18,10.78%,LTBP4;TGFBR1;TGFBR2;ACVR1B;ENG;ACVR2B
prerank,ankyrin binding (GO:0030506),-0.4858558869388286,-1.4295498675322698,0.07692307692307693,0.8322571148184494,1.0,4/19,9.74%,SPTBN1;CACNA1D;PLEC;SLC8A1
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.5970188811899867,-1.4231567403367689,0.09090909090909091,0.8090492408936096,1.0,6/10,16.92%,KDM4C;KDM4B;PHF8;RIOX2;KDM7A;KDM4A
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6048325965470099,1.421828902139523,0.07306590257879657,0.6695618081630662,1.0,8/18,18.51%,ALDH8A1;ALDH18A1;ALDH2;ALDH1A1;FAR1;AKR1B10;ALDH6A1;ALDH9A1
prerank,ATPase binding (GO:0051117),-0.34767348258822295,-1.4151094579764214,0.03,0.8010794896957801,1.0,35/71,25.01%,PSEN1;ABCA1;ATP6V0A2;NCSTN;ATP1B3;TOR1AIP1;ANK2;NOP58;RDX;SNTA1;CLPP;RALA;ATP6V1G1;NUFIP1;SRC;PEX19;ATP1B2;GABARAPL2;PGR;PKD2;TMTC4;TMEM106B;SVIP;SNX10;PDE4D;SELENOS;TOR1AIP2;METTL21A;SYVN1;NR1H2;PTPN3;CHMP4A;FBL;TCIRG1;BBC3
prerank,pyridoxal phosphate binding (GO:0030170),0.5780721132790985,1.4051927749050406,0.10533707865168539,0.7337113964911072,1.0,5/20,12.03%,PLPBP;SHMT2;AGXT;PDXK;ABAT
prerank,transcription cis-regulatory region binding (GO:0000976),0.43881723637860737,1.4036915538895192,0.0,0.7267382619818373,1.0,94/406,18.63%,ATF3;EGR2;MYC;SOX10;HOXD9;EGR1;BASP1;HOXD8;STAT3;ZNF513;KCNH2;ZNF436;TFAP2B;DRAP1;NFE2L2;CREB3L1;ZBTB8A;JUN;NFYA;HMGB1;ZNF177;SOX9;KLF11;KLF15;ATF4;RELA;CASZ1;ZBTB48;ARID5A;CREB3;PRDX5;LONP1;XRCC5;FOXP1;STAT6;ZBTB22;TBP;CRY2;ZBTB7B;TCF7L2;TBL1X;SPI1;KLF10;GABPB1;GABPB2;HDAC1;HOXB8;HDAC5;SFPQ;SOX2;ZBTB17;DR1;HNRNPL;PHOX2A;TCF3;ASCL4;FOXO3;KMT2D;RORA;SETX;LMX1B;JUND;ZFP69;NCOR1;POU2F2;ATF1;HOXC8;ATF6;ARID5B;CTCF;RUNX1;FOXK2;PAX2;CUX1;RXRA;NFKB1;RBAK;ZBTB4;PSPC1;NONO;ETV6;PER1;MEF2A;TCF12;NFYC;SMAD3;ATMIN;ETS1;DDIT3;MEF2C;CEBPB;CEBPA;EPAS1;TFCP2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.5311723769303969,1.4027849328662485,0.058823529411764705,0.7176265076536221,1.0,6/38,12.57%,SERPINF2;SERPINE1;AGT;FURIN;ANXA2;APP
prerank,phospholipase C activity (GO:0004629),0.5625764725369029,1.401239544891806,0.0912751677852349,0.7115358983111458,1.0,2/25,1.23%,PLCD4;PLCH1
prerank,C-C chemokine binding (GO:0019957),0.5711588923337831,1.3998787342424588,0.10612244897959183,0.7048300136982051,1.0,2/22,1.66%,CXCR4;ZFP36
prerank,SH3 domain binding (GO:0017124),0.48552276564627506,1.3975748349181822,0.06828703703703703,0.7031720875798508,1.0,19/62,15.31%,MICAL1;SHANK1;AKAP5;ABI2;ADAM9;ENAH;PTPN12;DNM2;LANCL1;AFAP1L1;CD2AP;CNTNAP1;CASP9;SH3BP2;ADAM12;CRK;ABI1;REPS1;WIPF1
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.6356051893702616,1.393446744463129,0.09715994020926756,0.7092683285724429,1.0,4/14,9.74%,MICAL1;NCF4;CYBB;NCF2
prerank,myosin II binding (GO:0045159),0.6610042657175484,1.3808892699477937,0.12355848434925865,0.7575291195773353,1.0,4/10,15.93%,TRIOBP;LLGL1;STXBP5L;STXBP5
prerank,sequence-specific mRNA binding (GO:1990825),0.6580992045739109,1.3727610483887027,0.128500823723229,0.7828609825665152,1.0,4/10,13.60%,ETF1;LARP6;DHX9;FMR1
prerank,aspartic-type peptidase activity (GO:0070001),0.662219000945404,1.371055185726098,0.12792511700468018,0.7777283204109167,1.0,2/10,1.51%,NAPSA;CTSD
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.42597079748989675,1.3666546401860729,0.01006036217303823,0.7863440152782696,1.0,82/269,16.98%,EGR2;BAG6;TRIOBP;KCNH2;JKAMP;LTBR;SQSTM1;CXCR4;CUL3;JUN;FZD5;USP2;GABARAP;HSP90AB1;FZD6;RNF20;GABARAPL1;UBE2T;ABI2;HDAC6;UCHL1;RELA;NEK6;TANK;PSMD1;HSPA8;RPS27A;UBC;RTN4;TRIB2;MAP1LC3A;GLMN;XRCC5;UBE2D1;HM13;TRIM28;UQCRC1;RALB;PCBP2;ACVR1B;MAP1LC3B;DNAJA1;TUBB;STAM;SUMO1;USP25;ACTG1;ARRB1;ATP6V0C;PA2G4;MID1;BAG1;NEDD8;RNF31;UBE2L3;UBXN1;HSPA5;SNCAIP;TMBIM6;MAGEC2;CLU;PRKAR2A;DERL1;SLC25A5;STUB1;HERC2;NAE1;TRAF3;CUL2;WFS1;IKBKE;EIF4E2;UBE2J1;TNFRSF1B;OTUB1;ARIH1;HSPD1;RNF34;CUL4A;APC;PER1;YWHAZ
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.5198583661093387,1.3606653004239795,0.11913814955640051,0.8019940319355939,1.0,7/33,12.53%,PNLDC1;DIS3;CNOT8;CNOT6;EXOSC10;CNOT7;ANGEL2
prerank,mitogen-activated protein kinase binding (GO:0051019),0.5363008530345126,1.3605166267586257,0.10673443456162643,0.7899789231861207,1.0,6/29,12.75%,MAPKAPK2;DUSP5;DUSP16;SIRT1;GCH1;TNIP1
prerank,protein kinase C activity (GO:0004697),0.6088448176311078,1.3598613418742056,0.1099236641221374,0.7808331301506802,1.0,3/14,8.90%,CCL3;PRKCH;PRKCZ
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5942760103566148,1.3547194503199134,0.1274074074074074,0.79295328049334,1.0,7/15,16.83%,HS3ST3A1;HS3ST3B1;NDST2;HS3ST6;HS3ST5;HS3ST4;HS6ST2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.588596807926471,1.3527738294055531,0.12482269503546099,0.7892173404203443,1.0,2/16,3.68%,ALOXE3;CDO1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5900550417991741,1.3527183880360354,0.13161659513590845,0.7662786595108126,1.0,6/16,10.28%,ATP6V1D;ATP6V1A;ATP6V0D1;ATP6V0E1;ATP6V0A1;ATP6V0C
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5900550417991741,1.3527183880360354,0.13161659513590845,0.7662786595108126,1.0,6/16,10.28%,ATP6V1D;ATP6V1A;ATP6V0D1;ATP6V0E1;ATP6V0A1;ATP6V0C
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.5747376360030705,1.3525897991958458,0.13353566009104703,0.7449305254651722,1.0,4/16,13.97%,TTYH2;TTYH3;ANO10;ANO4
prerank,intracellular chloride channel activity (GO:0061778),0.5747376360030705,1.3525897991958458,0.13353566009104703,0.7449305254651722,1.0,4/16,13.97%,TTYH2;TTYH3;ANO10;ANO4
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.5593918659917091,1.3524919755763962,0.12634408602150538,0.7348936570611065,1.0,5/22,9.97%,DUSP5;DUSP16;DUSP19;MTMR3;PPM1F
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5426403750787102,1.3424558579349861,0.12640449438202248,0.7684642100529357,1.0,4/25,11.15%,MICAL1;POR;MICAL2;MSMO1
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.6016848166304505,1.342306434223797,0.14201183431952663,0.7585677326352311,1.0,5/14,8.31%,MTMR10;MTMR14;MTM1;MTMR3;MTMR12
prerank,neuropeptide receptor activity (GO:0008188),-0.41464259261709485,-1.340205939198731,0.08064516129032258,1.0,1.0,18/29,51.94%,OPRM1;GPR37;HCRTR2;SORCS1;TACR3;SORCS2;TACR1;GALR1;NPY1R;GRPR;NPY5R;NPSR1;SSTR2;NMUR2;NPY2R;KISS1R;NTSR1;GAL
prerank,calcium channel regulator activity (GO:0005246),0.49759188311188096,1.3336075584974896,0.125,0.7860680927672686,1.0,5/37,5.77%,NPY;INAFM2;FKBP1B;CACNG8;INAFM1
prerank,DNA-binding transcription factor binding (GO:0140297),0.4210938515714481,1.3328067768629703,0.026804123711340205,0.7791905593212074,1.0,53/189,18.17%,EGR2;MYC;STAT3;DDX20;NFE2L2;BEX1;JUN;HMGB1;PRRX1;NLRP3;ATF4;KAT5;RELA;NEK6;TAF1;CRTC1;ZBTB7A;CHD4;BBS4;TBP;DHX9;TCF7L2;SIRT1;SPI1;NBN;CTNNB1;HDAC1;CREBBP;HDAC5;RBPJ;KDM1A;ZBTB17;TTC8;TCF3;DGKQ;MIER1;CBX5;TLE3;NCOR1;MTDH;CREB1;EIF4E;LDB2;LDB1;SIN3A;MEF2A;YWHAZ;TCF12;ZBTB49;SMAD3;RUNX1T1;DDIT3;MEF2C
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5567955992976364,1.330723802301315,0.14285714285714285,0.7784721519994456,1.0,4/18,8.66%,BAMBI;TGFBR1;TGFBR2;ENG
prerank,channel activity (GO:0015267),-0.36366681825032526,-1.3303804851733718,0.0718232044198895,1.0,1.0,10/41,25.58%,MPV17;BAX;MCUB;TMEM266;TMEM120B;CHRNA7;TRPV4;SLC14A1;TMEM120A;PANX1
prerank,translation initiation factor activity (GO:0003743),0.4915624439032792,1.326490660077604,0.13205128205128205,0.7862543737045127,1.0,14/36,16.99%,EIF3I;EIF2B2;EIF1;EIF2S1;EIF4A1;EIF3A;EIF4A2;EIF3B;EIF4G2;EIF5B;EIF4E2;EIF3H;EIF4E;EIF2B3
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.5321385875167035,1.3254858745560032,0.13154362416107382,0.7807562395829817,1.0,8/26,16.54%,SLC16A3;SLC16A14;SLC16A1;SLC6A11;SLC6A6;MPC1;SLC16A6;SLC16A7
prerank,lysophospholipase activity (GO:0004622),0.5561471941629318,1.324344380695,0.15126050420168066,0.7759922422291122,1.0,2/20,4.37%,PLB1;PLA2G4A
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.6104841698018485,1.3227524266736244,0.14751552795031056,0.7733546593846005,1.0,4/12,8.66%,LTBP4;TGFBR1;TGFBR2;ENG
prerank,chemokine binding (GO:0019956),0.5110560775181054,1.3153926173358694,0.12250332889480692,0.7951286733166092,1.0,4/30,5.62%,CXCR4;ZFP36;HMGB1;ITGB3
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.5684127327865658,1.3117782427948468,0.14285714285714285,0.8019824759421827,1.0,4/18,6.09%,AGAP2;PIK3R3;SOCS6;PIK3R1
prerank,leak channel activity (GO:0022840),0.5546688565577836,1.31038523080456,0.15895953757225434,0.798714185752617,1.0,2/18,5.23%,KCNK4;KCNK9
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6411999681353581,1.3103712087121837,0.16996699669966997,0.7892406541784803,1.0,5/10,14.80%,SHANK1;SQSTM1;GNAS;NSF;IGSF11
prerank,sulfotransferase activity (GO:0008146),0.49837704311583325,1.3083875270444292,0.14030612244897958,0.7877197743094897,1.0,3/33,2.95%,HS3ST3A1;CHST11;CHST12
prerank,poly(U) RNA binding (GO:0008266),-0.4484161556429501,-1.3069371766970015,0.13448275862068965,1.0,1.0,3/20,1.61%,KHDRBS1;RBMS1;DAZAP1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.40593420248566714,1.3050367020021447,0.003,0.7924395186669101,1.0,117/597,18.73%,ATF3;EGR2;NKX2-8;SOX10;EGR3;HOXD9;EGR1;BASP1;HOXD8;STAT3;ZNF513;KCNH2;ZIC1;GLIS1;TFAP2B;NR4A1;HOXB7;NFE2L2;CREB3L1;HSF4;NR2F6;JUN;FOXE1;NFYA;HMGB1;ZNF177;HNRNPU;SOX9;KLF11;NR1D2;KLF15;NFATC3;ATF4;RELA;ZBTB48;ARID5A;MCM2;CREB3L4;CREB3;TGIF1;ZBTB7A;TSPYL2;MLH3;XRCC5;MAFG;FOXP1;ZBTB22;TBP;DHX9;CRY2;ORC5;ZBTB7B;TCF7L2;HIVEP1;TBL1X;SPI1;KLF10;ZBTB2;GABPB1;GABPB2;RUNX2;POU3F2;IRF8;HOXB8;HDAC5;YBX1;SFPQ;SOX2;ELF2;CENPC;HNRNPL;PHOX2A;TCF7L1;CREB5;FOXO3;HMBOX1;BCL6;KMT2D;SKOR2;LMX1B;JUND;NCOR1;POU2F2;CREB1;HOXC8;ATF6;ARID5B;MBD4;CTCF;RUNX1;FOXK2;PAX2;IRF9;HSPD1;CUX1;RXRA;BACH2;NFKB1;PSPC1;NONO;TEF;PER1;MEF2B;TCF12;FOXJ2;NFYC;SMAD3;ATMIN;ETS1;DDIT3;MEF2C;CEBPB;GMEB2;CEBPA;HLF;TFCP2;ZBTB37
prerank,RNA polymerase binding (GO:0070063),-0.4503242698918546,-1.3022160509330123,0.1291390728476821,1.0,1.0,9/18,11.28%,CCNT2;TCERG1;PHRF1;PABPN1;ANP32B;BIN1;YTHDC2;TCERG1L;PPIB
prerank,SUMO transferase activity (GO:0019789),0.564462191467136,1.3000996558325744,0.1593984962406015,0.8039275178814747,1.0,4/16,12.23%,EGR2;TRIM28;CBX4;UBE2I
prerank,tau protein binding (GO:0048156),0.48045183307148137,1.2982209165810963,0.12833545108005082,0.8023694791578928,1.0,18/40,18.47%,BRSK1;HSP90AB1;PIN1;PICALM;HDAC6;APOE;BRSK2;TAOK2;CLU;PPP2CB;STUB1;ACTB;DYRK1A;MAP1A;PPP5C;DCTN1;TTBK2;PRKAA1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.5503365666262591,-1.2976508302693326,0.18635170603674542,1.0,1.0,5/10,20.05%,GABRG3;GABRG2;GABRA5;GABRG1;GABRA1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.5654155101026794,1.2973587689484845,0.1630901287553648,0.7972487991220318,1.0,6/16,12.61%,MTMR10;MTMR14;MTM1;MTMR3;MTMR12;INPP5F
prerank,cAMP response element binding (GO:0035497),0.6134937469305572,1.2925801335150597,0.18877551020408162,0.8090946506071097,1.0,4/10,14.85%,CREB3L1;JUN;CREB5;CREB1
prerank,lipid phosphatase activity (GO:0042577),0.5722221041112916,1.2871447826730817,0.1793002915451895,0.8230796774298993,1.0,3/14,3.96%,SGPP2;INPP5K;PLPPR4
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.49347618630010553,1.286724555914836,0.14158163265306123,0.8158041474703229,1.0,11/33,17.70%,UVSSA;DRAP1;HNRNPU;TBP;DHX9;WDR43;RPRD1A;NCOA3;ELP2;RPRD1B;CTR9
prerank,enoyl-CoA hydratase activity (GO:0004300),-0.5257369933170348,-1.2821030554410042,0.1794871794871795,1.0,1.0,4/10,11.13%,ECHS1;AUH;HADHB;ECHDC1
prerank,myosin binding (GO:0017022),0.4530498474356983,1.280022684865404,0.1375722543352601,0.8360704737065916,1.0,9/55,11.46%,TRIOBP;MYRIP;LLGL1;CXCR4;RAB39B;LARP6;TRAK1;PYCARD;STXBP5L
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5188911107872073,1.277121539674893,0.14583333333333334,0.8396449992685424,1.0,8/24,18.13%,MAPKAPK2;CAMKK1;PTK2B;CAMK2G;MKNK1;PHKA2;DAPK1;MAPKAPK3
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.4457638231350072,-1.2763137441323273,0.16666666666666666,1.0,1.0,5/17,6.05%,GRIA3;GRIN2B;GRIN3A;GRIK4;GRIA1
prerank,RNA stem-loop binding (GO:0035613),0.5913014691584668,1.2739581416586,0.1895734597156398,0.8444635849632859,1.0,7/12,17.55%,LARP6;DHX9;RC3H1;RC3H2;FMR1;MYH10;ZC3H12A
prerank,protein heterodimerization activity (GO:0046982),0.40270493770224414,1.2727072228560714,0.07543323139653414,0.8408383722631296,1.0,33/178,13.61%,ATF3;LSM5;TFAP2B;NR4A1;BCL2L1;RRAGC;ADD1;PDGFA;TPM4;IKBKB;ATF4;FXR2;GTF2A1;CYBB;BCL2L2;TAF1;GCA;SDCBP;PDGFB;DGKD;QTRT1;BMP6;TENM2;ATP1B1;PEF1;RCC1;PAFAH1B1;IRAK2;TCF3;P4HB;ADCY8;FMR1;NAE1
prerank,kinase activity (GO:0016301),0.4175819155420568,1.2725836522342773,0.10695187165775401,0.832856369386566,1.0,21/109,13.46%,CCL3;PGK1;PI4KA;TKFC;BCKDK;DGKZ;TAF1;ITPKC;PIK3C3;TRRAP;DGKD;PDXK;ITPKB;PI4KB;IP6K2;IPPK;CDKL5;PANK3;DGKQ;PSTK;PGM2L1
prerank,peptidase inhibitor activity (GO:0030414),0.48052003262477017,1.2710908613413436,0.16580310880829016,0.8306425580911645,1.0,2/33,1.04%,SERPINF2;UCHL5
prerank,nucleoside-diphosphatase activity (GO:0017110),0.5875283841262062,1.2697231176950265,0.20458265139116202,0.8276723247494204,1.0,4/12,12.68%,ENTPD1;NUDT5;ENTPD7;ENTPD5
prerank,Wnt-activated receptor activity (GO:0042813),0.559873265936798,1.2670002747057043,0.19393939393939394,0.8304505193348614,1.0,5/15,15.26%,FZD5;FZD6;RYK;ROR1;LRP5
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.5173788557316616,-1.265256643497342,0.18820224719101122,1.0,1.0,4/12,16.30%,PDE7B;PDE8B;PDE4A;PDE4D
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4100425091548294,-1.2638475473797905,0.13043478260869565,1.0,1.0,6/23,9.17%,PLEKHA5;KIF16B;HIP1;WDR45B;CLVS2;SESTD1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.5920823419701261,1.261189423629224,0.20583468395461912,0.8462132466721096,1.0,5/11,15.73%,GNPTAB;PTDSS2;SGMS1;PIGN;PIGF
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.4948865171871439,1.2596126897043463,0.18733850129198967,0.8444256910839627,1.0,11/28,20.13%,RPP38;ELAC1;EDC3;ENDOV;RPP30;POP1;DROSHA;AGO3;RNASEH1;RNASEH2A;AGO2
prerank,ligand-gated anion channel activity (GO:0099095),-0.4538227235295463,-1.2591789367696387,0.15806451612903225,1.0,1.0,9/17,20.05%,GLRB;GABRG3;GABRG2;GLRA1;GABRA5;GLRA2;GLRA3;GABRG1;GABRA1
prerank,mRNA 3'-UTR binding (GO:0003730),0.42584237798842983,1.2589375847266944,0.12138084632516703,0.8389082392420111,1.0,20/79,13.90%,ZFP36;ILF3;HNRNPU;RNF20;TARDBP;FXR2;LARP4B;SECISBP2L;CPEB1;EXOSC8;PUM2;RC3H1;TUT1;ELAVL3;ELAVL2;ANGEL2;YBX3;DDX5;FMR1;SECISBP2
prerank,transcription coregulator binding (GO:0001221),0.45961404329865824,1.2580682694305643,0.15659679408138102,0.8341653694235739,1.0,25/50,21.10%,CTBP2;HDGF;CHD6;HDAC6;RELA;NEK6;ZBTB7A;CTNNB1;ZBTB17;UBE2I;RORA;CIT;VGLL4;MED25;CTCF;CNOT2;PER1;ZBTB49;SMAD3;EZH2;CDK9;RPL23;THRB;LMO2;ESR1
prerank,3'-5' exonuclease activity (GO:0008408),0.45476242027016467,1.2577330463820933,0.15476190476190477,0.8277596453708025,1.0,8/45,12.53%,PNLDC1;DIS3;EXD1;CNOT8;CNOT6;EXOSC10;CNOT7;ANGEL2
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.4802652340938154,1.2557086770700003,0.17015706806282724,0.8281442783918239,1.0,10/32,19.13%,SLC7A5;SFXN2;SLC3A2;SLC6A6;SLC36A1;SLC1A1;SLC38A1;SLC36A4;MFSD12;SLC6A9
prerank,general transcription initiation factor binding (GO:0140296),0.49283182455644026,1.2525466024084786,0.1994572591587517,0.8327953299739455,1.0,7/25,11.29%,DRAP1;RELA;GTF2A1;TAF1;TAF12;TBP;DR1
prerank,MHC class II protein complex binding (GO:0023026),0.5886549092071097,1.252340228997378,0.19938176197836166,0.8259365094845663,1.0,4/11,9.67%,HSP90AB1;ANXA11;HSPA8;ATP1B1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",-0.31526517627409434,-1.2520983181168368,0.09322033898305085,1.0,1.0,22/69,14.80%,CERS5;ZDHHC14;ZDHHC17;LPCAT3;NMT1;PLAAT3;ZDHHC13;ZDHHC18;ZDHHC1;ZDHHC6;ESCO1;EP300;NAA15;HHAT;ZDHHC2;GTF2B;MBOAT7;DBT;KAT2B;NAA16;MOGAT3;ZDHHC20
prerank,lipase activity (GO:0016298),0.45297253627591144,1.2511434192088942,0.1746031746031746,0.8229405846202438,1.0,3/43,6.95%,PLB1;LPL;SMPD3
prerank,double-stranded DNA binding (GO:0003690),0.3880284584288169,1.2504994228393285,0.01701701701701702,0.818076381900637,1.0,72/531,14.86%,ATF3;EGR2;NKX2-8;RAD51AP2;SOX10;EGR3;HOXD9;EGR1;HOXD8;ZIC1;GLIS1;TFAP2B;NR4A1;HOXB7;CREB3L1;HSF4;NR2F6;JUN;HDGF;FOXE1;HMGB1;ZNF177;HNRNPU;SOX9;KLF11;NR1D2;KLF15;NFATC3;ATF4;TARDBP;ZBTB48;CREB3L4;CREB3;APTX;PCID2;GTF2H4;TGIF1;ZBTB7A;XRCC5;MAFG;FOXP1;ZBTB22;DHX9;ZBTB7B;POLG2;TDP1;HIVEP1;KLF10;ZBTB2;RUNX2;POU3F2;MSH3;IRF8;HOXB8;YBX1;POLR3F;ELF2;PHOX2A;TCF7L1;CREB5;MBD1;FOXO3;HMBOX1;BCL6;SKOR2;LMX1B;TDG;JUND;POU2F2;CREB1;HOXC8;ATF6
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3976921249318108,1.2495075756067857,0.09773662551440329,0.8146318571948844,1.0,22/173,11.11%,ATF3;MYC;HOXD9;ZNF436;THAP1;CREB3L1;SKIL;JUN;ZNF177;NFATC3;ZBTB25;ZBTB6;RELA;MYPOP;TGIF1;FOXP1;BCL11A;ZBTB2;IRF8;MITF;ZNF148;ZBTB17
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.5153185070313275,1.249290585932795,0.18850267379679145,0.8081189698291176,1.0,6/22,10.28%,ATP6V1D;ATP6V1A;ATP6V0D1;ATP6V0E1;ATP6V0A1;ATP6V0C
prerank,alanine transmembrane transporter activity (GO:0022858),0.5696746917183515,1.249085854362405,0.22204213938411668,0.8016606977716654,1.0,4/12,16.12%,SLC3A2;SLC6A6;SLC36A1;SLC36A4
prerank,regulatory RNA binding (GO:0061980),0.47620024669583505,1.2472178272304746,0.16728624535315986,0.8021613843454396,1.0,16/38,17.58%,TARBP2;MATR3;TUT7;DHX9;DDX21;TLR7;PUM2;RC3H1;YBX1;SOX2;FMR1;RBM10;AGO3;HNRNPA1;ZC3H12A;ELAVL1
prerank,glutamate receptor binding (GO:0035254),0.542380762430526,1.247191301835669,0.2,0.7952882430389623,1.0,8/17,18.49%,SHANK1;SQSTM1;AKAP5;GNAS;NSF;IGSF11;SYNDIG1;HOMER2
prerank,sequence-specific DNA binding (GO:0043565),0.38635825703323645,1.2447654695861556,0.013,0.7982747354561858,1.0,121/590,20.24%,ATF3;EGR2;NKX2-8;SOX10;EGR3;HOXD9;EGR1;HOXD8;CHTOP;ZIC1;GLIS1;TFAP2B;NR4A1;HOXB7;THAP1;NFE2L2;CREB3L1;HSF4;NR2F6;JUN;HNRNPD;FOXE1;ACD;ZNF177;HNRNPU;NLRP3;SOX9;KLF11;NR1D2;KLF15;NFATC3;ATF4;ARID5A;CREB3L4;CREB3;CSRNP2;CXXC1;LONP1;TAF1;TGIF1;ZBTB7A;XRCC5;MAFG;SMG7;FOXP1;ZBTB22;ZBTB7B;TCF7L2;HIVEP1;KLF10;PBX4;ZBTB2;STN1;TET1;RUNX2;POU3F2;IRF8;HOXB8;YBX1;RBPJ;KDM1A;ZNF148;SOX2;ELF2;SLTM;PHOX2A;TCF7L1;KMT2B;CREB5;MBD1;FOXO3;HMBOX1;BCL6;RORA;SKOR2;LMX1B;JUND;POU2F2;CREB1;HOXC8;ATF6;CTCF;KMT2A;FOXK2;PAX2;IRF9;CUX1;SNAPC1;RXRA;BACH2;ZBTB4;TET3;TEF;MEF2A;MEF2B;TCF12;FOXJ2;ZBTB49;SMAD3;SAFB;UPF1;MEF2C;CEBPB;GMEB2;KDM2B;EPAS1;HLF;TFCP2;ZBTB37;JUNB;TERF2IP;PRMT1;TFAM;SP3;THRB;PKNOX2;TFE3;ZNF740;KDM2A;NR5A1;SP4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.35989648450008127,-1.2443604080018096,0.1791044776119403,1.0,1.0,9/34,19.70%,FCHSD2;KIF16B;DAPP1;FERMT2;ADAP2;MYO1G;PARD3;CYTH3;COMMD1
prerank,alpha-tubulin binding (GO:0043014),0.4836195127164388,1.2435694488140911,0.2037037037037037,0.795787037905339,1.0,10/31,15.93%,EFHC1;EFHC2;HDAC6;FNTA;TRAPPC14;BBS4;TBCE;EML4;ARL8B;TRIM36
prerank,histone acetyltransferase binding (GO:0035035),0.5075633447035982,1.2430673813697246,0.2062841530054645,0.7909931375231111,1.0,10/21,19.95%,EGR1;ECD;PCNA;ZBTB7A;KANSL1;SIRT2;MEF2A;EID1;EPAS1;KANSL1L
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3843694244500764,1.2419270014068415,0.008,0.78865781022508,1.0,131/730,18.36%,ATF3;EGR2;MYC;NKX2-8;ZFP82;RELB;SOX10;EGR3;KDM6B;HOXD9;EGR1;ZNF319;LITAF;STAT3;ZNF83;ZBTB11;ZIC1;GLIS1;TFAP2B;NR4A1;HOXB7;THAP1;NFE2L2;CREB3L1;HSF4;SKIL;ZNF471;NR2F6;JUN;FOXE1;NFYA;HNRNPU;PRRX1;SOX9;KLF11;NR1D2;KLF15;NFATC3;ZBTB25;HIVEP3;ZBTB6;ATF4;SARS1;HDAC6;RELA;ZBTB48;CREB3L4;CREB3;MYPOP;ZKSCAN5;ZNF691;SALL3;TGIF1;ZBTB7A;MAFG;EBF2;FOXP1;BCL11A;STAT6;DHX9;ZBTB7B;E2F5;TCF7L2;HIVEP1;MED8;SPI1;KLF10;PBX4;ZBTB2;ZNF467;CHD2;RUNX2;POU3F2;HDAC1;KLF7;IRF8;HDAC5;RBPJ;MITF;ZNF148;SOX2;ZBTB17;ZNF496;TCF7L1;TCF3;CREB5;ZBTB40;DNMT3A;FOXO3;BCL6;RORA;POU6F2;SKOR2;JUND;EBF4;HOXC6;ZSCAN26;POU2F2;ATF1;CREB1;ATF6;CTCF;RUNX1;FOXK2;PAX2;IRF9;RXRA;BACH2;NFKB1;ZBTB4;HOXB3;TEF;PER1;MEF2A;ZFHX4;NLRC5;MEF2B;CC2D1B;TCF12;FOXJ2;ZBTB49;NFYC;SMAD3;SAFB;ETS1;DDIT3;MEF2C;CEBPB;PATZ1;GMEB2;CEBPA
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.5653241887668238,1.2409550162669454,0.22150882825040127,0.7857657385283074,1.0,6/12,19.02%,PNLDC1;CNOT8;CNOT6;CNOT7;CNOT2;CNOT1
prerank,double-stranded RNA binding (GO:0003725),0.42499108477646774,1.240941190116087,0.17048054919908467,0.7793284534569328,1.0,22/70,16.37%,ILF3;HSP90AB1;HNRNPU;TARBP2;EIF2AK2;APTX;EIF4A1;SLC3A2;DGCR8;DHX9;TLR7;MSN;CLTC;RC3H1;RC3H2;SIDT1;DROSHA;FMR1;MTDH;ADARB1;HSPD1;AGO3
prerank,carboxy-lyase activity (GO:0016831),0.5070404793482981,1.2395430284186884,0.20939597315436242,0.7780852120067758,1.0,4/23,8.17%,PISD;ACOD1;GGCX;UROD
prerank,acetylcholine receptor activity (GO:0015464),-0.41200134072874245,-1.239373360637743,0.18045112781954886,1.0,1.0,6/22,36.37%,CHRM2;CHRFAM7A;CHRNA7;ANXA9;CHRM3;CHRNA4
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3994605206848722,1.2387925772710637,0.11857292759706191,0.7742828881353621,1.0,31/134,19.13%,SLC52A2;SLC7A5;SLC6A8;SLC7A1;SLC23A2;SLC23A1;SLC16A1;ABCC5;SFXN2;SLC3A2;SLC39A8;SLC25A13;SLC1A3;SLC25A21;SLC6A6;MPC1;SLC36A1;SLC35D2;SLC1A1;SFXN5;SLC38A1;SLC35D1;SLCO5A1;SLC36A4;SLC16A7;MFSD12;SLC25A25;SLC15A4;SLC17A6;GJA1;SLC6A9
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.47115377461645636,1.2386546970370444,0.196405648267009,0.7685124670254216,1.0,8/37,11.34%,WARS1;KARS1;IARS2;SARS1;SARS2;IARS1;LARS1;EARS2
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.4795675650104165,-1.2358710711291203,0.21204188481675393,1.0,1.0,6/13,32.39%,SREBF2;ECI1;EBP;IDI1;MIF;ECH1
prerank,SUMO binding (GO:0032183),0.5599824092610812,1.232215527117223,0.24468085106382978,0.7863816413907446,1.0,5/13,14.07%,HABP4;USP25;CBX4;HERC2;TDG
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.3810231620199254,1.2310988398548246,0.009,0.7842281961792373,1.0,130/731,18.36%,ATF3;EGR2;MYC;NKX2-8;ZFP82;RELB;SOX10;EGR3;KDM6B;HOXD9;EGR1;ZNF319;LITAF;STAT3;ZNF83;ZBTB11;ZIC1;GLIS1;TFAP2B;NR4A1;HOXB7;THAP1;NFE2L2;HSF4;SKIL;ZNF471;NR2F6;JUN;FOXE1;NFYA;HNRNPU;PRRX1;SOX9;KLF11;NR1D2;KLF15;NFATC3;ZBTB25;HIVEP3;ZBTB6;ATF4;SARS1;HDAC6;RELA;ZBTB48;CREB3L4;CREB3;MYPOP;ZKSCAN5;ZNF691;SALL3;TGIF1;ZBTB7A;MAFG;EBF2;FOXP1;BCL11A;STAT6;DHX9;ZBTB7B;E2F5;TCF7L2;HIVEP1;MED8;SPI1;KLF10;PBX4;ZBTB2;ZNF467;CHD2;RUNX2;POU3F2;HDAC1;KLF7;IRF8;HDAC5;RBPJ;MITF;ZNF148;SOX2;ZBTB17;ZNF496;TCF7L1;TCF3;CREB5;ZBTB40;DNMT3A;FOXO3;BCL6;RORA;POU6F2;SKOR2;JUND;EBF4;HOXC6;ZSCAN26;POU2F2;ATF1;CREB1;ATF6;CTCF;RUNX1;FOXK2;PAX2;IRF9;RXRA;BACH2;NFKB1;ZBTB4;HOXB3;TEF;PER1;MEF2A;ZFHX4;NLRC5;MEF2B;CC2D1B;TCF12;FOXJ2;ZBTB49;NFYC;SMAD3;SAFB;ETS1;DDIT3;MEF2C;CEBPB;PATZ1;GMEB2;CEBPA
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.5614680634559559,1.2299267374348162,0.22085889570552147,0.7823091250961358,1.0,5/13,18.51%,ALDH1B1;ALDH2;ALDH1A1;ADH5;ALDH9A1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.46954126137682867,1.2295159924332464,0.20742637644046094,0.7777502499146633,1.0,7/34,12.53%,PNLDC1;DIS3;CNOT8;CNOT6;EXOSC10;CNOT7;ANGEL2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3770136966670893,1.2204769621841498,0.008,0.805240940605269,1.0,139/830,17.31%,ATF3;EGR2;MYC;NKX2-8;ZFP82;RELB;SOX10;EGR3;KDM6B;HOXD9;EGR1;ZNF319;HOXD8;LITAF;STAT3;ZNF83;ZNF436;ZBTB11;ZIC1;GLIS1;TFAP2B;NR4A1;HOXB7;THAP1;NFE2L2;HSF4;ZBTB8A;SKIL;ZNF471;NR2F6;JUN;FOXE1;NFYA;ZNF177;HNRNPU;PRRX1;SOX9;KLF11;NR1D2;KLF15;NFATC3;ZBTB25;HIVEP3;ZBTB6;ATF4;SARS1;HDAC6;RELA;CASZ1;ZBTB48;CREB3L4;CREB3;GTF2A1;MYPOP;ZKSCAN5;TAF1;ZNF691;SALL3;TGIF1;ZBTB7A;MAFG;EBF2;FOXP1;BCL11A;STAT6;ZBTB22;TBP;DHX9;ZBTB7B;E2F5;TCF7L2;HIVEP1;MED8;SPI1;KLF10;PBX4;ZBTB2;ZNF467;CHD2;RUNX2;POU3F2;HDAC1;KLF7;IRF8;HOXB8;HDAC5;RBPJ;MITF;ZNF148;SOX2;ZBTB17;ZNF496;PHOX2A;TCF7L1;TCF3;CREB5;ZBTB40;DNMT3A;ASCL4;FOXO3;BCL6;RORA;POU6F2;SKOR2;LMX1B;JUND;ZFP69;EBF4;HOXC6;ZSCAN26;POU2F2;ATF1;CREB1;HOXC8;ATF6;CTCF;RUNX1;FOXK2;PAX2;IRF9;CUX1;RXRA;BACH2;NFKB1;RBAK;ZBTB4;HOXB3;ETV6;TEF;PER1;MEF2A;ZFHX4;NLRC5;MEF2B;CC2D1B;TCF12;FOXJ2;ZBTB49;NFYC
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.5099398083934678,-1.220102706193057,0.2345360824742268,1.0,1.0,5/10,22.95%,TATDN1;DCLRE1C;MGME1;DCLRE1A;DCLRE1B
prerank,carboxypeptidase activity (GO:0004180),0.45249884847476246,1.2193871504015135,0.22093023255813954,0.8031367300471509,1.0,9/35,21.48%,CPXM1;SCPEP1;CTSA;FOLH1;CPA6;CPD;AGBL5;BLMH;CTSZ
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.5517694597409165,1.2156353566653033,0.24659606656580937,0.8109012710982695,1.0,7/12,21.20%,ITGB3;VEGFC;PGF;ITGA5;CCDC88A;VEGFB;DAB2IP
prerank,ribosome binding (GO:0043022),0.4377502047775065,1.2149845657287146,0.21480582524271843,0.8071837702129797,1.0,11/46,14.68%,BAG6;C1QBP;ETF1;SRP72;EIF2S1;EIF6;CPEB1;RPSA;MRPS27;FMR1;CCDC47
prerank,FAD binding (GO:0071949),0.4847482990212326,1.2138358607394861,0.22470433639947437,0.8049651705212708,1.0,5/24,13.27%,MICAL1;MMACHC;CRY2;MICAL2;CYB5R1
prerank,vinculin binding (GO:0017166),-0.4949098968359311,-1.2130906385467362,0.2388451443569554,1.0,1.0,4/11,7.47%,PXN;UTRN;ACTN1;RTCB
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.5979076136820981,1.2102256461808873,0.2555205047318612,0.8123741656471144,1.0,3/10,9.74%,NCF4;CYBB;NCF2
prerank,acylglycerol lipase activity (GO:0047372),-0.4947697980174175,-1.2094203481741161,0.24383561643835616,1.0,1.0,5/11,31.69%,MGLL;ABHD15;ABHD12;FAAH;ABHD2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),0.5240579129047577,1.2075773680344086,0.2409090909090909,0.8107160539155928,1.0,9/16,13.57%,PTPRC;PTPRR;PTPRD;PTPN6;PTPRU;PTPRO;PTPRA;PTPRN2;PTPRE
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),0.5240579129047577,1.2075773680344086,0.2409090909090909,0.8107160539155928,1.0,9/16,13.57%,PTPRC;PTPRR;PTPRD;PTPN6;PTPRU;PTPRO;PTPRA;PTPRN2;PTPRE
prerank,inward rectifier potassium channel activity (GO:0005242),0.4899702121732765,1.2035365653890144,0.24704336399474375,0.8188499778783033,1.0,3/24,8.68%,KCNH2;KCNJ6;KCNJ2
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4507121248184432,1.2035228648452692,0.22572178477690288,0.8129517598444647,1.0,13/34,17.04%,UBE2S;UBE2T;TAF1;UBE2D1;UBE2E1;UBE2D3;BIRC6;UBE2L3;UBE2I;UBE2Z;UBE2J1;UBE2F;AKTIP
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.5521032189247398,1.2022679492549155,0.2568218298555377,0.8115200529876972,1.0,5/12,10.01%,RELA;GTF2A1;TAF1;TBP;HDAC1
prerank,damaged DNA binding (GO:0003684),0.4482226717081703,1.2021201129251695,0.21859903381642512,0.8062550348661434,1.0,12/44,14.07%,DDB2;HMGB1;APTX;PCNA;XRCC1;CRY2;NBN;CREBBP;ERCC2;MPG;DDB1;TDG
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.48210730378338196,-1.1999001237238418,0.23676880222841226,1.0,1.0,3/12,9.29%,SLC9A9;SLC9A6;LETM1
prerank,kinesin binding (GO:0019894),0.46414670480963366,1.1996896751410515,0.2393048128342246,0.8090856227262997,1.0,12/27,19.99%,NEK6;PLEKHM2;CROCC;CLSTN1;SPAG9;AP1G1;ACTB;ARHGEF10;TOR1B;TTBK2;KIFAP3;SNCA
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.40451685263070686,-1.1995038590906202,0.22837370242214533,1.0,1.0,14/21,59.39%,GLRB;CHRNA7;P2RX7;CHRNA4;CHRNB2;P2RX3;P2RX5;P2RX4;CHRNA5;P2RX6;P2RX1;CHRNA3;CHRNA9;CHRNB4
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3326060172775164,-1.1988401627436407,0.12442396313364056,1.0,1.0,13/38,16.39%,PLEKHA5;KIF16B;HIP1;WDR45B;SNX12;ZFYVE28;RUBCNL;SESTD1;ZFYVE19;ATG2B;PARD3;ATG2A;SNX20
prerank,Notch binding (GO:0005112),0.48285984383667874,1.1982105309513444,0.24175824175824176,0.8086009243150912,1.0,4/22,8.42%,ADAM17;CUL3;JAG1;TCIM
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.5615060752023817,1.1980668892373876,0.2747603833865815,0.803364063643968,1.0,1/11,0.87%,KCNH2
prerank,ion gated channel activity (GO:0022839),0.47364391730932953,1.197389613897374,0.2482468443197756,0.8002738902163489,1.0,5/24,13.97%,TTYH2;TTYH3;TRPM4;ANO10;ANO4
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.48571394154965913,1.1965609125734602,0.2564102564102564,0.7977598229704574,1.0,7/22,17.58%,ZFP36;ILF3;CPEB1;EXOSC8;ELAVL3;ZC3H12A;ELAVL1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),-0.49370266818070924,-1.1949665958253544,0.2520107238605898,1.0,1.0,1/10,0.04%,SLCO2B1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.376175465798506,-1.1918311438918199,0.20761245674740483,1.0,1.0,6/25,13.22%,HIP1;GRB2;FER;ERBB4;CNOT9;TNK2
prerank,ligand-gated ion channel activity (GO:0015276),-0.3589328358592513,-1.190509729312654,0.17768595041322313,1.0,1.0,5/30,6.05%,GRIA3;GRIN2B;GRIN3A;GRIK4;GRIA1
prerank,cation transmembrane transporter activity (GO:0008324),0.4301660857745431,1.18834951026075,0.24324324324324326,0.8216106895674112,1.0,13/48,19.13%,SLC7A5;SLC7A1;SFXN2;SLC3A2;SLC6A6;SLC36A1;SLC1A1;SLC38A1;SLC36A4;MFSD12;SLC15A4;MMGT1;SLC6A9
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4910790613262396,1.1880032790835304,0.2716927453769559,0.8173870213224023,1.0,4/20,11.77%,SLC39A14;SLC39A3;SLC39A8;SLC30A5
prerank,transcription coactivator binding (GO:0001223),0.5001029891955246,1.1877136418464644,0.2542372881355932,0.8128896263503957,1.0,12/20,21.10%,RELA;ZBTB17;RORA;CIT;VGLL4;MED25;ZBTB49;SMAD3;CDK9;RPL23;THRB;ESR1
prerank,voltage-gated chloride channel activity (GO:0005247),0.5712871633742372,1.1872447012057026,0.27835051546391754,0.8090506204625495,1.0,2/10,8.48%,CLCN2;CLCN6
prerank,ubiquitin-specific protease binding (GO:1990381),0.5082236201957209,1.1866374070685146,0.2725988700564972,0.8058503080249021,1.0,6/19,14.96%,BAG6;DERL2;SUMO1;CLTC;DERL1;SART3
prerank,phosphatase binding (GO:0019902),0.3958483930238103,1.1865201920442665,0.17754010695187167,0.8009026283062123,1.0,33/105,19.93%,STAT3;SFI1;PPP6R1;SIRPA;MAP2K7;TBK1;CSRNP2;JUP;PIK3R1;STAT6;EIF2AK3;CRY2;MTMR3;ELL;ANK1;CNST;PPP6R3;ANAPC5;CTNNB1;CD33;BAD;TRAF3;IKBKE;MAST2;ANAPC7;SMAD3;HSP90B1;JAK1;TSC2;TERF2IP;KIFAP3;TRPC4AP;VCP
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.46121992457145583,1.1859275651026893,0.23469387755102042,0.7976691912646002,1.0,3/31,9.16%,KCNK4;KCNK9;SLC12A6
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.5312590116191768,1.184885373155449,0.2727272727272727,0.7962379815468718,1.0,2/14,8.68%,KCNH2;KCNJ2
prerank,single-stranded RNA binding (GO:0003727),0.43358992616293524,1.1847176731825841,0.2521419828641371,0.7917352262990338,1.0,15/43,16.77%,ILF3;HNRNPU;LONP1;U2AF2;DHX9;TLR7;CNBP;ENDOV;LACTB2;EXOSC10;FMR1;PTBP1;AGO3;POLR2G;HNRNPA1
prerank,metallopeptidase activity (GO:0008237),0.39107849048710047,1.1840221821433983,0.1908315565031983,0.7889709666408166,1.0,26/113,19.85%,ADAMTS1;ADAMTS12;ADAM8;ADAM18;ADAM17;ADAM9;ADAM19;ADAMTSL4;LAP3;DPEP1;ADAM12;IDE;MYSM1;AFG3L2;PAPPA;EIF3H;TRABD2B;ADAM23;METAP1;ADAMTS4;MPND;ADAMTS10;THSD4;MMP14;COPS5;ADAMTS6
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.37500540742743904,1.1824667054081097,0.15734989648033126,0.789255001106564,1.0,46/181,16.45%,EGR2;STAT3;NFE2L2;BEX1;JUN;PRRX1;GABARAPL1;ATF4;RELA;TAF1;JUP;BAZ2A;CHD4;BBS4;TBP;DHX9;TCF7L2;SIRT1;SPI1;DNAJA1;CTNNB1;RNF25;HDAC1;CREBBP;CTDP1;HDAC5;RBPJ;KDM1A;COMMD6;TTC8;TAF6;SMARCB1;TCF3;MIER1;NCOR1;MTDH;TACC2;NCOA3;CREB1;TACC1;MED1;ACTB;LDB2;LDB1;SIN3A;RXRA
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.548486098095036,1.1822881581873386,0.2854984894259819,0.7848266321364865,1.0,7/11,23.65%,DUSP19;MAP4K2;TCF3;STK38;DAB2IP;SASH1;MAP3K11
prerank,RNA binding (GO:0003723),0.3651524560856431,1.180542145304879,0.008,0.7853749969908392,1.0,342/1321,18.07%,RPUSD2;PNLDC1;MAGOH;MAGOHB;GSPT2;LSM5;STAT3;DDX20;CHTOP;MRPL40;PNO1;SLBP;UCHL5;MYH9;ZYX;IPO5;SAMSN1;DCP1A;DHX35;UBFD1;ZFP36;PHF6;UNC50;NOP14;RPL31;DDX42;C1QBP;JUN;PEBP1;HDGF;UTP15;PRPF31;KHDC4;PPP1R10;FUS;SLC16A3;EXD1;ETF1;ADD1;KARS1;HNRNPK;EIF3I;ILF3;DDX49;MRPS26;RPP38;LGALS1;HNRNPD;RPS15;HEATR6;RBM4B;PES1;RPL3;HSP90AB1;HMGB1;HNRNPU;HABP4;ZRANB2;SRP72;TARBP2;URB1;PRR3;MATR3;RPL13A;HNRNPM;RIDA;FUBP3;RIMS1;PFN1;RPL15;RPL10;EIF2AK2;TARDBP;SARS1;SARS2;ANXA11;EIF1;RADX;NOP2;EIF2S1;RRP7A;SSBP1;NIFK;RPS8;FXR2;PSMD4;NUDT5;UTP11;DDX54;LARP6;UTP18;NOP56;APTX;NOSIP;MRPS35;MRPS28;MRPL28;MANF;EDC3;RPL22L1;RPS19BP1;PRPF40A;EIF4A1;RBPMS;HSPA8;LARP7;GPATCH4;RPS27A;UBC;RTN4;DDX41;RAMAC;TAF15;RPL9;PCID2;MAP4;DQX1;LONP1;HDLBP;MRPS31;NCBP3;SNRPA1;PEG10;LARP4B;TUT7;PTCD1;ESF1;SNRPA;TRIM56;GNL3L;DHX34;AFF2;HNRNPH2;NUFIP2;SLC3A2;RPL22;DGCR8;DDX31;EIF3A;BAZ2A;RRP1B;RRP1;ZCCHC8;XRCC5;SUGP2;TRIM28;RBM18;PTBP2;CSNK1E;SMG7;EIF4A2;U2AF2;ZC3H15;RBM39;YRDC;DHX9;UBAP2;C1D;LRP1;REPIN1;PCBP2;EIF1AX;DDX56;DDX21;RPS21;SAMD4B;TLR7;SECISBP2L;CNBP;RPL23A;NXF1;NCOA5;NVL;CPSF6;TRMT10A;ALDH18A1;UTP4;SRSF2;CHD2;RBM38;UBA1;MSN;NOL7;FAM98B;SUMO1;CLTC;GLRX3;U2AF1;SRSF10;PPRC1;NCBP1;RANGAP1;PUM2;ENDOV;SRSF12;PEF1;MRPS12;RPP30;PA2G4;CWC15;RPL34;MYEF2;DCP1B;RC3H1;YBX1;LACTB2;SFPQ;BZW1;TMSB4X;KDM1A;GTPBP4;FIP1L1;CNOT4;EXOSC10;RRBP1;UBE2L3;GIGYF2;TUT1;NSUN5;POP1;RC3H2;KPNA2;EIF3B;GOT2;RPSA;SCAF11;SLTM;DENR;ELAVL2;HNRNPL;RRP36;MRPS7;ANXA2;PRPF40B;DHX40;EIF4G2;UBE2I;MRPL37;MRPL2;MEX3C;DIAPH1;TRMT10B;RPS14;PPIG;TDRD3;WDR43;TSFM;YBX3;SF3A2;MRPL41;MRPL27;CCDC86;P4HB;PSTK;SLC25A5;DDX5;SIDT1;SRPK2;MRPS27;DROSHA;FMR1;EIF5B;HNRNPH1;TSN;SND1;AKAP8L;SF3A1;SETX;SECISBP2;ANXA7;NUP98;PTBP1;RPL27;TFB2M;SNRPG;POLR2B;FAM133B;MTDH;BUD13;LARP1B;ZC3H14;CCDC47;FLNA;U2SURP;EIF4E2;SART3;EIF3H;PATL1;EIF4E;ADARB1;ATP5F1C;USO1;OTUD4;MYH10;GPATCH8;RBM10;RBM8A;DDX50;RPL8;LSM14B;DHX57;HSPD1;HNRNPLL;ACIN1;SNRNP40;DYNC1LI1;PUS7;MTO1;AGO3;POLR2G;YTHDF2;GPATCH1;CCT6A;STIP1;PSPC1;HNRNPA1;NONO;ATXN2;YARS1;YWHAZ;CORO1A;PSMC1;NSRP1;DDX55;ERAL1;IREB2;CPNE3;ZC3H12A;ELAVL1;HNRNPR;SAFB;RPS24;RBM14;PTCD2;TYW5;UPF1;ALKBH5;NSUN6;CALR;SNRNP70;RPL38;CEBPZ
prerank,ligand-gated channel activity (GO:0022834),-0.3589366237405527,-1.1802334611264729,0.19672131147540983,1.0,1.0,5/29,6.05%,GRIA3;GRIN2B;GRIN3A;GRIK4;GRIA1
prerank,RNA polymerase II complex binding (GO:0000993),0.4511346980883525,1.1788846458191657,0.2441860465116279,0.7863660238120869,1.0,11/32,17.70%,UVSSA;HNRNPU;DHX9;SCAF1;WDR43;RPRD1A;BRD4;NCOA3;ELP2;RPRD1B;CTR9
prerank,mRNA methyltransferase activity (GO:0008174),-0.4673965722238316,-1.1783238296923026,0.25513196480938416,1.0,1.0,9/12,33.70%,METTL16;PCIF1;TRMT61B;METTL14;CMTR1;NSUN2;METTL8;RNMT;TRMT10C
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.35912698303261953,-1.1743999345463365,0.226890756302521,1.0,1.0,8/28,20.05%,GRIK4;GABRG3;GABRG2;GABRA5;CHRNA7;GABRG1;GRIK3;GABRA1
prerank,protease binding (GO:0002020),0.39110349304934794,1.1722164764502212,0.21336206896551724,0.8043089189057395,1.0,27/99,17.05%,SERPINF2;BAG6;DERL2;SERPINE1;COL1A2;UBC;ITGB3;COL1A1;FURIN;F3;PRNP;PYCARD;SUMO1;CLTC;RIPK2;CARD16;ADAMTSL4;ANXA2;CFLAR;DERL1;PSAP;COL3A1;SART3;FLOT1;TNFAIP3;RIOK3;ADAMTS4
prerank,pre-mRNA binding (GO:0036002),0.46436030711426746,1.1711511827771799,0.27984084880636606,0.8026582288065854,1.0,10/28,16.77%,SLBP;HNRNPU;TARBP2;U2AF2;U2AF1;HNRNPL;DDX5;PTBP1;ZRSR2;HNRNPA1
prerank,NAD binding (GO:0051287),0.46044501188490783,1.1710198193435302,0.28396739130434784,0.7982294031486991,1.0,8/26,11.25%,ALDH1B1;NUDT6;SIRT1;ALDH2;GLUD1;SIRT5;ALDH1A1;SIRT2
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.4009798627106068,1.1707508406000047,0.24287343215507412,0.7942754247315221,1.0,2/73,2.61%,MC2R;INPP5K
prerank,flavin adenine dinucleotide binding (GO:0050660),0.42217741538961256,1.1694741221899785,0.23696682464454977,0.7941371120152905,1.0,9/53,10.92%,MICAL1;MMACHC;AIFM2;ILVBL;CYBB;POR;CRY2;MICAL2;KDM1A
prerank,GTPase regulator activity (GO:0030695),0.37079243018454805,1.1677709912636274,0.15634517766497463,0.794908440724601,1.0,60/212,17.52%,RANBP3;AGAP2;ARFGAP3;RGS1;IPO5;TBC1D10B;RIC8A;LLGL1;JUN;ARHGAP30;IQGAP3;TBC1D17;NPRL2;RIMS1;ALS2;SIRPA;USP6NL;KRIT1;ASAP1;RABGAP1;RGS11;SGSM2;SH3BP1;RGS7;ARHGEF6;GMIP;RAP1GAP2;LARS1;SMAP2;TBC1D30;ARHGAP22;RASGRP3;ARRB1;RANGAP1;TAGAP;ALDH1A1;STXBP5L;SRGAP2;EVI5L;OCRL;RP2;GPS2;ELMOD1;NPRL3;TBC1D7;TBC1D4;SOS1;RALBP1;RUNDC1;ARHGAP17;RALGAPA2;FLCN;STXBP5;MYO9B;ARHGAP1;CCDC88A;ARHGAP32;TBC1D22A;TBC1D10A;TBC1D15
prerank,syntaxin binding (GO:0019905),0.4050000863012969,1.1661823833004432,0.25381903642773207,0.7955112124511113,1.0,19/61,16.05%,NAPA;BLOC1S6;SNAP47;CACNA1A;VAMP1;TMED10;SCFD2;VPS52;SYPL1;SYP;STXBP3;STXBP5L;NSF;SNPH;SYT1;SYNPR;DAPK1;STXBP5;VPS18
prerank,chemokine receptor activity (GO:0004950),0.4697776975919852,1.1650651034193937,0.2878787878787879,0.7945881601988397,1.0,3/24,11.82%,CXCR4;CMKLR1;CCR5
prerank,GTPase activator activity (GO:0005096),0.3661716838246682,1.161845576958804,0.13139418254764293,0.8005886259511851,1.0,99/313,19.99%,RANBP3;EEF1B2;AGAP2;PSD;DIS3;ARFGAP3;RGS1;TBC1D10B;RIC8A;LLGL1;DENND3;JUN;DENND4B;ARHGAP30;IQGAP3;EIF2B2;TBC1D17;NPRL2;ARFGEF2;KALRN;ALS2;RASGEF1B;RABGEF1;USP6NL;DENND2D;ASAP1;RABGAP1;RASGRF1;RGS11;SGSM2;ARHGEF4;SH3BP1;RGS7;ARHGEF6;GMIP;RAP1GAP2;LARS1;SMAP2;TBC1D30;ARHGAP22;RASGRP3;FGD1;SERGEF;ARRB1;RANGAP1;TAGAP;ALDH1A1;RCC1;DOCK10;RIC1;STXBP5L;SH3BP5L;DOCK2;SRGAP2;EVI5L;OCRL;RP2;DOCK9;DENND1B;HERC2;ELMOD1;DENND5A;RINL;NPRL3;TBC1D7;TBC1D4;SOS1;RALBP1;RUNDC1;ARHGAP17;ARHGEF10;RALGAPA2;FLCN;STXBP5;MYO9B;ARHGAP1;CCDC88A;RASGRP2;ARHGAP32;EIF2B3;ARHGEF2;TBC1D22A;TBC1D10A;TBC1D15;DENND1A;TIAM1;ITSN1;RGL2;ARHGAP25;ASAP3;ARHGAP24;ELMO1;RAB3GAP1;TSC2;ARHGAP42;IQGAP2;NUCB1;RANBP2;STARD8
prerank,voltage-gated ion channel activity (GO:0005244),-0.43611286328585397,-1.1611917920588806,0.28291316526610644,1.0,1.0,5/14,15.05%,KCND2;GPR89B;GPR89A;CACNA1E;PKD2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.5036397120299793,1.1599496218220755,0.2998477929984779,0.8017786277625507,1.0,4/15,9.87%,PI4KA;PIK3R3;PIK3C3;PI4KB
prerank,phospholipase activity (GO:0004620),0.4042918746170891,1.1586544065519113,0.2471655328798186,0.8014167443541517,1.0,6/67,8.49%,PLB1;LPL;PLD3;PLA2G4A;SMPD3;SMPD1
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.49351525912279026,1.1568669442073383,0.30758226037195996,0.7979274688960436,1.0,2/17,1.25%,EPHA1;EPHA2
prerank,ephrin receptor activity (GO:0005003),0.49351525912279026,1.1568669442073383,0.30758226037195996,0.7979274688960436,1.0,2/17,1.25%,EPHA1;EPHA2
prerank,mRNA binding (GO:0003729),0.36458025304258546,1.1558586340487484,0.171225937183384,0.796858323578217,1.0,66/249,18.05%,SHMT2;SLBP;DCP1A;ZFP36;C1QBP;ETF1;HNRNPK;RBM4B;HNRNPU;RNF20;RPL13A;HNRNPM;RIDA;FUBP3;TARDBP;FXR2;LARP6;EDC3;EIF4A1;RBPMS;HDLBP;NCBP3;LARP4B;EIF3A;PTBP2;DHX9;PCBP2;SAMD4B;SECISBP2L;CNBP;CPSF6;CPEB1;NCBP1;PUM2;MYEF2;DCP1B;RC3H1;TUT1;RC3H2;DENR;ELAVL2;HNRNPL;MRPS7;EIF4G2;RPS14;ANGEL2;YBX3;DDX5;FMR1;SECISBP2;NUP98;PTBP1;ADARB1;MYH10;RBM8A;LSM14B;HNRNPLL;YTHDF2;NSRP1;IREB2;ZC3H12A;ELAVL1;HNRNPR;RBM14;CALR;SNRNP70
prerank,DNA binding (GO:0003677),0.358434261582969,1.1552589050462636,0.067,0.7940288177460009,1.0,154/694,18.71%,EGR2;MYC;NKX2-8;RAD51AP2;SOX10;EGR1;JRK;STAT3;ZNF513;TFAP2B;DRAP1;NR4A1;DDB2;THAP1;NFE2L2;NR2F6;JUN;HDGF;AIFM2;HMGN1;ILF3;RPS15;MAP1S;LIN9;FOXE1;NFYA;HMGB1;HNRNPU;NLRP3;SOX9;NUPR1;FUBP3;ZBTB6;ATF4;TARDBP;RYBP;RADX;RELA;SSBP1;ARID5A;MCM2;APTX;GTF2A1;CSRNP2;PCID2;GTF2H4;PCNA;LONP1;TAF1;QRICH1;ZBTB7A;TAF12;GTF3C2;PARP4;XRCC5;RAD52;CHD4;TRIM28;CHRAC1;ZBTB22;DHX9;C1D;CRY2;REPIN1;PCBP2;POLG2;TCF7L2;TDP1;SMARCA1;PBX4;CNBP;STN1;CHD2;TET1;NBN;POU3F2;MSH3;CREBBP;ERCC2;ENDOV;MPG;YBX1;ZMYM4;SFPQ;RBPJ;ZNF148;SOX2;POLR3F;DEDD2;CENPC;ZNF496;RC3H2;SLTM;TAF6;SMARCB1;ATAD5;GTF3C5;TCF7L1;TCF3;APP;DDB1;DNMT3A;NABP1;MBD1;FOXO3;HMBOX1;BCL6;ZNF292;KMT2D;RORA;TSN;SETX;TDG;FAM111A;POU2F2;ATF6;ARID5B;MBD4;CCNT1;TSHZ2;CTCF;FOXK2;PAX2;HSPD1;DNASE1L1;CUX1;SNAPC1;RXRA;POLR2G;ZBTB4;NEIL3;HNRNPA1;HMCES;MEF2A;ZBTB49;NFYC;SMAD3;ZC3H12A;SAFB;HDGFL2;ETS1;RLF;CALR;CEBPZ;DDIT3;CEBPB;PATZ1;CEBPA;KDM2B;EPAS1;HLF;TFCP2;CDK9;CGAS
prerank,amino acid:sodium symporter activity (GO:0005283),0.5421102465698754,1.1534324589951837,0.30307941653160453,0.7954561020975416,1.0,4/11,13.66%,SLC6A11;SLC1A3;SLC1A1;SLC38A1
prerank,beta-tubulin binding (GO:0048487),0.4426901366632102,1.1528592946078897,0.2855313700384123,0.7928169316907309,1.0,7/31,11.48%,GABARAP;MAP1S;FGF13;GABARAPL1;UXT;BBS4;EML4
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.4428453814482298,1.1517456402284856,0.28627450980392155,0.7919335908174114,1.0,5/29,6.14%,PARG;GUSB;OVGP1;HEXD;CTBS
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.4400385987566221,1.1515343345110618,0.3048128342245989,0.7881996555848565,1.0,11/31,17.04%,UBE2S;UBE2T;TAF1;UBE2D1;UBE2E1;UBE2D3;BIRC6;UBE2L3;UBE2Z;UBE2J1;AKTIP
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.44334729811894885,1.151462978422805,0.2813333333333333,0.7841026405208957,1.0,11/27,21.21%,POLR2J;POLR1D;POLR3B;CRCP;POLR3F;POLR2E;POLR2B;POLR2G;MED20;MED21;POLR1A
prerank,protein phosphatase binding (GO:0019903),0.3803699025636101,1.1500964049744486,0.23799359658484526,0.7841908941662196,1.0,24/117,14.43%,PPP1R3E;STAT3;AKAP5;PPP6R1;SIRPA;MAP2K7;TBK1;JUP;PIK3R1;SMG7;STAT6;EIF2AK3;MTMR3;ANK1;PPP6R3;ANAPC5;CTNNB1;CD33;BAD;CTTNBP2NL;ADCY8;TRAF3;PPP1R16B;IKBKE
prerank,ATP binding (GO:0005524),0.36499837747178804,1.1496123539628733,0.16129032258064516,0.7812811310623754,1.0,56/266,16.55%,ABCB8;STK38L;AGAP2;PGK1;PFKM;HSPA4;MYH9;BRSK1;VPS4A;EIF2B2;BCKDK;MTHFD1L;HSP90AB1;HNRNPU;TLK1;SARS2;NEK6;TGFBR1;HSPA8;LONP1;SNRK;ACLY;MAP4K5;BRSK2;DHX9;CDK6;MAP4K2;P2RY1;LATS1;PDXK;ACVR1B;NVL;PRKAG1;CDKL5;SYN3;HSPA5;MKNK1;STK17B;PANK3;MLKL;PDK3;MAP4K3;SRPK2;IDE;NDUFA13;TDG;OLA1;PNPLA8;MYH10;PEAK1;DAPK1;MYO9B;ATP1A3;MAST2;ATP5F1D;PPIP5K1
prerank,triglyceride lipase activity (GO:0004806),0.48197494221082327,1.148874173820336,0.31313131313131315,0.7793879013169988,1.0,1/20,1.49%,LPL
prerank,MAP kinase kinase activity (GO:0004708),0.5130990416550176,1.1457750577832533,0.2978723404255319,0.7851133546028932,1.0,4/15,4.92%,MAPK10;MAP2K3;MAP2K7;MAP2K1
prerank,voltage-gated anion channel activity (GO:0008308),0.5010143721355792,1.1450702024507933,0.29384615384615387,0.7829644384420167,1.0,3/15,8.48%,CLCN2;VDAC2;CLCN6
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.43684016115017443,-1.1450303074197636,0.2932551319648094,1.0,1.0,6/14,15.73%,USP13;USP15;USP7;MINDY3;OTUD5;MINDY1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5460179720240941,1.1433068807759834,0.32919254658385094,0.7844590653949409,1.0,3/12,7.15%,NAPSA;SPPL3;HM13
prerank,ribonuclease P RNA binding (GO:0033204),0.5505164903672978,1.1419762565905613,0.32682926829268294,0.7844477967397443,1.0,3/10,11.52%,RPP38;RPP30;POP1
prerank,endodeoxyribonuclease activity (GO:0004520),-0.39189633232271515,-1.1418434531050166,0.2721311475409836,1.0,1.0,7/20,15.67%,MRE11;RBBP8;DNA2;DCLRE1C;ZRANB3;RPS3;EXOG
prerank,poly(A) binding (GO:0008143),-0.3810592201710935,-1.1416559943931839,0.2825278810408922,1.0,1.0,4/21,5.73%,KHDRBS1;TIA1;RBMS1;DDX1
prerank,protein homodimerization activity (GO:0042803),0.354458548227117,1.1399959360383753,0.099,0.7866306353197774,1.0,107/590,14.70%,GDNF;ATF3;SERPINF2;MAD2L1;CSF1;STAT3;MMACHC;SHMT2;KCNH2;TFAP2B;MYH9;BCL2L1;THAP1;LPL;PLEK;BLOC1S6;PRMT2;WARS1;TYROBP;EXD1;IDH1;ADD1;KARS1;CARNMT1;MTHFD1L;PDGFA;HSP90AB1;TARBP2;NECTIN3;GLB1;TPM4;SNX6;CADM3;IKBKB;NDP;EIF2AK1;SARS1;RELA;SSBP1;ALS2;FXR2;HSD17B1;NUDT5;PDCD6IP;HPGDS;RBPMS;PHETA1;APOE;CADM1;NAA60;STARD3;BCL2L2;JUP;GLIPR2;GCA;PDGFB;SPPL3;NAGA;AGXT;DGCR8;HM13;CARD9;ZDHHC3;CAMK2G;ZBTB7B;DGKD;QTRT1;PDXK;MFSD1;TENM2;PYCARD;GCH1;RIPK2;MSH3;PPCS;GNPTG;MID1;STARD3NL;SFPQ;PTPRO;SCARB2;TPD52;PANK3;IRAK2;TCF3;SRGAP2;INPP5F;PSAP;STUB1;ADCY8;DROSHA;HMGCS1;IDE;FMR1;TIMM9;MASP1;PGRMC1;TDG;ABCB10;CST7;GOLGA5;ABCB7;SPPL2A;ADRB2;TKT;SLC11A1;FLNA
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.45519335463248634,-1.1370409998455644,0.2931937172774869,1.0,1.0,8/11,38.82%,SLC25A17;SLC35B3;SLC17A9;LRRC8A;SLC25A24;SLC35B2;SLC25A42;SLC19A1
prerank,protein tyrosine kinase binding (GO:1990782),-0.2748015619399248,-1.1361736183495614,0.168,1.0,1.0,20/71,14.91%,KHDRBS1;DOCK4;NEDD9;CBL;HSP90AA1;GAS6;TJP2;GRM5;SOCS5;BMPR2;BANK1;SHC3;RNF41;ITGAX;PTPN1;ANGPT1;PTPN11;PITPNM1;MAP3K7;ITGB1
prerank,cholesterol binding (GO:0015485),0.41746084091357155,1.135529600116757,0.296969696969697,0.7968788861924677,1.0,13/47,13.37%,APOD;STARD3;VDAC2;ANXA6;GRAMD1A;STARD5;OSBPL1A;SYP;OSBPL8;STARD3NL;SCARB2;SIDT1;OSBP2
prerank,N-acyltransferase activity (GO:0016410),-0.3341413594296747,-1.1306133849804618,0.22277227722772278,1.0,1.0,7/32,9.90%,CERS5;SAT1;SMARCE1;NMT1;PLAAT3;ESCO1;EP300
prerank,zinc ion binding (GO:0008270),0.35396502668366564,1.1297350367440127,0.19657258064516128,0.811158177243904,1.0,65/293,17.01%,EGR1;TIMM8B;LITAF;SHMT2;MYRIP;HPF1;ARIH2;THAP1;ADAM8;ATP13A2;TMEM163;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;CALB1;MDM4;ZKSCAN5;TET2;LANCL1;CHD4;TRIM28;CRIP1;RPH3A;BAZ1B;PDXK;SMPD1;WDFY1;GCH1;TET1;HHIP;KLF7;SIRT5;RC3H1;LACTB2;NPEPPS;SIRT2;SLC30A5;SEC24C;RABGGTB;KMT2B;ADH5;RNF112;DPEP1;MBD1;IDE;SEC24A;TIMM9;GRIN2A;LIMS1;ENPP5;BBOX1;PAPPA;CTCF;KMT2A;MT2A;ARIH1;RXRA;RBAK;TET3;ARHGEF2
prerank,syntaxin-1 binding (GO:0017075),0.4579702942669681,1.1292872646809644,0.32253521126760565,0.8083473833068554,1.0,10/22,17.30%,SYPL1;SYP;STXBP3;NSF;SNPH;SYT1;SYNPR;DAPK1;STXBP5;UNC13B
prerank,ATPase regulator activity (GO:0060590),0.4183967114981348,1.129266900021559,0.3157894736842105,0.8041664639095271,1.0,11/38,13.53%,PFN1;FNIP2;DNAJC19;DNAJC1;BRSK2;DNAJA1;ATP1B1;BAG1;DNAJA2;DNAJB2;DNAJC15
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.38770106870407167,-1.1265822501705594,0.29333333333333333,1.0,1.0,7/19,20.05%,GRIK4;GABRG3;GABRG2;GABRA5;GABRG1;GRIK3;GABRA1
prerank,receptor tyrosine kinase binding (GO:0030971),0.3988615508478994,1.1260320608869157,0.31627906976744186,0.8101370670177663,1.0,11/56,11.66%,SQSTM1;SH2B2;NCK1;TOB1;ANGPT2;PTPN14;PCNA;PIK3R1;LRP4;BLNK;ELMO2
prerank,poly-purine tract binding (GO:0070717),-0.3546395533941498,-1.124235608314383,0.28879310344827586,1.0,1.0,5/27,5.73%,KHDRBS1;TIA1;RBMS1;DAZAP1;DDX1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.4697423828955251,-1.1222917770605487,0.34300791556728233,1.0,1.0,6/10,35.32%,NSD1;SETD5;ASH1L;SMYD2;SETD2;SETMAR
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.466515528741414,-1.1208907751260135,0.3569620253164557,1.0,1.0,4/10,11.26%,PKIG;PKIA;PRKAR2B;PKIB
prerank,motor activity (GO:0003774),0.3880688754783209,1.1204683962514994,0.29859484777517564,0.8236610625311565,1.0,7/60,6.79%,KIF19;MYO1E;MYH9;PIN1;KLC1;KIF5A;MYL6
prerank,kinase activator activity (GO:0019209),0.4328655314164102,1.1202574281527742,0.3431241655540721,0.8200866789766029,1.0,4/30,6.67%,AGAP2;FGF13;DUSP19;MOB1B
prerank,potassium channel regulator activity (GO:0015459),-0.29518752768691364,-1.1199880702289877,0.24561403508771928,1.0,1.0,9/49,13.52%,DPP6;KCNIP4;DPP10;KCNIP1;KCNIP3;DLG1;WNK2;KCNAB1;WNK3
prerank,cholesterol transfer activity (GO:0120020),-0.3950016451266456,-1.1182285419125237,0.29141104294478526,0.9906740354320542,1.0,3/16,5.20%,GRAMD1B;ABCA1;NPC2
prerank,RNA cap binding (GO:0000339),0.4835483347892205,1.1171397778893113,0.33839150227617604,0.8258084631514192,1.0,10/16,23.15%,EIF4A1;NCBP3;CYFIP1;NCBP1;EIF4E2;EIF4E;SNUPN;AGO2;CYFIP2;NCBP2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.43437962431027977,1.11704878681303,0.33558863328822736,0.8218799155688998,1.0,11/27,21.21%,POLR2J;POLR1D;POLR3B;CRCP;POLR3F;POLR2E;POLR2B;POLR2G;MED20;MED21;POLR1A
prerank,alpha-actinin binding (GO:0051393),-0.3634008788432852,-1.1162903253846217,0.28975265017667845,0.9809028459273799,1.0,14/24,29.53%,CACNA1D;KCNN2;CACNA1C;PDLIM5;PPARG;PKD2;NRAP;PDLIM2;PDLIM4;RARA;PDLIM1;SYNPO2;PKD2L1;PDLIM7
prerank,adenyl ribonucleotide binding (GO:0032559),0.3528945864318924,1.1156733518077853,0.21651560926485397,0.8220968400291198,1.0,58/291,16.55%,ABCB8;STK38L;AGAP2;PGK1;PFKM;HSPA4;MYH9;BRSK1;VPS4A;EIF2B2;BCKDK;MTHFD1L;HSP90AB1;HNRNPU;TLK1;SARS2;NEK6;POPDC3;TGFBR1;HSPA8;LONP1;SNRK;ACLY;MAP4K5;BRSK2;DHX9;CDK6;MAP4K2;P2RY1;LATS1;PDXK;ACVR1B;NVL;GLUD1;PRKAG1;CDKL5;SYN3;HSPA5;MKNK1;STK17B;PANK3;MLKL;PDK3;MAP4K3;SRPK2;IDE;NDUFA13;TDG;OLA1;PNPLA8;MYH10;PEAK1;DAPK1;MYO9B;ATP1A3;MAST2;ATP5F1D;PPIP5K1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.49701017393519675,1.1131091672227755,0.34923076923076923,0.8257535318070744,1.0,3/15,10.58%,ALDH1B1;ALDH2;ALDH1A1
prerank,protein serine/threonine kinase activity (GO:0004674),0.3480168985184448,1.1093429863649562,0.23618090452261306,0.8332016154307403,1.0,91/335,18.91%,STK38L;MAPKAPK2;BRSK1;MAPK6;FAM20C;RIOK1;SQSTM1;NEK7;PRKD2;MAPK10;CDKL3;BCKDK;IKBKB;EIF2AK2;TLK1;KALRN;FASTK;NEK6;PIK3R4;MAP2K1;TBK1;BMP2K;TGFBR1;CAMKK1;TGFBR2;ULK3;TAF1;SNRK;PRKCH;MAP4K5;CSNK1E;BRSK2;EIF2AK3;PTK2B;CAMK2G;TP53RK;CDK6;MAP4K2;LATS1;ACVR1B;CCNK;PRKCZ;MAPK8;PIM3;CLK4;RIPK2;ACVR2B;TAOK2;CSNK1G2;CDKL5;TNIK;LIMK1;MKNK1;STK17B;TRIO;IRAK2;PDK3;MAP4K3;CSNK1G3;HUNK;CDK8;CDK12;SRPK2;IKBKE;CIT;BRD4;CDK19;MTOR;RAF1;DAPK1;DYRK1A;MAST2;RIOK3;ILK;CSNK1D;BRD2;PRKCB;ACVR1;CPNE3;GRK2;MAPKAPK3;TTBK2;PLK3;SGK1;ARAF;PRKAA1;MAP3K4;CDK9;ALPK1;STK38;IRAK4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.5103217570871739,1.1088765296361587,0.3380952380952381,0.8305533330082412,1.0,7/12,18.71%,CDK6;CCNK;CDK8;CDK12;BRD4;CDK19;CDK9
prerank,transition metal ion binding (GO:0046914),0.34685646586092234,1.108802589464242,0.19438877755511022,0.8266891611091662,1.0,83/397,17.01%,EGR1;TIMM8B;LITAF;FDX1;SHMT2;MYRIP;HPF1;ARIH2;SCD5;RNF7;FAM20C;THAP1;ADAM8;ATP13A2;TMEM163;ABL2;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;CALB1;MDM4;ACO2;ZKSCAN5;HMGCL;TET2;LANCL1;CHD4;TRIM28;CRIP1;MGAT5;POMGNT1;RPH3A;IL1A;BAZ1B;PDXK;SMPD1;WDFY1;PRNP;GCH1;TET1;MGAT5B;HHIP;KLF7;SIRT5;GALNT1;XXYLT1;RC3H1;LACTB2;NPEPPS;SIRT2;FBXL5;SLC30A5;SEC24C;RABGGTB;KMT2B;CUTC;ADH5;RNF112;DPEP1;MBD1;IDE;SEC24A;TIMM9;GRIN2A;LIMS1;ENPP5;BBOX1;PAPPA;CTCF;KMT2A;MT2A;ARIH1;B4GALT7;RXRA;RBAK;TET3;SOD2;ARHGEF2
prerank,protein phosphatase regulator activity (GO:0019888),0.3945136105457965,1.1075531507761194,0.32708089097303633,0.826304913028973,1.0,10/53,8.65%,PPP1R15B;PPP6R1;EIF2AK2;PPP4R1;PPP2R5B;PPP2R5A;MGAT5;SET;PPP2R2D;PPP6R3
prerank,signaling receptor complex adaptor activity (GO:0030159),0.41474730196184917,1.1048066756200177,0.3375,0.8311579873843391,1.0,8/38,11.20%,DLG5;SHANK1;SH2B2;NCK1;PIK3R1;BLNK;SPAG9;DEDD2
prerank,single-stranded DNA binding (GO:0003697),0.3679055137813205,1.1048034566983984,0.31101511879049676,0.8270836835246118,1.0,23/93,16.86%,RAD51AP2;HMGB1;HNRNPU;FUBP3;RADX;SSBP1;MCM2;APTX;LONP1;RAD52;DHX9;CRY2;PCBP2;TDP1;STN1;MSH3;NABP1;FAM111A;HSPD1;POLR2G;NEIL3;HNRNPA1;HMCES
prerank,endopeptidase inhibitor activity (GO:0004866),0.377693633357827,1.104220558884216,0.3106904231625835,0.8250695788588548,1.0,13/82,14.16%,SERPINF2;UCHL5;SERPINE1;AGT;FURIN;PRNP;CARD16;BIRC6;ANXA2;APP;UBE2Z;PROS1;CST7
prerank,hexosaminidase activity (GO:0015929),0.5090653454558325,1.1032222695011,0.3467741935483871,0.8241207525159535,1.0,3/12,8.58%,HEXD;NAGA;CEMIP2
prerank,translation elongation factor activity (GO:0003746),0.5011248452302929,1.1018060664495097,0.3602391629297459,0.8247610230417374,1.0,2/14,3.20%,EEF1B2;GFM2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.3727331643627836,1.1002675801974198,0.3213507625272331,0.8252633247183888,1.0,5/85,4.77%,PLB1;LPL;PAFAH2;PLA2G4A;ABHD8
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.4557970116773512,-1.0982839762778696,0.35074626865671643,1.0,1.0,2/10,0.64%,DPP6;DPP10
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.38988350198964683,1.0978776729893096,0.32660332541567694,0.8285999669152534,1.0,13/49,16.23%,BAG6;SQSTM1;HDAC6;PSMD4;OTUD7B;ZRANB1;PARP10;UBXN1;OPTN;TNIP1;IKBKE;ABRAXAS2;TNFAIP3
prerank,metal ion binding (GO:0046872),0.34418980550892436,1.0960358470362497,0.2042042042042042,0.8304453903080713,1.0,83/477,16.14%,SELP;CRACR2A;LTBP4;STK38L;CLEC4E;BRSK1;LPL;LCP1;ADAM8;RRAGC;PGM1;ARSA;IDH1;TPM4;ANXA11;NEK6;NUDT5;PLA2G4A;ABL2;MAP2K7;MT1F;MT1X;MT1M;MT1H;MT1G;MT1A;MT1E;MT1B;CALB1;HPGDS;APOE;ANXA3;EFHD2;SPARC;SNRK;HMGCL;GCA;SLC25A13;TRPM4;BRSK2;LRP1;FKBP9;ANXA6;RPH3A;MTHFD2;LATS1;PDXK;CEMIP2;SMOC2;PRNP;RASGRP3;ENDOV;ASPH;PPA2;XXYLT1;RHEB;MAN1C1;HSPA5;SCUBE1;TPD52;TRPM2;ANXA2;IDS;EYA2;CSGALNACT1;RP2;SRPK2;ADPRS;CDH12;ANXA7;MASP1;TDG;TKT;NT5C3A;CCDC47;CAMKK2;SYT1;DCHS1;CDH19;IDH2;FOXK2;MT2A;SDF4
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.4292943774893416,1.0948238691409746,0.36684782608695654,0.830185027560812,1.0,7/27,15.98%,ARIH2;SIAH2;UBE3D;DCUN1D1;RNF144A;RNF19B;ARIH1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3745164388043415,1.0946514969807861,0.33934611048478014,0.8267955994777669,1.0,24/74,20.76%,PI4KA;FAM20C;TKFC;XYLB;FAM20B;DGKZ;PIK3C3;DGKD;PDXK;GALK2;PI4KB;IPPK;PANK3;DGKQ;PGM2L1;NT5C3A;NMRK1;PIK3CG;DCAKD;PANK1;DGKH;DGKG;NOL9;PIK3CD
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.25839850529520003,-1.0945334938416835,0.21518987341772153,1.0,1.0,25/100,17.26%,PLEKHA5;FCHSD2;KIF16B;HIP1;DAPP1;WDR45B;SNX12;GOLPH3L;FERMT2;ZFYVE28;LAPTM4B;CLVS2;RUBCNL;SESTD1;ADAP2;GOLPH3;ZFYVE19;MYO1G;PLEKHN1;ATG2B;PARD3;ATG2A;TTPAL;SNX20;CYTH3
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4359930183551315,1.0937342325630126,0.3637602179836512,0.8258192839683048,1.0,5/26,12.89%,CHPF;B4GALNT1;GBGT1;B3GALNT2;CSGALNACT1
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4060112352708828,1.0936406968201955,0.36049382716049383,0.8222394267924925,1.0,9/42,13.54%,SAMSN1;PIK3R3;PIN1;PFN1;ABL2;PIK3R1;PTPN6;SH3BP2;CRK
prerank,voltage-gated cation channel activity (GO:0022843),-0.2530449135337261,-1.0936244165180644,0.25,1.0,1.0,25/97,19.71%,GRIN2B;CACNA1D;KCND2;ITGAV;GRIN3A;KCNB2;CACNA2D3;KCND3;CACNA1C;KCNC2;OPRM1;CACNA1B;KCNH7;KCNA6;CACNA1E;CACNG7;GRIN1;CACNB2;PKD2;CACNG3;HCN2;TPCN2;CACNG4;KCNC3;CACHD1
prerank,nuclear localization sequence binding (GO:0008139),0.4674514714991426,1.093097058368804,0.3646723646723647,0.8201639145340048,1.0,5/18,14.14%,IPO5;NUP153;TNPO2;KPNA2;IPO4
prerank,actin binding (GO:0003779),0.3490879643283014,1.0930899605274071,0.31794871794871793,0.8163895255278686,1.0,15/170,4.45%,TNNI2;MICAL1;MYRIP;MYH9;LCP1;CXCR4;LDB3;ADD1;MAP1S;LIMA1;FLII;HNRNPU;PFN1;BCL7B;ABL2
prerank,magnesium ion binding (GO:0000287),0.3557822941862925,1.0923506452626188,0.30987394957983194,0.8149873157844943,1.0,29/135,15.71%,STK38L;BRSK1;RRAGC;PGM1;IDH1;NEK6;NUDT5;ABL2;MAP2K7;HPGDS;SNRK;HMGCL;BRSK2;MTHFD2;LATS1;PDXK;ENDOV;PPA2;XXYLT1;RHEB;EYA2;RP2;SRPK2;ADPRS;TDG;TKT;NT5C3A;IDH2;FOXK2
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3896765828170336,1.0903074737701852,0.34530706836616454,0.8175775646982033,1.0,10/51,14.09%,SLC7A5;SLC22A4;SLC25A3;SLC20A2;ANKH;SLC35D2;TMEM241;SLC20A1;SLC35D1;SLCO5A1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.489563472293423,1.0896555806477897,0.3668639053254438,0.8156506710148868,1.0,3/15,6.09%,PIK3R3;SOCS6;PIK3R1
prerank,phosphotyrosine residue binding (GO:0001784),0.41005425709672155,1.0844906262837115,0.3727735368956743,0.8277390868749918,1.0,8/37,13.54%,SAMSN1;PIK3R3;PFN1;ABL2;PIK3R1;PTPN6;SH3BP2;CRK
prerank,carboxylic acid binding (GO:0031406),0.40427766013668226,1.0844862051119966,0.3504380475594493,0.8240025224804598,1.0,3/38,0.79%,SESN2;CASTOR1;SHMT2
prerank,metallocarboxypeptidase activity (GO:0004181),0.4261820015314494,1.0834505983549607,0.3575418994413408,0.8233650649723211,1.0,5/26,20.16%,CPXM1;FOLH1;CPA6;CPD;AGBL5
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.49996832468503544,1.0818524930276758,0.3790951638065523,0.8243360147612289,1.0,3/12,10.80%,SH2B2;PIK3R1;BLNK
prerank,nuclear export signal receptor activity (GO:0005049),-0.45076295836841296,-1.0808745001158173,0.36193029490616624,1.0,1.0,5/11,25.98%,NUP214;XPO7;NUP42;CSE1L;XPO5
prerank,miRNA binding (GO:0035198),0.42655155807060385,1.080468824396385,0.3931297709923664,0.82466445255627,1.0,13/30,17.58%,MATR3;TUT7;DDX21;PUM2;RC3H1;YBX1;SOX2;FMR1;RBM10;AGO3;HNRNPA1;ZC3H12A;ELAVL1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.3313060470848333,-1.0781175546807098,0.30268199233716475,1.0,1.0,10/28,23.30%,STAT1;TRAF5;BABAM2;TRAF6;TRAF2;RIPK1;CASP8AP2;TRAP1;MADD;MYD88
prerank,sterol binding (GO:0032934),0.3851148615617824,1.076832041461888,0.35924617196702,0.8317267144552267,1.0,16/56,15.37%,APOD;STARD3;VDAC2;GPR183;ANXA6;GRAMD1A;STARD5;OSBPL1A;SYP;OSBPL8;STARD3NL;SCARB2;SIDT1;OSBP2;RORA;OSBP
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.44604629358423487,-1.0763823145910234,0.4035532994923858,1.0,1.0,4/10,14.80%,CACNA1D;CACNA1C;CACNA1B;CACNB2
prerank,endopeptidase regulator activity (GO:0061135),0.40041698082318317,1.0761118359484705,0.3620689655172414,0.8300611878266475,1.0,5/40,14.16%,SERPINF2;UCHL5;PSME3;PROS1;CST7
prerank,endoribonuclease activity (GO:0004521),0.4094721339093145,1.0751430923553789,0.36666666666666664,0.8294455895472675,1.0,12/32,22.73%,NOB1;RIDA;YBEY;ENDOV;LACTB2;SND1;AGO3;ZC3H12A;TSNAX;AGO2;SMG6;INTS11
prerank,single-stranded DNA helicase activity (GO:0017116),0.45124107882188086,1.0745442770384743,0.3940677966101695,0.827546999355804,1.0,3/19,7.77%,WRNIP1;MCM2;DHX9
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.402683572759013,-1.0739041433492704,0.3626062322946176,1.0,1.0,6/14,17.84%,CTSH;BCL2L13;NOD1;CASP1;EBAG9;CASP8AP2
prerank,potassium:proton antiporter activity (GO:0015386),-0.45146252378915597,-1.0721786179349502,0.3844221105527638,1.0,1.0,2/10,7.73%,SLC9A9;SLC9A6
prerank,protein kinase C binding (GO:0005080),0.3981504633204598,1.0709993524940362,0.3737745098039216,0.834263797024895,1.0,7/43,11.09%,SQSTM1;PLEK;PRKD2;ADAM9;PRKCSH;HDAC5;NELL2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.49460444788401603,1.0684409586136459,0.38810641627543035,0.8384103837289918,1.0,2/12,11.60%,FDX1;ISCA1
prerank,androgen receptor binding (GO:0050681),0.4319238959961147,1.0681834198249758,0.3907103825136612,0.8355311806738149,1.0,13/25,22.88%,PRMT2;ARID5A;ZBTB7A;FOXP1;KDM1A;DDX5;WIPI1;PRKCB;CALR;PRPF6;PKN1;SMARCA4;RNF14
prerank,calcium ion transmembrane transporter activity (GO:0015085),-0.2836820964426633,-1.066429301852385,0.34306569343065696,1.0,1.0,20/55,25.58%,CACNA1D;PSEN1;PKD1;ITPR2;ATP2A2;SEC61A1;ORAI1;CUL5;TMCO1;ITPR1;GRIN1;CACNB2;PKD2;CHRNA7;ATP2B1;ATP2B3;TRPV4;TMEM165;ATP2C1;PANX1
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.3407942976233888,-1.0640147517518699,0.36,1.0,1.0,6/23,10.56%,PDE7B;PDE1C;PDE8B;PDE1A;PDE4A;PDE10A
prerank,nucleotidase activity (GO:0008252),-0.389808218340039,-1.0630298470041815,0.34782608695652173,0.9975150403208602,1.0,6/15,31.13%,BPNT2;NT5DC3;BPNT1;NT5C3B;NT5C;NT5E
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.37545069251215135,1.06143222781995,0.37139561707035756,0.8522392521981561,1.0,11/60,15.30%,PDGFRB;EPHA1;EPHA2;CRIM1;RYK;DDR2;EFEMP1;NRP2;EPHA3;ROR1;EPHA6
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.44001120371180996,1.0604063981449054,0.4053295932678822,0.8516577883695529,1.0,7/21,14.56%,AKAP5;ARFGEF2;ACBD3;AKAP6;AKAP9;AKAP8L;PRRC1
prerank,thyroid hormone receptor binding (GO:0046966),0.416345455773713,1.0599183390395213,0.3877284595300261,0.8496083430340026,1.0,10/28,15.66%,PRMT2;HMGN3;ARID5A;BRD8;NCOR1;NCOA3;TACC1;MED1;MED13;JMJD1C
prerank,cytokine receptor binding (GO:0005126),0.3565312754803534,1.0587791153458987,0.3840985442329227,0.849176358046915,1.0,9/83,10.68%,OSM;CSF1;ADAM17;IL34;SDCBP;VEGFC;PYCARD;IL27RA;IL18
prerank,TBP-class protein binding (GO:0017025),0.4378534251070534,1.05740227985217,0.418705035971223,0.8494492248616223,1.0,5/21,11.29%,DRAP1;GTF2A1;TAF1;TAF12;DR1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.33052230417996137,1.0551616591293667,0.352,0.852525112861534,1.0,95/431,17.99%,TUBA8;ABCB8;STK38L;AGAP2;PGK1;PFKM;HSPA4;MYH9;BRSK1;ADSS2;RRAGC;VPS4A;EIF2B2;BCKDK;MTHFD1L;HSP90AB1;HNRNPU;TLK1;SARS2;NEK6;RHOB;ARL6;TGFBR1;HSPA8;DNM2;RHOG;LONP1;SNRK;ACLY;MAP4K5;RHOU;RAB31;BRSK2;RALB;NRAS;DHX9;ATL3;ARL3;ANXA6;CDK6;MAP4K2;P2RY1;LATS1;PDXK;ACVR1B;TUBB;NVL;GCH1;GLUD1;RHOQ;RHEB;PRKAG1;GTPBP4;CDKL5;SYN3;HSPA5;MKNK1;STK17B;PANK3;RAB32;MLKL;PDK3;MAP4K3;RNF112;SRPK2;IDE;TUBB6;NDUFA13;TDG;TUBB2A;ARF4;OLA1;ARL8B;PNPLA8;MYH10;TUBD1;ARL1;PEAK1;MMAA;DAPK1;RAC1;MYO9B;DYNC1LI1;ATP1A3;MAST2;ATP5F1D;PPIP5K1;KRAS;TAP2;ACVR1;RAB7A;RANBP17;RAP1B;PPP5C;ARL5B
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.3797824112964287,-1.0551121755597683,0.37752161383285304,1.0,1.0,7/15,27.94%,PLEKHA5;RUBCNL;SESTD1;SH3PXD2B;SAP30L;LANCL2;PLA2G4E
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.5111574543247092,1.053004368971704,0.41971383147853736,0.8552213324984745,1.0,1/10,4.57%,SLC6A11
prerank,ribonuclease P activity (GO:0004526),0.4987576416436379,1.0528075766178429,0.40634920634920635,0.8522780322180017,1.0,3/11,11.52%,RPP38;RPP30;POP1
prerank,aminopeptidase activity (GO:0004177),-0.3287171589254399,-1.0523969406459457,0.3524590163934426,1.0,1.0,8/26,19.02%,LNPEP;METAP1D;XPNPEP3;CTSH;ANPEP;MMP16;LTA4H;XPNPEP1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3413848465895194,1.051864727186199,0.37460978147762747,0.8512686562312055,1.0,40/147,19.22%,EEF1B2;PSD;DIS3;RIC8A;DENND3;DENND4B;EIF2B2;ARFGEF2;KALRN;ALS2;RASGEF1B;RABGEF1;DENND2D;RASGRF1;ARHGEF4;ARHGEF6;FGD1;SERGEF;RCC1;DOCK10;RIC1;SH3BP5L;DOCK2;DOCK9;DENND1B;HERC2;DENND5A;RINL;SOS1;ARHGEF10;CCDC88A;RASGRP2;EIF2B3;ARHGEF2;DENND1A;TIAM1;ITSN1;RGL2;ELMO1;RAB3GAP1
prerank,P-type ion transporter activity (GO:0015662),-0.4079429754774966,-1.049348554160704,0.40431266846361186,1.0,1.0,7/12,40.02%,ATP2A2;ATP2B1;ATP2B3;ATP2C1;ATP7B;ATP7A;ATP2A3
prerank,protein phosphatase 1 binding (GO:0008157),0.43823517933409584,1.046511817939298,0.4211994421199442,0.8635007780968222,1.0,1/21,0.36%,PPP1R3E
prerank,N-methyltransferase activity (GO:0008170),-0.3578185609280932,-1.0462554399252253,0.37966101694915255,0.9973161977227204,1.0,7/20,22.87%,ZCCHC4;METTL15;TRMT1L;HNMT;DIMT1;N6AMT1;TRMO
prerank,peptide hormone receptor binding (GO:0051428),-0.4180462743962686,-1.0462483027056209,0.4052631578947368,0.9838675967429649,1.0,6/11,53.01%,PSMC5;ADCYAP1;CCK;PTHLH;GNRH1;VIP
prerank,microtubule motor activity (GO:0003777),-0.2757956742875486,-1.0459203386291533,0.3795180722891566,0.9716113837095193,1.0,15/51,19.07%,KIF16B;APPBP2;STARD9;SMC3;KIF3A;KIF21A;KIF26B;KIF21B;KIF6;KIF13A;KIF5C;DYNLRB1;KIFC3;KIF9;KIF24
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4913621900065854,1.0452225768993035,0.43452380952380953,0.8632909302890728,1.0,4/12,14.29%,ARSA;GALNS;IDS;SULF2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.48034532847946715,1.044476666298173,0.3891472868217054,0.8616482939379728,1.0,4/11,23.10%,DHRS13;AKR1B10;RDH11;AKR1A1
prerank,iron ion binding (GO:0005506),0.37285737306929273,1.0394394581146136,0.4133811230585424,0.8721625322660714,1.0,8/48,11.62%,FDX1;SCD5;CDO1;ACO2;EGLN2;TET2;TET1;FBXL5
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.36709857628001336,1.038011618418824,0.40232558139534885,0.8728790945451179,1.0,10/60,15.30%,PDGFRB;EPHA1;EPHA2;TGFBR2;RYK;ACVR1B;DDR2;EPHA3;ROR1;EPHA6
prerank,growth factor receptor binding (GO:0070851),0.34323436638330396,1.037674435852704,0.41721132897603486,0.8702224146345428,1.0,19/95,16.81%,PDGFRB;IL1R1;ADAM17;PDGFA;ITGB3;SDCBP;PDGFB;GLMN;VEGFC;PYCARD;IL27RA;EFEMP1;ARF4;IL6;PGF;ITGA5;FGF9;CCDC88A;ATXN2
prerank,amino acid transmembrane transporter activity (GO:0015171),0.37563709948114765,1.0351356668119365,0.42053789731051344,0.8736248489456252,1.0,6/47,10.85%,SLC7A5;SLC7A1;SLC22A4;SLC3A2;SLC6A6;SLC36A1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.41576589043749074,1.0349573919463726,0.44129554655870445,0.8705641189397169,1.0,7/24,16.55%,ITPKC;AK8;CMPK1;ITPKB;IP6K2;NME6;PPIP5K1
prerank,C-C chemokine receptor activity (GO:0016493),0.42508948944695757,1.0327441836554538,0.4343015214384509,0.8733047291325541,1.0,2/21,11.82%,CXCR4;CCR5
prerank,calcium:sodium antiporter activity (GO:0005432),-0.42761619747501844,-1.0325947246164293,0.39896373056994816,1.0,1.0,3/10,9.74%,SLC8B1;SLC8A3;SLC8A1
prerank,LRR domain binding (GO:0030275),0.46793753180323766,1.0313784850331718,0.43267776096822996,0.8736068035305018,1.0,5/14,18.07%,POLR2J;ATF4;ERC1;ZXDC;DDIT3
prerank,metal ion:proton antiporter activity (GO:0051139),-0.40310429840787404,-1.0312180720898558,0.39325842696629215,0.9948806443801537,1.0,3/13,9.29%,SLC9A9;SLC9A6;LETM1
prerank,metalloendopeptidase activity (GO:0004222),0.3530084930144312,1.0311919986238107,0.4406215316315205,0.8706568488808699,1.0,14/76,19.85%,ADAMTS1;ADAMTS12;ADAM17;ADAM9;ADAM19;ADAMTSL4;IDE;AFG3L2;TRABD2B;ADAMTS4;ADAMTS10;THSD4;MMP14;ADAMTS6
prerank,sterol transfer activity (GO:0120015),-0.3601672931725729,-1.0302778593559618,0.39805825242718446,0.98511512040462,1.0,3/17,5.20%,GRAMD1B;ABCA1;NPC2
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.42231761894232484,-1.0297766790967948,0.4092140921409214,0.9744430503968895,1.0,5/11,28.98%,SRRM2;EHMT2;MBD2;HMGA2;THAP7
prerank,transcription corepressor binding (GO:0001222),0.40725249128705815,1.0287602948931833,0.43967828418230565,0.8741493613098431,1.0,5/27,6.47%,CTBP2;HDGF;HDAC6;NEK6;ZBTB7A
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.41574017481798636,-1.0281838140715358,0.44173441734417346,0.9672703631010796,1.0,5/12,29.62%,B3GNT2;B3GALT5;B3GALT1;B3GALNT1;B3GALT2
prerank,voltage-gated calcium channel activity (GO:0005245),-0.29997135455829627,-1.0271489140928243,0.375,0.9589924762839386,1.0,14/37,19.71%,CACNA1D;ITGAV;CACNA2D3;CACNA1C;OPRM1;CACNA1B;CACNA1E;CACNG7;CACNB2;PKD2;CACNG3;TPCN2;CACNG4;CACHD1
prerank,tropomyosin binding (GO:0005523),-0.36832898942813624,-1.0257767055315077,0.4174454828660436,0.9516015222958903,1.0,3/16,13.50%,TMOD3;TMOD1;NEBL
prerank,protein phosphatase 2A binding (GO:0051721),-0.34294138938528673,-1.0251438368134096,0.40458015267175573,0.9417198529150952,1.0,5/23,8.03%,STRN;GRIN3A;SMG5;STRN3;BOD1L1
prerank,cysteine-type endopeptidase activity (GO:0004197),-0.25421227663139456,-1.0248025959645246,0.40963855421686746,0.9315561474835273,1.0,24/78,14.96%,USP33;USP24;USP14;PIGK;CASP8;CTSH;USP35;USP29;USP34;USP13;USP15;LGMN;CAPN2;USP30;CTSO;USP18;CASP7;CASP2;USP11;USP7;CASP1;CAPN3;USP42;USP10
prerank,actin monomer binding (GO:0003785),0.4261555407992941,1.0244812826833467,0.4275568181818182,0.8824366190586421,1.0,4/22,10.87%,LIMA1;PFN1;ABL2;TMSB4X
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.4078096553455961,-1.023827787196016,0.40161725067385445,0.9235767476764994,1.0,9/12,59.24%,ELOVL4;OPN3;GPR88;RRH;GPR52;OPN1MW3;OPN1MW;OPN5;OPN4
prerank,cadherin binding (GO:0045296),0.32209357598609173,1.0235872033802267,0.43661971830985913,0.8816301405051242,1.0,79/315,17.53%,PI4KA;MYH9;EPHA2;UBFD1;IDH1;ADD1;HNRNPK;LIMA1;NCK1;NUDC;HSP90AB1;TAGLN2;PICALM;PFN1;RPL15;NOP56;BAIAP2L1;HSPA8;RTN4;ASAP1;CTNND1;EFHD2;HDLBP;JUP;SLC3A2;CCT8;ZC3H15;UBAP2;PACSIN2;CD2AP;PSMB6;CEMIP2;EHD4;RPL23A;TRPC4;CTNNB1;RANGAP1;EPS15L1;RPL34;BAIAP2;BZW1;GIGYF2;HSPA5;PTPRO;MPRIP;ANXA2;EIF4G2;ARVCF;ERC1;GLOD4;DOCK9;CDH12;SCRIB;SCYL1;MRTFB;SND1;SPTAN1;USP8;COBLL1;OLA1;ABI1;FLNA;IST1;DBNL;STX5;USO1;DCHS1;CDH19;MICALL1;ARHGAP1;CLINT1;APC;PKP4;YWHAZ;CSNK1D;CTNNA2;ACVR1;TBC1D10A;NUMB
prerank,RNA polymerase core enzyme binding (GO:0043175),0.3938112295430539,1.020218377591827,0.45395590142671854,0.8876727124262686,1.0,9/33,17.70%,UVSSA;HNRNPU;DHX9;WDR43;RPRD1A;NCOA3;ELP2;RPRD1B;CTR9
prerank,hormone receptor binding (GO:0051427),-0.3790078760683395,-1.0199148974984913,0.4208955223880597,0.9253340027843074,1.0,3/14,2.93%,JAK2;TYK2;NCOA6
prerank,ribosomal small subunit binding (GO:0043024),-0.35973184243900713,-1.0194509632040665,0.3987341772151899,0.916025853609015,1.0,7/17,20.73%,PTCD3;MTIF2;LARP1;CPEB2;EIF4B;EIF1B;MTIF3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.45050223862017225,1.0167038162118966,0.43536404160475484,0.8940773424928073,1.0,1/15,4.37%,PLA2G4A
prerank,sodium:proton antiporter activity (GO:0015385),-0.4149409405027491,-1.016273357410885,0.4348958333333333,0.9149263984298333,1.0,2/11,7.73%,SLC9A9;SLC9A6
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.33655870177192415,-1.0156449128057439,0.39144736842105265,0.9067184174835431,1.0,8/19,31.64%,GAS6;GRM5;PAK2;ERCC6;EFNA5;ERBB3;AFAP1L2;CD24
prerank,insulin-like growth factor receptor binding (GO:0005159),0.46373307276563935,1.0149541190495563,0.4765625,0.8956695929396036,1.0,4/12,12.34%,GNAS;PIK3R1;ARRB1;IGF1
prerank,snRNA binding (GO:0017069),0.37020640246774805,1.0145025983708367,0.4652014652014652,0.8934504421443539,1.0,13/42,18.71%,PRPF31;HNRNPU;LARP7;SNRPA1;SNRPA;DDX21;TUT1;SART3;CCNT1;PRPF4;SF3B3;SNRNP70;CDK9
prerank,MHC class I protein binding (GO:0042288),0.46837184263969855,1.014358225572886,0.4582043343653251,0.89037132626151,1.0,4/13,17.33%,PILRA;TUBB;DERL1;TAP2
prerank,nucleosomal DNA binding (GO:0031492),0.4225168932076895,1.013567227067703,0.46534653465346537,0.8891838659219554,1.0,8/21,15.46%,SMARCC1;ACTL6A;SMARCD2;CHD4;HDAC1;RCC1;SMARCB1;ACTB
prerank,hyaluronic acid binding (GO:0005540),0.49025484840338074,1.0133628934355077,0.46021840873634945,0.8863097639587417,1.0,1/10,1.92%,C1QBP
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.37978564427590794,1.011233338282471,0.450063211125158,0.8886898497143222,1.0,8/34,17.83%,KMT5B;KMT5A;DOT1L;SMYD3;SETDB1;SETD7;EEF1AKMT1;EZH2
prerank,thioesterase binding (GO:0031996),-0.4089331841118965,-1.0091629099416795,0.4418604651162791,0.9163689892051031,1.0,3/11,7.28%,TRAF5;TRAF6;TRAF2
prerank,GTPase binding (GO:0051020),0.32159413084242877,1.0088877770177915,0.48981670061099797,0.8917592267946715,1.0,54/195,15.99%,TRIOBP;LCP1;RRAGC;ATG16L1;CHML;PPP6R1;PICALM;ABI2;RIMS1;IARS1;ALS2;RABGEF1;USP6NL;TMEM127;RABGAP1;GGA1;NCKAP1;SGSM2;GNB2;TRIP11;MYO1C;EXOC5;SORL1;CYRIB;CYFIP1;TBC1D30;FGD1;RANGAP1;RCC1;YBX1;GOLGA4;ATP6AP1;CDKL5;GNB1;RIC1;CHM;ERC1;SRGAP2;EVI5L;RABGGTB;YBX3;OCRL;OPTN;AP1G1;GOLGA5;WHAMM;TBC1D7;FLNA;RUSC2;RALBP1;KIF3B;RAF1;MICALL1;MYO9B
prerank,tRNA binding (GO:0000049),0.36783021285350237,1.0076934565729614,0.4703748488512696,0.8917268752281187,1.0,13/43,19.15%,KARS1;SARS1;SARS2;PTCD1;YRDC;TRMT10A;TRMT10B;PSTK;MRPS27;TYW5;NSUN6;EEF1A1;FARS2
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.4385006635704244,1.0067218957165507,0.4692982456140351,0.8909483756581968,1.0,5/16,16.67%,OARD1;NEIL2;ADPRS;TDG;NEIL3
prerank,actinin binding (GO:0042805),-0.33389548214792536,-1.0066175712084553,0.41836734693877553,0.9142421464698207,1.0,5/21,9.05%,CACNA1D;KCNN2;CACNA1C;PDLIM5;PPARG
prerank,potassium ion antiporter activity (GO:0022821),-0.36888583191070673,-1.004836808622496,0.4585635359116022,0.9095003626744037,1.0,2/15,7.73%,SLC9A9;SLC9A6
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.47686318297363944,1.0013983377246636,0.4782608695652174,0.9020731083572784,1.0,1/11,2.89%,SLC22A4
prerank,I-SMAD binding (GO:0070411),0.45029156422573746,1.00065669160909,0.471608832807571,0.9007702677207692,1.0,3/13,9.75%,TGFBR1;SMURF1;CTNNB1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.3825753791201426,1.0001570439408274,0.4755784061696658,0.898717190853651,1.0,6/30,14.69%,SLC39A14;SLC39A3;SLC39A8;SLC31A1;SLC30A5;SLC11A1
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.4062146892655368,-0.9980391108908614,0.4444444444444444,0.9196074582924436,1.0,7/11,59.39%,CHRNA7;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNA9;CHRNB4
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.3721494400207416,-0.9952637940976652,0.4476744186046512,0.9178861211450526,1.0,5/14,28.15%,CAPN2;CAPN3;CAPN1;CAPN10;CAPN5
prerank,microtubule plus-end binding (GO:0051010),0.42016655194718455,0.9938186737572277,0.4884393063583815,0.9126119488077605,1.0,8/20,19.61%,CLIP3;FBXW11;CLIP2;PAFAH1B1;APC;DCTN1;TTBK2;MAPRE3
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.404877647169004,-0.9933238385217373,0.4726775956284153,0.9139027942771552,1.0,4/11,24.90%,RASA3;ITPR1;ITPR3;RYR3
prerank,chloride channel activity (GO:0005254),0.34598219102617384,0.9929035981796694,0.48702830188679247,0.9116472098958079,1.0,6/59,8.48%,CLCN2;TTYH2;TTYH3;GABRB2;CLIC4;CLCN6
prerank,nuclear import signal receptor activity (GO:0061608),0.4383524594454673,0.9924925131611962,0.47583081570996977,0.9093490927497172,1.0,4/15,14.14%,IPO5;TNPO2;KPNA2;IPO4
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.3349554557653446,-0.9908838332411086,0.47151898734177217,0.9114708047105006,1.0,7/20,18.37%,DLG2;TJP2;MAGI3;DLG1;CASK;AK6;AK3
prerank,metalloaminopeptidase activity (GO:0070006),-0.35576549472331925,-0.9901832794580627,0.44966442953020136,0.9041939236971762,1.0,6/16,19.02%,LNPEP;XPNPEP3;ANPEP;MMP16;LTA4H;XPNPEP1
prerank,manganese ion binding (GO:0030145),0.3547630513160629,0.9881449796700051,0.49939686369119424,0.9177812310860854,1.0,9/48,10.51%,FAM20C;ATP13A2;ABL2;HMGCL;MGAT5;POMGNT1;MGAT5B;GALNT1;XXYLT1
prerank,proton transmembrane transporter activity (GO:0015078),-0.2793874562303148,-0.9877654391024169,0.5172413793103449,0.9023107888886664,1.0,17/39,27.90%,CLCN5;CTNS;UQCRH;COX8A;NDUFA4;COX4I1;DMAC2L;COX6A1;COX15;SLC33A1;ATP6V1F;CLCN3;UQCRQ;NNT;SLC11A2;UQCR10;COX5B
prerank,serine-type peptidase activity (GO:0008236),0.3331698293467889,0.985808238695569,0.5016146393972013,0.9207750842158606,1.0,14/96,17.28%,RHBDF2;PRSS36;TPP1;MBTPS1;FURIN;F3;PCSK1;PIK3IP1;HPN;PRSS8;MASP1;HGF;PROC;HTRA2
prerank,MAP kinase activity (GO:0004707),0.44242872062976807,0.9857567482995605,0.4936708860759494,0.917539668669306,1.0,3/14,9.32%,MAPK6;MAPK10;MAPK8
prerank,leucine zipper domain binding (GO:0043522),0.480520493725834,0.9846766113816863,0.5103011093502378,0.916813114812237,1.0,3/10,18.07%,ATF4;ERC1;DDIT3
prerank,exoribonuclease activity (GO:0004532),0.4565382369951491,0.9845210306078142,0.48717948717948717,0.9139277008981733,1.0,5/12,17.55%,CNOT6;EXOSC8;EXOSC10;CNOT7;ZC3H12A
prerank,galactosyltransferase activity (GO:0008378),-0.3997617229165572,-0.9821290184142053,0.4786096256684492,0.9093192969934872,1.0,4/11,14.52%,B4GALT6;B4GALT1;B4GALT4;B4GALT3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.44450687147805085,0.9812361704235386,0.48439821693907875,0.9192747814033388,1.0,3/14,11.52%,RPP38;RPP30;POP1
prerank,snoRNA binding (GO:0030515),0.38207882475072746,0.9808176944743501,0.5013297872340425,0.9169648265393149,1.0,5/30,8.47%,NOP14;NUDT5;NOP56;XRCC5;DDX21
prerank,fibroblast growth factor binding (GO:0017134),0.40591910479514526,0.9800895036969248,0.4889196675900277,0.9155453203932638,1.0,3/21,6.66%,FIBP;ITGB3;GLG1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.3540480675822634,0.9800637232763344,0.5171232876712328,0.9123384628245408,1.0,11/54,12.63%,AMDHD2;HDAC6;HINT3;GLS2;GLS;SIRT1;HDAC1;SIRT5;HDAC5;SIRT2;MIER1
prerank,calcium ion binding (GO:0005509),0.3101330018467594,0.9788056856819499,0.5740181268882175,0.9124439098740175,1.0,53/323,18.39%,SELP;CRACR2A;LTBP4;CLEC4E;LPL;LCP1;ADAM8;ARSA;TPM4;ANXA11;PLA2G4A;CALB1;HPGDS;ANXA3;EFHD2;SPARC;GCA;SLC25A13;TRPM4;LRP1;FKBP9;ANXA6;RPH3A;CEMIP2;SMOC2;PRNP;RASGRP3;ASPH;MAN1C1;HSPA5;SCUBE1;TPD52;TRPM2;ANXA2;IDS;CDH12;ANXA7;MASP1;TKT;CCDC47;CAMKK2;SYT1;DCHS1;CDH19;SDF4;GLCE;RASGRP2;SYT4;CALR;PDCD6;ITSN1;CDH13;HSP90B1
prerank,1-phosphatidylinositol binding (GO:0005545),0.43102782255100636,0.9784830710206018,0.4918518518518519,0.9100763586348479,1.0,4/15,11.69%,PICALM;WDFY3;WDFY1;ZFYVE16
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.3862269062629642,-0.9776902704680166,0.4823848238482385,0.9124357212953877,1.0,5/12,17.84%,CTSH;BCL2L13;NOD1;CASP1;CASP8AP2
prerank,water transmembrane transporter activity (GO:0005372),-0.39196484620213434,-0.9772938398219883,0.5027777777777778,0.9045874911338042,1.0,6/11,60.81%,PDPN;AQP11;AQP4;AQP1;SLC5A1;SLC4A11
prerank,alkali metal ion binding (GO:0031420),-0.3767508238000181,-0.9772558210004494,0.4880952380952381,0.8958021127980142,1.0,5/13,16.40%,DRG1;ATP1A2;IMPA1;CAPN3;ADPRH
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.44938897620406687,0.9759695411782675,0.5307443365695793,0.9134829665161305,1.0,8/12,23.15%,NCBP3;CYFIP1;NCBP1;EIF4E2;EIF4E;AGO2;CYFIP2;NCBP2
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3103329353598888,0.9757097536468956,0.5540950455005056,0.9109422478205655,1.0,49/232,16.21%,EGR2;TRIM69;ARIH2;RNF7;UBR4;CUL3;SIAH2;RNF115;UBE3D;RNFT2;UBE3A;TRIM56;SMURF1;UBE2D1;UBR1;PELI3;UBE2D3;RNF25;RNF24;COP1;RNF38;DTX3;RC3H1;TRIM17;RNF167;UFL1;RFWD3;RC3H2;CBX4;MYLIP;RNF43;MEX3C;RNF144A;RNF19B;RNF112;RNF215;PDZRN3;STUB1;ZNRF3;HERC2;NSMCE1;GID4;NEURL3;NEURL1B;ARIH1;VPS18;IRF2BPL;LTN1;RNF34
prerank,E-box binding (GO:0070888),0.36530715584724877,0.9756861222615756,0.5006369426751592,0.9078146734662275,1.0,1/34,0.09%,MYC
prerank,telomeric DNA binding (GO:0042162),0.3709326820273329,0.973966999802817,0.5134099616858238,0.9090433728752351,1.0,8/32,13.47%,HNRNPD;ACD;ZBTB48;XRCC5;SMG7;STN1;KDM1A;HMBOX1
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.34922141702258963,0.9733726873428327,0.5096385542168674,0.9073532705497519,1.0,12/53,19.13%,SLC7A5;SLC7A1;SLC3A2;SLC25A13;SLC1A3;SLC36A1;SLC1A1;SLC38A1;SLC36A4;SLC15A4;SLC17A6;SLC6A9
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3915162239775865,0.9730871324081088,0.5216178521617852,0.9049269219724428,1.0,9/22,20.76%,SQSTM1;OTUD7B;ZRANB1;PARP10;OPTN;IKBKE;TNFAIP3;ZBTB1;RNF169
prerank,exopeptidase activity (GO:0008238),-0.2608739930412541,-0.9723098462743308,0.5256410256410257,0.9008420591289766,1.0,14/50,21.32%,DPP6;DPP10;LNPEP;METAP1D;XPNPEP3;CTSH;ANPEP;MME;CPM;LTA4H;XPNPEP1;GGH;DPP8;DPEP3
prerank,nuclear receptor coactivator activity (GO:0030374),-0.25398250020129015,-0.9713058763026207,0.5031446540880503,0.8950030195515967,1.0,21/52,22.16%,NCOA2;NCOA7;NCOA6;PPARGC1B;CARM1;ACTN1;PPARGC1A;USP22;CNOT9;ATXN7L3;DCAF6;CALCOCO1;CCAR2;MED30;BUD31;FGF2;SFR1;WDR77;HELZ2;ZMIZ2;MED12
prerank,ATPase activator activity (GO:0001671),0.40066398266482073,0.9711618012844271,0.5197183098591549,0.9067966090741569,1.0,7/20,13.53%,DNAJC19;DNAJC1;DNAJA1;ATP1B1;DNAJA2;DNAJB2;DNAJC15
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.38105130065583237,0.9691812484855009,0.5129251700680272,0.9085487310472622,1.0,4/28,4.92%,MAPK10;MAP2K3;MAP2K7;MAP2K1
prerank,protein phosphatase activator activity (GO:0072542),-0.3720701839883035,-0.9666385818182325,0.5044510385756676,0.899116781157998,1.0,6/13,16.55%,PHACTR4;CALM2;CALM1;B3GAT3;PPP2R5E;CALM3
prerank,protein kinase binding (GO:0019901),0.30108619178959983,0.9655676652132058,0.618,0.9143872254164489,1.0,67/480,11.47%,RELB;MAPKAPK2;AGAP2;STAT3;PDGFRB;EPHA1;DUSP5;BCL2L1;SQSTM1;LLGL1;PLEK;ZFP36;CTBP2;PEBP1;PRKD2;DUSP16;WARS1;FZD5;RICTOR;PIN1;SOX9;DUSP19;MAP2K3;IKBKB;ATF4;ADAM9;RELA;NEK6;SIRPA;MAP2K7;RHOB;CSPG4;STK11IP;RHOG;ADIPOR1;PRKCSH;PPP1CB;TRIB2;GYS1;TPRKB;MAP4K2;TCF7L2;LATS1;CCNK;SIRT1;AP2A1;ERCC6L2;UNC5C;PTPRC;CNKSR2;PTPRR;GCH1;MSN;TOM1L1;CLTC;FBXW5;HDAC5;BLNK;CASP9;SPAG9;PRKAG1;PTPN6;NELL2;TAOK2;UFL1;BAD;MAML1
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.40773756877172307,-0.9655229182327163,0.5128205128205128,0.8937941377969523,1.0,6/10,25.63%,USP15;DNAJC2;FAN1;FAAP20;ANKRD13D;ANKRD13B
prerank,hexosyltransferase activity (GO:0016758),-0.22501538287790376,-0.9651401494728291,0.5131578947368421,0.8866592682949199,1.0,24/101,15.32%,GCNT1;FUT9;CHSY1;B4GALT6;TMTC1;HEXA;B3GLCT;CHSY3;DPY19L1;PIGV;ALG6;PIGB;B3GNT2;B3GAT3;B4GALT1;CHPF2;ALG5;MGAT4B;CSGALNACT2;B4GALT4;POMT2;B4GALT3;POGLUT1;TMTC4
prerank,serine-type endopeptidase activity (GO:0004252),0.3322341283575998,0.9650289407614994,0.5494028230184582,0.9124965013617135,1.0,12/80,17.28%,RHBDF2;PRSS36;MBTPS1;FURIN;F3;PCSK1;PIK3IP1;HPN;MASP1;HGF;PROC;HTRA2
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.3954174513496548,-0.963018311230634,0.48314606741573035,0.8840333660451424,1.0,7/11,60.47%,HCN2;HCN4;CNGB3;AQP1;HCN1;CNGB1;CNGA3
prerank,CARD domain binding (GO:0050700),0.4322015855287641,0.9626685600539926,0.5221374045801527,0.915203775419398,1.0,4/14,10.16%,CASP4;CARD9;RIPK2;CARD16
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3382709680270162,0.9601864629274429,0.5272305909617613,0.9182656527769346,1.0,14/60,13.25%,CTDSP2;PPP1CB;CAMK2G;MTMR3;PHLPP1;CTDNEP1;PPM1F;RPAP2;CTDP1;LRRC39;PPM1G;CTDSP1;PPM1H;PPP2CB
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),-0.22878424910116452,-0.960130067979594,0.589041095890411,0.8839934816468744,1.0,23/91,16.39%,PLEKHA5;KIF16B;HIP1;WDR45B;FCHO2;GSN;SVIL;TWF2;LAPTM4B;EXOC1;CLVS2;CAPG;SESTD1;ADAP2;SNX18;LDLRAP1;MYO1G;RAB35;PARD3;SYT7;TTPAL;MARK1;SNX20
prerank,ion channel activity (GO:0005216),-0.23486873646528034,-0.9595153284354289,0.49473684210526314,0.8776625925595504,1.0,18/80,18.86%,GRIA3;GRIN2B;NALCN;UNC80;GRIN3A;GRIK4;PIEZO2;GRIA1;TMEM63B;PIEZO1;MCUB;GRIN1;TMEM120B;PKD2;CHRNA7;CALHM2;TMEM63A;GRIK3
prerank,copper ion binding (GO:0005507),0.352349572330777,0.9589204512818047,0.5380894800483675,0.9183460033903265,1.0,6/42,12.67%,RNF7;ATP13A2;IL1A;PRNP;SUMF1;CUTC
prerank,small GTPase binding (GO:0031267),0.3070005599316061,0.9588920687013406,0.5853909465020576,0.9152997196738358,1.0,50/170,17.30%,TRIOBP;CHML;PPP6R1;PICALM;ABI2;RIMS1;ALS2;RABGEF1;USP6NL;TMEM127;RABGAP1;GGA1;NCKAP1;SGSM2;TRIP11;MYO1C;EXOC5;SORL1;CYRIB;CYFIP1;TBC1D30;FGD1;RANGAP1;RCC1;GOLGA4;ATP6AP1;CDKL5;RIC1;CHM;ERC1;SRGAP2;EVI5L;RABGGTB;YBX3;OCRL;OPTN;AP1G1;GOLGA5;WHAMM;TBC1D7;FLNA;RUSC2;RALBP1;KIF3B;RAF1;MICALL1;MYO9B;ARHGAP1;ARHGEF2;UNC13B
prerank,AMP binding (GO:0016208),0.450095096514904,0.958022188701083,0.5321543408360129,0.9142949463425397,1.0,2/11,10.95%,PFKM;PRKAG1
prerank,H4 histone acetyltransferase activity (GO:0010485),-0.38824749605547426,-0.9558452907688738,0.5070821529745042,0.8795713868922896,1.0,6/10,19.19%,HAT1;EP300;USP22;KAT8;BRCA2;NAA40
prerank,amino acid binding (GO:0016597),0.36517415293444805,0.9545950987832672,0.5524296675191815,0.919309988437407,1.0,3/31,6.65%,CASTOR1;SHMT2;AGXT
prerank,mannose binding (GO:0005537),0.43587988420098794,0.9544076633301265,0.5190839694656488,0.9166218044804996,1.0,1/12,2.63%,CLN5
prerank,PDZ domain binding (GO:0030165),0.3325831502849992,0.954008457607963,0.544405997693195,0.9145749516425286,1.0,10/61,12.45%,ADAM17;CXADR;KIDINS220;SLC22A4;CADM1;CRIM1;TMEM88B;SNTG2;NSF;ERC1
prerank,methylation-dependent protein binding (GO:0140034),-0.2402478292454733,-0.9522858651797498,0.5517241379310345,0.8812568344315155,1.0,17/57,17.21%,CHD8;ZMYND8;NCAPD3;BPTF;SUZ12;ING2;PHF8;ING3;WDR5;NCAPG2;TRIM24;ZMYND11;KDM7A;ZCWPW1;KAT8;KDM4A;SGF29
prerank,acetyltransferase activity (GO:0016407),-0.28453168486141567,-0.9516349969756671,0.5345622119815668,0.8750619642717569,1.0,11/31,16.70%,SAT1;SMARCE1;ESCO1;EP300;NAA15;GTF2B;PAFAH1B2;DBT;KAT2B;NAA16;KAT8
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.2860336646116668,-0.951082245600291,0.5219512195121951,0.8689664790041837,1.0,15/32,23.62%,ALKBH1;KDM4C;PHYHD1;KDM4B;ALKBH3;PHF8;EGLN1;PHYH;RIOX2;KDM7A;HSPBAP1;KDM4A;HIF1AN;ALKBH2;P4HTM
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.42429942470916804,0.9508912337659853,0.5397301349325337,0.9190315988042006,1.0,4/15,10.71%,AGPAT4;ABHD8;GPAT4;LPCAT1
prerank,calcium activated cation channel activity (GO:0005227),0.41046770055258475,0.9506412001853888,0.5415430267062314,0.9166304253401438,1.0,5/17,13.65%,TRPM4;KCNMB2;KCNMB3;ANO10;KCNMA1
prerank,mechanosensitive ion channel activity (GO:0008381),0.44696080956340234,0.9499443641302846,0.5422647527910686,0.9152695215881367,1.0,1/12,0.93%,TMC8
prerank,anion transmembrane transporter activity (GO:0008509),0.43158114464715785,0.9489636125393752,0.537842190016103,0.9146229657138897,1.0,3/12,6.62%,ABCC5;SLC4A2;SLC39A8
prerank,mRNA 5'-UTR binding (GO:0048027),0.3814054461243456,0.9488530142434141,0.5527027027027027,0.9118585624900575,1.0,5/24,15.50%,SHMT2;LARP6;RPS14;FMR1;MYH10
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.3977483927027693,-0.9482973293776993,0.5081967213114754,0.8685712335196484,1.0,7/10,33.22%,SETD5;ASH1L;EHMT2;SUV39H1;EHMT1;MECOM;SUV39H2
prerank,GTP binding (GO:0005525),0.3048443609742242,0.9482559797436767,0.6016597510373444,0.9102866006856896,1.0,44/172,19.52%,TUBA8;AGAP2;ADSS2;RRAGC;EIF2B2;RHOB;ARL6;DNM2;RHOG;RHOU;RAB31;RALB;NRAS;ATL3;ARL3;ANXA6;TUBB;GCH1;GLUD1;RHOQ;RHEB;GTPBP4;RAB32;RNF112;TUBB6;TUBB2A;ARF4;ARL8B;TUBD1;ARL1;MMAA;RAC1;DYNC1LI1;KRAS;RAB7A;RANBP17;RAP1B;ARL5B;DRG2;EEF1A1;RAN;ARL5C;RAP2B;TUBB4A
prerank,thiol-dependent deubiquitinase (GO:0004843),0.32227910435249735,0.9479032095710684,0.564185544768069,0.908208179966831,1.0,23/83,17.55%,UCHL5;USP2;USP32;OTUD3;UCHL1;TANK;USP5;USP3;OTUD7B;USP19;ZRANB1;USP25;USP21;JOSD1;USP8;MYSM1;OTUD4;OTUB1;TNFAIP3;USP40;OTULIN;MPND;ZC3H12A
prerank,adenylate cyclase binding (GO:0008179),0.4516128792744615,0.9478954507251763,0.5414781297134238,0.9052721687051428,1.0,4/10,13.86%,AKAP5;ADCY5;AKAP6;CAP1
prerank,endopeptidase activity (GO:0004175),0.30338697752119553,0.9442901530471423,0.6368209255533199,0.9108603818760757,1.0,41/257,17.28%,NAPSA;ADAMTS1;ADAMTS12;CTSB;ADAM17;CTSL;RHBDF2;USP2;PRSS36;TPP1;MBTPS1;ADAM9;UCHL1;USP5;CASP4;ADAM19;PSMB6;FURIN;F3;PCSK1;PIK3IP1;USP25;PSMB1;CASP9;HPN;ADAMTSL4;PSMA2;PSMB10;IDE;MASP1;USP8;ATG4B;AFG3L2;HGF;TRABD2B;PSMB3;TPP2;USP40;PROC;ADAMTS4;HTRA2
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.2767282986867968,-0.9440743410907007,0.5342465753424658,0.8716639030828061,1.0,11/34,16.55%,CCNT2;CAB39;STK3;CALM2;MAP2K2;CALM1;IRGM;CAB39L;DBF4;INCENP;CALM3
prerank,deubiquitinase activity (GO:0101005),0.3175469333221435,0.9423285831091565,0.5897435897435898,0.912508465244755,1.0,24/88,17.55%,UCHL5;USP2;USP32;OTUD3;UCHL1;TANK;USP5;USP3;OTUD7B;USP19;ZRANB1;USP25;USP21;JOSD1;USP8;MYSM1;EIF3H;OTUD4;OTUB1;TNFAIP3;USP40;OTULIN;MPND;ZC3H12A
prerank,exonuclease activity (GO:0004527),-0.26481244867173204,-0.9408119313911378,0.5964912280701754,0.8725024533856722,1.0,21/46,27.80%,CPSF3;ENPP1;MRE11;APEX2;DCLRE1C;REXO1;FAN1;REXO5;ISG20L2;EXOSC1;EXOG;AEN;WRN;EXOSC9;EXOSC5;DCLRE1B;APLF;RAD9A;ERI1;RAD50;EXOSC3
prerank,histone methyltransferase activity (GO:0042054),0.36075656198036365,0.9395454293691065,0.5723431498079385,0.9162145025532024,1.0,7/32,13.93%,PRMT2;KMT5B;KMT5A;DOT1L;SMYD3;SETDB1;SETD7
prerank,RNA methyltransferase activity (GO:0008173),-0.31087988789246224,-0.938551980961797,0.5180327868852459,0.8706412068994195,1.0,14/19,36.14%,TRDMT1;METTL4;FTSJ1;MEPCE;FTSJ3;FBL;METTL8;TRMT12;LCMT2;TRMT9B;TRMT5;BCDIN3D;TYW3;MRM2
prerank,insulin-like growth factor binding (GO:0005520),-0.34937978003143355,-0.9375044725172521,0.5380281690140845,0.8658899398817427,1.0,10/15,38.07%,ITGAV;INSR;IGF2R;IGFBP5;ITGA6;IGFBP2;IGFBP4;ITGB4;IGFBP6;IGFBP3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.35583740091256777,0.9373958921667553,0.5629820051413882,0.9153310667237291,1.0,8/34,16.49%,NDUFS6;NDUFB10;NDUFB4;NDUFA10;NDUFA3;NDUFA13;NDUFA5;NDUFV2
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.35583740091256777,0.9373958921667553,0.5629820051413882,0.9153310667237291,1.0,8/34,16.49%,NDUFS6;NDUFB10;NDUFB4;NDUFA10;NDUFA3;NDUFA13;NDUFA5;NDUFV2
prerank,ribosomal large subunit binding (GO:0043023),0.44207700858642307,0.9369913053306623,0.552870090634441,0.9133733486685764,1.0,3/11,9.06%,MALSU1;EIF6;CPSF6
prerank,lipoprotein particle binding (GO:0071813),0.3955688107109965,0.9365659097521608,0.5541490857946554,0.9114746880856015,1.0,3/20,8.32%,LPL;COLEC12;SORL1
prerank,cell adhesion mediator activity (GO:0098631),0.3786673178218345,0.9353128734937021,0.5622377622377622,0.9113790721661575,1.0,7/24,17.35%,BCAM;NINJ1;SIRPA;DSCAM;NPTN;CNTN4;PALLD
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.3291557776557116,0.9343089106944301,0.5812064965197216,0.9108917705872228,1.0,11/57,14.37%,NDUFS6;COX5A;NDUFB10;UQCRC1;NDUFB4;COX7A2L;NDUFA10;NDUFA3;UQCRFS1;NDUFA13;NDUFA5
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.30357570398341926,-0.933916977940792,0.5068027210884354,0.8678596663395486,1.0,5/24,10.55%,PLEKHA5;GOLPH3L;RUBCNL;SESTD1;GOLPH3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3373593569007156,0.932568358239851,0.5811764705882353,0.9119563591263361,1.0,10/49,17.60%,CPNE9;PLA2G4A;CPNE8;ANXA3;ANXA6;RPH3A;ANXA2;SYT1;CPNE3;SYT4
prerank,GDP binding (GO:0019003),-0.24284998780913303,-0.9306244164932767,0.5966386554621849,0.8693939123593866,1.0,18/63,14.31%,RAB22A;RAB5A;RAB27A;RAB5B;RAB28;MRAS;RALA;RIT2;RAP2C;RRAGD;RIT1;RAB9A;RRAS2;RAB35;RAB27B;RAB11B;GNAI1;RAB8A
prerank,guanyl ribonucleotide binding (GO:0032561),0.29561706679174143,0.9288448784470609,0.6663244353182751,0.9173637872410872,1.0,47/196,19.52%,TUBA8;AGAP2;ADSS2;RRAGC;EIF2B2;RAB18;RHOB;ARL6;RAB8B;DNM2;RHOG;RHOU;RAB31;RALB;NRAS;ATL3;ARL3;ANXA6;TUBB;GCH1;GLUD1;RHOQ;RHEB;GTPBP4;RAB32;RNF112;TUBB6;TUBB2A;ARF4;ARL8B;TUBD1;ARL1;MMAA;RAC1;DYNC1LI1;KRAS;RAB7A;RANBP17;RAP1B;ARL5B;DRG2;EEF1A1;RAN;PDE11A;ARL5C;RAP2B;TUBB4A
prerank,microtubule binding (GO:0008017),0.29195955106148597,0.9287929289851948,0.6476578411405295,0.9146255424976837,1.0,43/222,17.01%,KIF19;REEP2;NDEL1;CLIP3;MAP1S;FMN1;FGF13;FBXW11;HDAC6;KRIT1;DNM2;UXT;MAP4;CLIP2;FNTA;KIF5A;MAP1LC3A;MDM1;ARL3;POLB;CCDC61;MAP1LC3B;TUBGCP5;HAUS8;TUBGCP6;PRNP;SUN2;DLGAP5;MID1;EML4;PAFAH1B1;HOOK2;SNPH;FMR1;WHAMM;TUBGCP4;ABRAXAS2;KIF3B;MAP1A;MAST2;CCDC88A;APC;ARHGEF2
prerank,tubulin binding (GO:0015631),0.2899517453371914,0.9277720298563035,0.6905241935483871,0.9140365868534822,1.0,39/296,10.55%,KIF19;BRSK1;REEP2;NDEL1;PHF6;CLIP3;GABARAP;MAP1S;FMN1;EFHC1;FGF13;GABARAPL1;EFHC2;HDAC6;KRIT1;DNM2;UXT;MAP4;CLIP2;RABGAP1;FNTA;KIF5A;MAP1LC3A;TRAPPC14;BBS4;MDM1;ARL3;POLB;CCDC61;MAP1LC3B;TUBGCP5;HAUS8;UNC5C;TUBGCP6;PRNP;SUN2;TBCE;DLGAP5;MID1
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",-0.26480969983205965,-0.9245625259615824,0.5630630630630631,0.8765498157949775,1.0,22/35,35.49%,ALKBH1;TRIT1;PUS10;DTWD2;TRDMT1;DUS2;TARS2;QTRT2;QRSL1;FTSJ1;GATC;DUS3L;DUS1L;TRMT12;LCMT2;ELAC2;TRMT9B;TRMT5;BCDIN3D;DTWD1;MRPL58;TYW3
prerank,glucuronosyltransferase activity (GO:0015020),0.39074923185595545,0.9203503896036821,0.5809128630705395,0.9276037541490908,1.0,4/19,18.91%,CHPF;CSGALNACT1;B3GAT1;EXT2
prerank,heme binding (GO:0020037),0.3238721351176587,0.9185476943064061,0.6130483689538808,0.9284515790953206,1.0,16/65,22.91%,PTGES2;CYB561D1;EIF2AK1;CYBB;DGCR8;TBXAS1;PGRMC1;CYP2A6;HCCS;SDHC;CAT;CYP27A1;CYB5A;HMOX2;CYB5B;PGRMC2
prerank,phosphatidylinositol binding (GO:0035091),-0.21815012458415436,-0.9162468550918882,0.6666666666666666,0.8893022810502883,1.0,32/91,22.93%,HIP1;ITPR2;SNX9;NUMA1;FCHO2;PIGK;SNX12;PHF12;SNX5;SCARB1;RUBCNL;SESTD1;ING2;PARD3B;PITPNC1;ITPR1;PLEKHN1;PITPNM1;PARD3;SNX10;MITD1;BCAS3;MPPE1;NCF1;PLEKHF2;MREG;MCF2L;SNX17;ITPR3;SH3YL1;C2CD2L;PITPNM2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2786147526311105,-0.9158989333150349,0.5805084745762712,0.8829339326980913,1.0,7/29,13.83%,PKIG;PKIA;PRKAR2B;CDKN1B;PKIB;SPRED1;KAT2B
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2893048084219835,0.9151600084888206,0.7161484453360081,0.9330779071524509,1.0,75/346,16.32%,TRIM69;ARIH2;DDB2;RNF7;UBR4;CUL3;SIAH2;UBE2S;RNF20;RNF214;UBE2T;FBXW11;RNF115;UBE3D;SEL1L;FBXL3;RNFT2;UBE3A;TAF1;RBCK1;TRIM56;SMURF1;UBE2D1;TRIM28;RSPRY1;UBR1;PELI3;UBE2E1;UBE2D3;RNF25;RNF24;ANKRD39;COP1;BIRC6;RNF38;DTX3;RC3H1;CHFR;TRIM17;RNF167;RNF31;CNOT4;RFWD3;UBE2L3;RC3H2;FBXL5;MYLIP;RNF43;MEX3C;RNF144A;RNF19B;RNF112;RNF215;PDZRN3;UBE2Z;STUB1;ZNRF3;HERC2;TRAF3;CUL2;NSMCE1;FBXO4;UBE2J1;GID4;NEURL3;NEURL1B;TRIM36;ARIH1;VPS18;IRF2BPL;LTN1;RNF34;TNFAIP3;CUL4A;ZFP91
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3101666538028881,-0.9147647830703021,0.5923566878980892,0.8786684985279686,1.0,7/19,26.41%,GRIN2B;RASA3;ITPR1;GRIN1;ITPR3;RYR3;GRIN2D
prerank,histone deacetylase activity (GO:0004407),0.3901446405633941,0.9141523225191723,0.5887445887445888,0.9324785908001396,1.0,6/19,12.63%,HDAC6;SIRT1;HDAC1;HDAC5;SIRT2;MIER1
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.3305869346287007,0.9139761136403464,0.5921855921855922,0.9300537509113304,1.0,13/44,17.83%,KMT5B;KMT5A;DOT1L;CXXC1;SMYD3;WDR82;SETDB1;KMT2B;KMT2D;SETD7;KMT2A;SMYD5;EZH2
prerank,calcium channel inhibitor activity (GO:0019855),-0.36953058084076773,-0.9138361730882354,0.5683060109289617,0.8741343053413712,1.0,4/11,12.14%,CALM2;CALM1;ITPR1;MCUB
prerank,phosphatase activator activity (GO:0019211),-0.3446632548610309,-0.9123625022059827,0.5660377358490566,0.8708565600055636,1.0,6/14,16.55%,PHACTR4;CALM2;CALM1;B3GAT3;PPP2R5E;CALM3
prerank,chloride channel inhibitor activity (GO:0019869),-0.3827374418499813,-0.9123102502515461,0.5688311688311688,0.8641109543670266,1.0,6/10,35.39%,WNK2;WNK3;STX1A;STX7;VTI1B;CFTR
prerank,diacylglycerol kinase activity (GO:0004143),0.4294214101016898,0.9121740653726755,0.5604575163398693,0.9310364283755423,1.0,5/11,20.36%,DGKZ;DGKD;DGKQ;DGKH;DGKG
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",-0.3824638345392951,-0.9099062781195708,0.58656330749354,0.8631061003720016,1.0,3/10,14.43%,DSE;GNE;RENBP
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.3390799393242745,-0.9097189535614134,0.577639751552795,0.8569559900354798,1.0,6/14,35.57%,SLC26A11;SLC25A30;SLC25A11;SLC26A8;SLC26A6;SLC25A10
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.3481998656074345,0.9094434013891282,0.6124338624338624,0.9340371461499761,1.0,6/33,13.00%,ARIH2;SIAH2;UBE3D;DCUN1D1;RNF144A;RNF19B
prerank,3'-5' DNA helicase activity (GO:0043138),-0.32202254771451383,-0.9062697496997102,0.5861027190332326,0.8585696199686866,1.0,7/16,19.37%,FBH1;BLM;NAV2;HELQ;WRN;RECQL;ERCC3
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3466439192870219,-0.9060971498993043,0.5384615384615384,0.8524667677758944,1.0,5/13,16.07%,PJA2;PKIA;PRKAR2B;GSK3B;GSK3A
prerank,CoA hydrolase activity (GO:0016289),-0.32834597917506114,-0.9056416670175034,0.5800604229607251,0.8471250747083606,1.0,9/16,42.27%,NUDT7;ACOT11;ACOT8;ACOT9;ACAA2;ACOT6;ACOT2;ACOT7;ACOT1
prerank,kinase binding (GO:0019900),0.2825985985837677,0.9049788425281112,0.766,0.9404869239549458,1.0,95/435,19.23%,RELB;AGAP2;STAT3;PDGFRB;EPHA1;PFKM;BCL2L1;SQSTM1;LLGL1;ZFP36;CTBP2;PEBP1;WARS1;FZD5;RICTOR;HSP90AB1;MAP2K3;ABI2;IKBKB;ATF4;RELA;NEK6;MAP2K7;RHOB;CSPG4;STK11IP;RHOG;ADIPOR1;MIDN;PPP1CB;MOB1B;PPP2R5A;GYS1;TPRKB;DGKD;TCF7L2;LATS1;CCNK;AP2A1;ERCC6L2;UNC5C;PTPRC;CNKSR2;PTPRR;MSN;TOM1L1;PIK3IP1;CTNNB1;CLTC;CARD16;FBXW5;BLNK;CASP9;PRKAG1;PTPN6;UFL1;BAD;MAML1;WWC2;NSF;DGKQ;STUB1;FOXO3;CRK;CEP250;PRKAB1;LIMS1;CIT;FLNA;CDC37;PGAM1;ACTB;RAC1;IFNAR2;ZBTB4;APC;ILK;PER1;YWHAZ;PFKFB2;SMAD3;ELAVL1;TRIM5;TIAM1;DCTN1;STRADA;CEBPA;PIH1D1;RPTOR;DUSP3;IRAK4;EEF1A1;BCAR3;ITGB2;IBTK
prerank,pyrophosphatase activity (GO:0016462),0.3249584051145622,0.9039893828295598,0.6093366093366094,0.9398030236534162,1.0,9/50,15.11%,ENTPD1;NUDT6;NUDT5;DHX9;PPA2;ENTPD7;TRPM2;ENTPD5;PLPP1
prerank,retinoic acid receptor binding (GO:0042974),0.39090545229807117,0.9016864748177145,0.5923190546528804,0.9420489562402758,1.0,5/17,15.17%,PRMT2;ARID5A;MED25;TACC1;MED1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.42987829596815524,0.9010023245938128,0.5944170771756979,0.9406713781541537,1.0,4/11,11.65%,RPH3A;TRPC4;TRPC1;TRPC3
prerank,phospholipase binding (GO:0043274),0.40921786372894525,0.8989129153881134,0.5948406676783005,0.9419367385135172,1.0,3/13,12.62%,BLNK;PAFAH1B1;DGKQ
prerank,SH2 domain binding (GO:0042169),0.3466921971860354,0.8974501839231908,0.6104575163398693,0.9423765858831906,1.0,9/31,17.55%,SLAMF1;SQSTM1;SH2B2;BLNK;ARHGAP5;CRK;PAG1;CCDC88A;DAG1
prerank,omega peptidase activity (GO:0008242),0.30489766646365163,0.8970110548075181,0.6555075593952484,0.9404754721540297,1.0,23/89,17.55%,UCHL5;USP2;USP32;OTUD3;UCHL1;TANK;USP5;USP3;OTUD7B;USP19;ZRANB1;USP25;USP21;JOSD1;USP8;MYSM1;OTUD4;OTUB1;TNFAIP3;USP40;OTULIN;MPND;ZC3H12A
prerank,tau-protein kinase activity (GO:0050321),0.3730399650598241,0.8963444624988837,0.5967976710334789,0.9390082364442339,1.0,9/20,23.12%,BRSK1;BRSK2;TAOK2;DYRK1A;TTBK2;PRKAA1;TAOK1;PHKG2;TTBK1
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.355223181005596,0.8947110519179389,0.6352941176470588,0.9396155702207208,1.0,3/27,8.56%,SLC39A14;SLC39A8;ANKH
prerank,neuropeptide binding (GO:0042923),-0.3093276497301662,-0.8926579377655434,0.5911949685534591,0.8714680766921038,1.0,3/18,15.49%,OPRM1;GPR37;GPR149
prerank,active ion transmembrane transporter activity (GO:0022853),0.3311844138343881,0.8908852414779271,0.6179775280898876,0.9449703507216327,1.0,8/37,16.54%,SLC22A4;COX5A;UQCRC1;COX7A2L;ATP13A3;UQCRFS1;SLCO5A1;SLC16A7
prerank,glutamate receptor activity (GO:0008066),-0.3011375479802586,-0.8897017836093288,0.6302250803858521,0.8722198233562316,1.0,3/19,6.05%,GRM5;GRIK4;GRIA1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3466299432425204,-0.8894970932918325,0.6038251366120219,0.8662974080701957,1.0,3/12,8.40%,SLC25A17;SLC35B3;SLC17A9
prerank,histone acetyltransferase activity (GO:0004402),0.34445452055683357,0.8867982097427763,0.6398996235884568,0.9505534983162093,1.0,10/30,16.99%,KAT5;NAA60;TAF1;BAZ1A;TADA2A;ARRB1;CREBBP;NAA50;NCOA3;KAT2A
prerank,transmitter-gated ion channel activity (GO:0022824),-0.26989786744810795,-0.8846854934788007,0.6554621848739496,0.8702477740449704,1.0,9/29,20.05%,GRIK4;GABRG3;GABRG2;GABRA5;GLRA2;GLRA3;GABRG1;GRIK3;GABRA1
prerank,nuclear receptor binding (GO:0016922),0.2898894471223482,0.8841118237905687,0.6836518046709129,0.9530971519050884,1.0,31/111,18.42%,NR4A1;PRMT2;HMGN3;DDX54;ARID5A;TAF1;JUP;ZBTB7A;BAZ2A;FOXP1;TCF7L2;LATS1;SIRT1;BRD8;CTNNB1;KDM1A;DDX5;WIPI1;NCOR1;TACC2;NCOA3;MED25;TACC1;MED1;MED13;JMJD1C;RXRA;PRKCB;SMAD3;CALR;MED4
prerank,store-operated calcium channel activity (GO:0015279),0.42593898206258274,0.8840103497999103,0.6105769230769231,0.9505060213328201,1.0,4/10,18.56%,TRPC4;TRPC1;TRPC3;TRPC5
prerank,ubiquitin protein ligase activity (GO:0061630),0.28040459047440525,0.8819500872969114,0.7494949494949495,0.9518009454480956,1.0,47/228,16.21%,TRIM69;ARIH2;RNF7;UBR4;CUL3;SIAH2;RNF115;UBE3D;RNFT2;UBE3A;TRIM56;SMURF1;UBE2D1;UBR1;PELI3;UBE2D3;RNF25;RNF24;COP1;RNF38;DTX3;RC3H1;TRIM17;RNF167;RFWD3;RC3H2;MYLIP;RNF43;MEX3C;RNF144A;RNF19B;UBE4A;RNF112;RNF215;PDZRN3;STUB1;ZNRF3;HERC2;NSMCE1;GID4;NEURL3;NEURL1B;ARIH1;VPS18;IRF2BPL;LTN1;RNF34
prerank,methyl-CpG binding (GO:0008327),0.35809163666152644,0.8816889449487095,0.6300813008130082,0.9495398698389416,1.0,6/22,19.48%,CHTOP;TET1;MBD1;ZBTB4;TET3;PRMT1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.4077407942505641,0.8798114169764177,0.6283464566929133,0.9504714215565645,1.0,4/13,12.41%,THUMPD3;THUMPD2;TRMT10A;TRMT10B
prerank,N-acetyltransferase activity (GO:0008080),-0.2972098783451691,-0.8798003914491094,0.6329588014981273,0.8744557750565346,1.0,5/19,13.83%,SAT1;SMARCE1;ESCO1;EP300;KAT2B
prerank,protein kinase activator activity (GO:0030295),0.30978517044364756,0.879444274413098,0.6580188679245284,0.9484827450223784,1.0,6/60,4.92%,AGAP2;RICTOR;FGF13;DUSP19;ALS2;MAP2K1
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.37017125073505175,-0.8766135129173408,0.6214833759590793,0.8751033952033662,1.0,3/10,14.47%,CYLD;STAMBP;OTUD5
prerank,methylated histone binding (GO:0035064),0.30404547266238363,0.8760721076704737,0.6651480637813212,0.9521400813087649,1.0,12/62,15.24%,SPIN4;CHD5;DPF2;CXXC1;TAF1;ZCWPW2;CHD1;ING1;TDRD3;FMR1;CBX5;ING4
prerank,methyltransferase activity (GO:0008168),-0.2368251500538387,-0.8757158021816616,0.75,0.8707679798121407,1.0,28/46,36.14%,AS3MT;COQ5;NSUN3;COQ3;NTMT1;METTL4;ARMT1;N6AMT1;FTSJ1;BUD23;PRMT5;NSUN2;MEPCE;FTSJ3;DNMT3B;SUV39H1;EHMT1;DNMT1;PRMT7;RRP8;AMT;GCSH;MGMT;PRMT8;BCDIN3D;ASMT;COMTD1;MRM2
prerank,histone methyltransferase binding (GO:1990226),0.41398847145273193,0.8755681306534363,0.6214057507987221,0.9504515292381359,1.0,3/11,9.75%,HSP90AB1;NOP56;CTNNB1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.3162804443431128,0.8753925756301791,0.6467780429594272,0.9480636216733394,1.0,6/49,8.49%,DUSP5;DUSP16;PLCXD2;PPP1CB;ENPP6;SMPD1
prerank,MAP-kinase scaffold activity (GO:0005078),0.4076918587810425,0.8753475055132821,0.6287878787878788,0.945448111016114,1.0,3/11,10.90%,DUSP19;MAP2K1;SPAG9
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.36562028352273174,-0.8731580436431262,0.6283422459893048,0.8698465328962479,1.0,5/10,25.63%,PML;FAN1;FAAP20;ANKRD13D;ANKRD13B
prerank,DNA replication origin binding (GO:0003688),0.3564167684302293,0.8727414468901881,0.6359945872801083,0.947964449769765,1.0,3/23,8.11%,MCM2;DHX9;ORC5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.27410356500704897,0.871741545712945,0.7785642062689585,0.9472499488396499,1.0,40/248,14.08%,GSPT2;AGAP2;MYO1E;MYH9;RRAGC;PIN1;GFM2;RAB18;NKIRAS1;RHOB;GNAS;RAB8B;DNM2;RHOG;KLC1;KIF5A;MYL6;RHOU;GNB2;RAB31;RALB;NRAS;DHX9;ATL3;TOR3A;GCH1;RHOQ;CHD1L;RHEB;ENTPD7;GTPBP4;GNB1;GNAO1;CLU;RAB32;GNA15;RNF112;DYNC2H1;SAR1B;ABCB10
prerank,death domain binding (GO:0070513),0.42002808860261276,0.8708574937479453,0.6190476190476191,0.9463280941762678,1.0,1/11,1.33%,BCL2L1
prerank,glycerophospholipid flippase activity (GO:0140333),0.4189198536815374,0.8707525416214457,0.6282467532467533,0.9438026150401762,1.0,1/11,1.51%,ATP8B1
prerank,metalloexopeptidase activity (GO:0008235),0.306929199125696,0.8685124851539658,0.6654761904761904,0.9454293986427124,1.0,12/51,20.16%,CPXM1;NPEPPS;RNPEPL1;LAP3;DPEP1;FOLH1;CPA6;METAP1;CPD;MMP14;CPQ;AGBL5
prerank,palmitoyltransferase activity (GO:0016409),-0.27130216169059224,-0.8679836245345944,0.640625,0.8750957165959447,1.0,13/28,23.72%,ZDHHC14;ZDHHC17;ZDHHC13;ZDHHC18;ZDHHC1;ZDHHC6;HHAT;ZDHHC2;ZDHHC20;YKT6;ZDHHC4;ZDHHC24;ZDHHC16
prerank,pentosyltransferase activity (GO:0016763),0.32141599375330815,0.8663021996736936,0.665389527458493,0.9471683801546293,1.0,8/36,11.25%,PNP;PARP4;QTRT1;SIRT1;PARP10;SIRT5;PARP2;SIRT2
prerank,protein kinase regulator activity (GO:0019887),0.28884966145435553,0.8657112763563481,0.7038251366120218,0.9456465016330405,1.0,23/95,19.99%,AGAP2;KIDINS220;NCK1;FGF13;DUSP19;CCNL1;ELP3;CCNK;PRKAG1;GMFB;SH3BP5L;PRKAR2A;ANKRD54;MBIP;CCNT1;CCNL2;APC;STRADA;RPTOR;RPLP1;CCND1;TRIB1;SNCA
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.38164347301708423,0.8648776901597665,0.6401799100449775,0.9445747390485916,1.0,2/15,11.82%,CMKLR1;CCR5
prerank,gated channel activity (GO:0022836),0.3939975578411461,0.8643918981529644,0.6486068111455109,0.9427978292192364,1.0,1/14,0.93%,TMC8
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),-0.3435017494977153,-0.863916155035626,0.6203208556149733,0.8776181227996732,1.0,4/11,12.93%,UBE2K;ANAPC11;AMFR;UBOX5
prerank,ferrous iron binding (GO:0008198),-0.2839532730245263,-0.8637913560466679,0.6690140845070423,0.8718768400392543,1.0,11/21,23.67%,ALKBH1;DNAJC24;FTL;ALKBH3;EGLN1;PHYH;ISCU;HIF1AN;FECH;ALKBH2;HAAO
prerank,peptidase activator activity (GO:0016504),-0.281153924968585,-0.862976165374126,0.652,0.8674061791479137,1.0,10/22,24.14%,CLPX;PCOLCE2;EBAG9;PSME1;VSIR;CASP8AP2;PSME2;APH1A;PSENEN;NLRC4
prerank,cation channel activity (GO:0005261),0.2866297426818327,0.8596548857836429,0.7183406113537117,0.9490360747800907,1.0,12/94,12.12%,KCNK4;KCNK9;PKD2L2;TRPM4;ANXA6;TRPC1;ANO10;PKD1L2;TRPC3;TRPM2;TRPV2;ANXA2
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.3977277444318516,0.8583311486700591,0.6490683229813664,0.9488559678808862,1.0,4/11,12.46%,CASP4;PYCARD;CASP9;CFLAR
prerank,potassium channel activity (GO:0005267),0.2897411226261082,0.8569504131243727,0.7068965517241379,0.948893851123331,1.0,9/89,14.33%,KCNK4;KCNH2;KCNK9;KCNMB2;KCNMB3;KCNQ3;KCNC1;KCNMA1;GRIK5
prerank,clathrin adaptor activity (GO:0035615),-0.3137070893400049,-0.8564146642114243,0.6666666666666666,0.8754900721900333,1.0,6/15,17.43%,HIP1;AP2A2;STON2;LDLRAP1;DAB2;AP2S1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.3625010048270786,0.8555260228608188,0.6710334788937409,0.948753000929207,1.0,1/18,4.32%,HSD17B1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),0.3869340906690888,0.8555138330493043,0.6599378881987578,0.9461528435966432,1.0,4/14,18.05%,SLC25A13;SLC1A3;SLC1A1;SLC17A6
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4157959706255196,0.8554730880646529,0.6614906832298136,0.9436342240682222,1.0,2/10,12.31%,NAA60;NAA50
prerank,insulin-like growth factor I binding (GO:0031994),-0.3329942268563388,-0.8551060011239461,0.6397849462365591,0.8722020388135626,1.0,9/13,38.07%,ITGAV;INSR;IGFBP5;ITGA6;IGFBP2;IGFBP4;ITGB4;IGFBP6;IGFBP3
prerank,nuclease activity (GO:0004518),-0.22702837761752404,-0.8544755636502801,0.782608695652174,0.8675261915497442,1.0,14/52,15.97%,ENPP1;MRE11;N4BP2;DDX1;DNA2;RNASE7;RNASEL;REXO1;REXO5;ISG20L2;RNASE12;EXOG;AEN;WRN
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.41179979216401336,0.8530136143100174,0.6551155115511551,0.9454485184143603,1.0,2/10,6.02%,PIK3R3;PIK3C3
prerank,cysteine-type peptidase activity (GO:0008234),0.29355048136316475,0.850304031607809,0.7202643171806168,0.9478173972848402,1.0,11/73,10.90%,CTSB;ATG4D;CTSL;USP2;UCHL1;USP5;CASP4;OTUD7B;USP25;USP21;CASP9
prerank,hexose transmembrane transporter activity (GO:0015149),0.3939168936388264,0.8499644775726499,0.6408227848101266,0.9458937992729006,1.0,3/12,17.10%,SLC2A1;SLC5A3;MFSD4A
prerank,solute:proton symporter activity (GO:0015295),0.3675916673675249,0.849518964092661,0.6531204644412192,0.9441403041591312,1.0,3/16,10.85%,SLC25A3;SLC39A8;SLC36A1
prerank,carbohydrate kinase activity (GO:0019200),-0.3456246583183362,-0.8491889293747604,0.6472303206997084,0.8724305313144218,1.0,5/11,13.43%,FGGY;HK2;HK1;GNE;NAGK
prerank,ribonuclease activity (GO:0004540),0.2999002533145661,0.8491706018191533,0.693491124260355,0.942205253992853,1.0,16/56,20.13%,NOB1;YBEY;CNOT6;EXOSC8;LACTB2;EXOSC10;CNOT7;SND1;RNASE3;RNASE1;AGO3;ZC3H12A;RNASEH1;RNASEH2A;TSNAX;AGO2
prerank,MHC protein binding (GO:0042287),0.35614620297397975,0.8484494697081642,0.6459197786998617,0.9410534201241765,1.0,3/20,12.49%,PILRA;TUBB;DERL1
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.34914507299248715,0.8475271517736873,0.6822558459422283,0.9376048986157886,1.0,6/21,14.60%,CDKL3;CDK6;CCNK;CDK8;CDK12;CDK19
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.34914507299248715,0.8475271517736873,0.6822558459422283,0.9376048986157886,1.0,6/21,14.60%,CDKL3;CDK6;CCNK;CDK8;CDK12;CDK19
prerank,myosin V binding (GO:0031489),0.37404026252659356,0.8431769217039313,0.6785206258890469,0.942614868577538,1.0,1/15,2.15%,RAB39B
prerank,signal sequence binding (GO:0005048),0.32146450927945075,0.8422625186898639,0.7144622991347342,0.9416784721220797,1.0,7/35,16.52%,IPO5;NUP153;TNPO2;TOMM20;KPNA2;IPO4;AP2M1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.29194148303364287,-0.8399664219940258,0.667741935483871,0.8856989205103042,1.0,8/18,29.38%,XIAP;GAS6;BIRC2;BIRC3;PRDX3;CD27;MT3;RPS6KA1
prerank,protein tyrosine kinase activity (GO:0004713),0.2774615266615936,0.8399101299660661,0.7601713062098501,0.9431179857284504,1.0,21/108,19.33%,PDGFRB;EPHA1;EPHA2;ABL2;PTK2B;RYK;BAZ1B;DDR2;EPHA3;SCYL1;ROR1;CAMKK2;EPHA6;PEAK1;DYRK1A;TEC;HCK;AATK;NTRK2;JAK1;CSF1R
prerank,amyloid-beta binding (GO:0001540),0.28048918866669925,0.8369203791104846,0.7347391786903441,0.9456956887580681,1.0,22/79,19.55%,FZD5;FZD6;PICALM;CACNA1A;APOE;LRP1;ITM2C;SORL1;CLSTN1;PRNP;PFDN1;CLU;APBB3;GRIN2A;PGRMC1;ADRB2;ATP1A3;GRIA4;COL25A1;ITGB2;GSAP;TLR2
prerank,phospholipid transfer activity (GO:0120014),0.34741714286573855,0.8367058718555168,0.6694677871148459,0.9435975837454222,1.0,1/21,0.55%,PRELID1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.36988740912331286,0.8363338135120891,0.6827794561933535,0.9416996803001583,1.0,4/15,18.05%,SLC25A13;SLC1A3;SLC1A1;SLC17A6
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.3709279383174603,0.8306910361013118,0.6765163297045101,0.948916337596545,1.0,3/14,14.67%,AK8;CMPK1;NME6
prerank,estrogen receptor binding (GO:0030331),0.3180493995704484,0.8287931477007991,0.7139272271016311,0.9496272851632177,1.0,8/32,15.17%,PRMT2;DDX54;ARID5A;LATS1;CTNNB1;WIPI1;TACC1;MED1
prerank,fatty acid synthase activity (GO:0004312),0.4037073802663757,0.8278200472571512,0.6796747967479675,0.9488027684548404,1.0,3/10,18.41%,ELOVL1;ELOVL7;ELOVL6
prerank,protein tyrosine phosphatase activity (GO:0004725),0.2860659733780297,0.8272402697638527,0.7368421052631579,0.9472776630735464,1.0,16/71,15.11%,PTPN12;PTPN14;MTMR3;PTPRC;PTPRR;PTPRD;PTPN4;PTPN6;PTPRU;PTPRO;PTPRA;PTP4A3;EYA2;PTPRN2;PTPRE;PTPRS
prerank,endopeptidase activator activity (GO:0061133),-0.35023565623357,-0.8244305708442635,0.6666666666666666,0.9097411434401991,1.0,7/10,29.84%,PSME1;VSIR;PSME2;APH1A;PSENEN;NLRC4;APH1B
prerank,hydro-lyase activity (GO:0016836),-0.22286572166681395,-0.8215418162062957,0.8185840707964602,0.909341201384226,1.0,6/41,7.09%,PCBD2;HACD4;ECHS1;ACO1;AUH;HADHB
prerank,death receptor binding (GO:0005123),0.3633232192163982,0.8207535157480337,0.6906158357771262,0.9557491583145333,1.0,2/15,10.45%,BID;BDNF
prerank,glutathione transferase activity (GO:0004364),0.3284734531170449,0.8201043000026581,0.7030812324929971,0.9544204519594934,1.0,2/23,6.99%,HPGDS;LANCL1
prerank,chloride channel regulator activity (GO:0017081),-0.3154992510845841,-0.814506164383913,0.7194029850746269,0.9166564682791665,1.0,8/14,39.61%,WNK2;WNK3;CHRNA7;STX1A;STX7;VTI1B;CFTR;SGK3
prerank,sialyltransferase activity (GO:0008373),0.3405513772622711,0.8144598244852556,0.7276536312849162,0.9615322940092044,1.0,2/20,5.65%,ST6GALNAC2;ST8SIA6
prerank,rRNA binding (GO:0019843),0.30226940015378745,0.8139529144258649,0.7451456310679612,0.9598606415451214,1.0,7/42,13.39%,MRPL18;GTF3A;MRPS6;DDX21;MRPS7;RPS14;MRPS27
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.29366399450794195,-0.8137854180665878,0.7392739273927392,0.9122526541172273,1.0,7/17,17.44%,ABCA1;ATP10A;ABCB4;PITPNC1;ABCA7;PITPNM1;ABCG1
prerank,endonuclease activity (GO:0004519),0.29010765602891403,0.8110411481638722,0.720763723150358,0.9620207229925523,1.0,13/49,22.74%,DIS3;NOB1;YBEY;LACTB2;SND1;MBD4;AGO3;ZC3H12A;TSNAX;AGO2;SMG6;INTS11;ERCC4
prerank,phosphatidate phosphatase activity (GO:0008195),-0.30990980235972837,-0.80985856124857,0.7417417417417418,0.9139844882712337,1.0,4/13,12.67%,PLPPR5;PLPPR1;LPIN2;PLPP4
prerank,symporter activity (GO:0015293),0.38522377754064396,0.8064147842397564,0.7121464226289518,0.9668396961761611,1.0,10/10,61.50%,SLC28A3;SLC5A8;SLC4A4;SLC5A12;SLC5A5;SLC28A1;MFSD2A;SLC46A2;SLC28A2;SLC5A6
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.3892601755506566,0.8052881244398978,0.6727272727272727,0.9660709547670913,1.0,1/10,3.31%,INCA1
prerank,filamin binding (GO:0031005),0.37975560450779416,0.8032902091871607,0.7287319422150883,0.9667322402731775,1.0,1/11,3.36%,FBLIM1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.36468568675521856,0.8022831556198532,0.7220543806646526,0.965890072842696,1.0,3/13,10.71%,AGPAT4;GPAT4;LPCAT1
prerank,CoA-ligase activity (GO:0016405),0.36059398125603825,0.8013729297733698,0.7325227963525835,0.9649098217333454,1.0,1/14,2.64%,ACSF3
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.3777133089249308,0.8005488271298722,0.7277227722772277,0.961281751260372,1.0,5/11,22.82%,PFN1;BAG1;GRPEL2;HSPBP1;BAG3
prerank,adenyl nucleotide binding (GO:0030554),0.3777133089249308,0.8005488271298722,0.7277227722772277,0.961281751260372,1.0,5/11,22.82%,PFN1;BAG1;GRPEL2;HSPBP1;BAG3
prerank,chloride transmembrane transporter activity (GO:0015108),0.34813348442076214,0.8005122875028654,0.7320644216691069,0.9589076209235131,1.0,4/16,21.39%,CLCN6;SLC1A1;CLCN7;SLC26A2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.21785062929837148,-0.800328657895692,0.856353591160221,0.9251445610326866,1.0,21/48,35.76%,NALCN;UNC80;PIEZO2;PIEZO1;DMAC2L;PKD2;CALHM2;SLC41A1;TRPV4;SLC12A7;ATP6V1F;TMEM165;SLC39A1;SLC12A4;PKD2L1;TRPM6;SLC12A2;ATP6V1B2;ABCC9;TRPM3;SLC46A1
prerank,nucleotidyltransferase activity (GO:0016779),0.3417266701628334,0.7989181933203502,0.7052186177715092,0.9589266636226212,1.0,4/19,11.36%,NUDT5;TUT7;YRDC;TUT1
prerank,phosphatase activity (GO:0016791),0.27557817132360246,0.798763788892234,0.7918088737201365,0.9567628083990244,1.0,6/73,5.95%,DUSP5;DUSP16;INPP5K;PLPPR4;APTX;PPP1CB
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.31536210495985717,-0.7959353196722228,0.7158469945355191,0.9266304544857892,1.0,5/12,20.05%,GABRG3;GABRG2;GABRA5;GABRG1;GABRA1
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.35187163500244634,0.7956084207004124,0.7215568862275449,0.9592572311991518,1.0,5/15,15.66%,CXXC1;WDR82;KMT2B;KMT2D;KMT2A
prerank,calcium-release channel activity (GO:0015278),0.34246160627566924,0.7950713597280112,0.7339181286549707,0.957719367908238,1.0,3/17,11.95%,FKBP1B;MCOLN3;TRPM2
prerank,poly-pyrimidine tract binding (GO:0008187),0.32875199877821415,0.7932761666864891,0.7544097693351425,0.9582283317891452,1.0,6/23,15.04%,HNRNPU;U2AF2;FMR1;HNRNPH1;PTBP1;PATL1
prerank,calcium-activated potassium channel activity (GO:0015269),0.37783513919592976,0.7926951273286275,0.7068965517241379,0.9566787279132349,1.0,3/11,13.65%,KCNMB2;KCNMB3;KCNMA1
prerank,NADPH binding (GO:0070402),-0.30465810073137956,-0.7903561687055332,0.7119113573407202,0.9301904324169886,1.0,6/13,20.81%,KCNAB1;LBR;DUS2;DECR1;MTRR;CBR4
prerank,NAD+ binding (GO:0070403),0.3601844430910093,0.7899362523877292,0.7238689547581904,0.9584299888376909,1.0,4/12,11.25%,SIRT1;GLUD1;SIRT5;SIRT2
prerank,vitamin D receptor binding (GO:0042809),-0.28843229620414457,-0.7893586679391994,0.7507246376811594,0.926026626178088,1.0,9/14,32.71%,SNW1;MED30;TAF11;TAF7;MED12;MED24;MED14;MED16;THRAP3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.26884700915826176,0.7887549610047406,0.7910614525139665,0.9578060097133207,1.0,10/72,12.12%,FLII;PICALM;PFN1;KRIT1;SDCBP;GSDME;RPH3A;KCNJ2;FRMPD4;ANXA2
prerank,ligand-gated cation channel activity (GO:0099094),0.2730761637709854,0.7884731916584613,0.8113636363636364,0.9558884360665062,1.0,8/75,14.33%,KCNH2;KCNJ6;TRPM4;PTK2B;KCNJ2;TRPM2;GRIN2A;GRIK5
prerank,GABA-A receptor activity (GO:0004890),-0.27751839057403105,-0.7869910059958086,0.7571884984025559,0.9242465652600589,1.0,5/18,20.05%,GABRG3;GABRG2;GABRA5;GABRG1;GABRA1
prerank,four-way junction DNA binding (GO:0000400),-0.27806203795742435,-0.7868696177222125,0.7785234899328859,0.9186968102938577,1.0,10/17,33.56%,BLM;RAD51D;WRN;MSH6;HMGB2;ABL1;RAD51C;YY1;GEN1;XRCC2
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.31105172853202806,0.786541355775002,0.736551724137931,0.9563690423083476,1.0,7/25,14.82%,PARP4;SIRT1;PARP10;SIRT5;PARP2;SIRT2;ART4
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3595384198456134,0.786195090915687,0.7029096477794793,0.9545006306869624,1.0,1/13,1.29%,SLC7A1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.37138799278254087,0.7853468984537694,0.7278911564625851,0.9534473576410477,1.0,6/11,21.63%,STN1;HNRNPA1;TERF2IP;HNRNPA2B1;RPA1;TERF2
prerank,"DNA binding, bending (GO:0008301)",0.34898054971105213,0.7845057839361844,0.7342143906020558,0.952272050576704,1.0,1/14,2.99%,HMGB1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.3116808298753235,-0.7825629309506619,0.7574931880108992,0.920215897939156,1.0,7/12,26.31%,KDM4C;KDM4B;PHF8;KDM7A;KDM4A;KDM3A;KDM4D
prerank,histone deacetylase binding (GO:0042826),0.26094193938687543,0.7824706312764137,0.8320355951056729,0.9530632404964469,1.0,20/88,18.34%,PHF6;HSP90AB1;HDAC6;RELA;CHD4;SPI1;MAPK8;HDAC1;HDAC5;SFPQ;SIRT2;KPNA2;MIER1;AKAP8L;NCOR1;MEF2A;KAT2A;MEF2B;MEF2C;RBBP4
prerank,ubiquitin binding (GO:0043130),0.26641380114585717,0.7816939844141368,0.8274687854710556,0.9518540034515282,1.0,14/73,13.68%,SQSTM1;CXCR4;VPS28;UCHL1;USP5;RBCK1;TOM1L1;USP25;RNF31;SIRT2;UBXN1;DNAJB2;RNF19B;ILRUN
prerank,glucose transmembrane transporter activity (GO:0005355),0.3392760670774234,0.7809312815447645,0.7227138643067846,0.9506101494985333,1.0,3/17,17.10%,SLC2A1;SLC5A3;MFSD4A
prerank,histone demethylase activity (GO:0032452),0.3004378551699533,0.7809221639592034,0.757162346521146,0.9483099732461707,1.0,9/27,22.49%,KDM6B;HR;KDM1A;JMJD1C;KDM2B;KDM2A;KDM3B;KDM5C;PHF2
prerank,sodium channel activity (GO:0005272),-0.22151098696383897,-0.7794400009741475,0.8731707317073171,0.9197916879895482,1.0,8/37,18.86%,SCN1A;GRIK4;SCN3A;SCN2A;SCN9A;PKD2;HCN2;GRIK3
prerank,CXCR chemokine receptor binding (GO:0045236),0.36751220764173315,0.7793846961595801,0.7577235772357723,0.9482068970484417,1.0,2/11,19.69%,YARS1;ITCH
prerank,calcium channel activity (GO:0005262),0.2616802369364408,0.7766054714706407,0.8336980306345733,0.9498356187553725,1.0,14/84,12.12%,CACNA1A;CACNG8;PKD2L2;CACNA2D1;TRPM4;ANXA6;TRPC4;CACNG2;TRPC1;PKD1L2;TRPC3;TRPM2;TRPV2;ANXA2
prerank,adenylyltransferase activity (GO:0070566),0.32108158513037593,0.775845320969195,0.7579972183588317,0.9485779442928978,1.0,4/21,13.15%,KARS1;NMNAT1;TUT1;NMNAT2
prerank,solute:sodium symporter activity (GO:0015370),0.30565278431493076,0.774022916260949,0.7539893617021277,0.9489057113706013,1.0,3/27,14.53%,SLC20A2;SLC20A1;SLC5A3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.2911670217374206,0.7736199851344362,0.7703889585947302,0.9471796248084674,1.0,5/35,8.49%,PLD3;PLCXD2;SMPD3;ENPP6;SMPD1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3594807778510424,0.7726728984283777,0.745253164556962,0.9462652850712896,1.0,2/12,6.02%,PIK3R3;PIK3C3
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3264921088119819,0.7694881567884585,0.7420749279538905,0.9484821353858679,1.0,1/16,2.89%,SLC22A4
prerank,dynactin binding (GO:0034452),0.35616330550542113,0.7694593153754616,0.7421383647798742,0.9462564838487206,1.0,3/12,11.61%,SNX6;BBS4;PAFAH1B1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.36097715474973224,0.765600498067873,0.755192878338279,0.9493559455452728,1.0,2/11,12.31%,NAA60;NAA50
prerank,GABA receptor activity (GO:0016917),-0.25650343706276124,-0.7610795252199852,0.7986348122866894,0.9429675195672468,1.0,5/21,20.05%,GABRG3;GABRG2;GABRA5;GABRG1;GABRA1
prerank,sodium ion transmembrane transporter activity (GO:0015081),-0.23848428312080105,-0.7607632447391067,0.8445378151260504,0.9376829333571237,1.0,5/27,9.74%,SLC8B1;SLC9A9;SLC9A6;SLC8A3;SLC8A1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.2901443988385046,0.7599756855187979,0.7888040712468194,0.9547703257955843,1.0,3/32,13.26%,KCNH2;KCNQ3;KCNC1
prerank,acid-thiol ligase activity (GO:0016878),0.3469393741199073,0.7587695626288505,0.7711213517665131,0.9541590376623976,1.0,1/13,2.64%,ACSF3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.3395946991653686,0.7527909171189182,0.7873651771956857,0.9599984266762108,1.0,1/13,1.09%,ARHGDIA
prerank,gamma-tubulin binding (GO:0043015),0.3074640742705254,0.7436085658650314,0.8046448087431693,0.9699390107825449,1.0,3/22,9.09%,BRSK1;TUBGCP5;TUBGCP6
prerank,UDP-glycosyltransferase activity (GO:0008194),0.25855573501703144,0.7433266319991265,0.8458942632170978,0.9680345220491525,1.0,9/70,14.32%,CHPF;B4GALNT1;POMGNT1;B3GALNT2;XXYLT1;MGAT4A;CSGALNACT1;GCNT2;LFNG
prerank,GTPase activity (GO:0003924),0.23724960332656903,0.7428596433660484,0.920863309352518,0.9664324776745564,1.0,32/192,15.90%,GSPT2;AGAP2;RRAGC;GFM2;RAB18;NKIRAS1;RHOB;GNAS;RAB8B;DNM2;RHOG;RHOU;GNB2;RAB31;RALB;NRAS;ATL3;GCH1;RHOQ;RHEB;ENTPD7;GTPBP4;GNB1;GNAO1;RAB32;GNA15;RNF112;SAR1B;ARL8B;ARL1;MMAA;RAC1
prerank,bHLH transcription factor binding (GO:0043425),0.314278299873058,0.7424242406257939,0.7986394557823129,0.9647235295538473,1.0,6/19,17.45%,SIRT1;CREBBP;KDM1A;TCF3;TCF12;SMAD3
prerank,NADP binding (GO:0050661),-0.21689310481972834,-0.7412710702873118,0.8958333333333334,0.9601269848776854,1.0,10/32,20.81%,DPYD;KCNAB1;LBR;DUS2;DECR1;ME1;NOX1;GMDS;MTRR;CBR4
prerank,cation:chloride symporter activity (GO:0015377),-0.3146972772679157,-0.7409904962159032,0.7713498622589532,0.9547013921127323,1.0,6/10,31.77%,SLC12A9;SLC6A1;SLC12A7;SLC12A5;SLC12A4;SLC12A2
prerank,lysine-acetylated histone binding (GO:0070577),0.308827012571295,0.7378606095994222,0.7911301859799714,0.9661912109421513,1.0,7/20,17.18%,DPF2;TAF1;BAZ2A;ATAD2B;BRD4;KMT2A;BRD2
prerank,acetylation-dependent protein binding (GO:0140033),0.308827012571295,0.7378606095994222,0.7911301859799714,0.9661912109421513,1.0,7/20,17.18%,DPF2;TAF1;BAZ2A;ATAD2B;BRD4;KMT2A;BRD2
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.27373729320098605,-0.7366045014418393,0.847953216374269,0.9547532594981075,1.0,2/14,26.97%,RDH10;DHRS3
prerank,serotonin receptor activity (GO:0099589),0.3015254318734585,0.7358227716911594,0.7958904109589041,0.9620637125992352,1.0,2/22,8.17%,HRH2;HTR2C
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.3015254318734585,0.7358227716911594,0.7958904109589041,0.9620637125992352,1.0,2/22,8.17%,HRH2;HTR2C
prerank,G protein-coupled amine receptor activity (GO:0008227),0.3015254318734585,0.7358227716911594,0.7958904109589041,0.9620637125992352,1.0,2/22,8.17%,HRH2;HTR2C
prerank,semaphorin receptor activity (GO:0017154),0.35130192255079495,0.7345489215756352,0.7897271268057785,0.9613428167385353,1.0,2/11,11.10%,PLXNA1;NRP2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.34370044544326755,0.7318477370158324,0.7800312012480499,0.9624282731604402,1.0,2/12,11.36%,TENT5C;TUT1
prerank,antiporter activity (GO:0015297),-0.24865376258990976,-0.7303758497830785,0.8461538461538461,0.9573883201421513,1.0,9/20,26.52%,SLC35E2A;SLC35E2B;SLC35C2;SLC25A30;SLC25A16;SLC25A11;SLC35E1;CLCN3;SLC35E3
prerank,transferrin receptor binding (GO:1990459),0.34260119953959256,0.7289669706618012,0.7931034482758621,0.9636502371309327,1.0,1/10,3.76%,IKBKB
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.2917797894988306,0.7274084166609001,0.8203017832647462,0.9633653519437857,1.0,5/24,11.08%,ZDHHC9;ZDHHC7;ZDHHC8;ZDHHC3;ZDHHC21
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.2821797248883169,0.7271077362038398,0.824516129032258,0.9615191070740294,1.0,6/30,14.16%,PRDX5;CARD16;BIRC6;DPEP1;UBE2Z;CST7
prerank,DNA secondary structure binding (GO:0000217),-0.21091787484349614,-0.7263678648236425,0.9191489361702128,0.9565696472897305,1.0,15/31,35.10%,RBBP8;BLM;RAD51D;WRN;XPC;MSH6;HMGB2;ABL1;RAD51C;HMGA2;CLSPN;YY1;GEN1;XRCC2;RAD51AP1
prerank,peptidoglycan binding (GO:0042834),0.3460617036289322,0.7245195955180962,0.7983739837398374,0.9624113728375211,1.0,1/10,3.22%,NLRP3
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3015905765515707,-0.7233542191740184,0.8455497382198953,0.954458963896493,1.0,5/10,29.62%,B4GALT6;B4GALT1;B3GALT5;B3GALT1;B3GALT2
prerank,kinase inhibitor activity (GO:0019210),0.2808507933093564,0.7217590368977335,0.8317880794701987,0.9635221232661131,1.0,6/33,14.03%,WARS1;NCK1;DUSP19;GMFB;SH3BP5L;MBIP
prerank,nucleotide diphosphatase activity (GO:0004551),0.31901950357874787,0.7153771405848167,0.8174962292609351,0.968644463750943,1.0,4/14,22.60%,NUDT6;ENPP5;FHIT;NUDT4
prerank,neurexin family protein binding (GO:0042043),-0.2993868656930799,-0.7137493993507626,0.8419689119170984,0.9605929205559487,1.0,1/10,1.20%,NLGN1
prerank,mannosyltransferase activity (GO:0000030),0.2940392711469015,0.7124766974989273,0.840877914951989,0.9698158381852616,1.0,7/21,18.68%,ALG12;DPM1;DPY19L3;DPY19L4;PIGM;ALG9;ALG8
prerank,5'-nucleotidase activity (GO:0008253),-0.2747298338476704,-0.710911868832831,0.8396739130434783,0.9583363492486683,1.0,6/13,43.79%,NT5DC3;NT5C3B;NT5C;NT5E;ACP3;NT5DC2
prerank,Hsp70 protein binding (GO:0030544),0.2725179815058891,0.7072065495054497,0.863517060367454,0.9736254833866671,1.0,5/31,13.29%,IQCG;DNAJA1;DNAJB2;DNAJC8;STUB1
prerank,muscle alpha-actinin binding (GO:0051371),0.30708978391772723,0.7045612981216338,0.8303303303303303,0.9745046934094577,1.0,1/15,2.06%,LDB3
prerank,anion channel activity (GO:0005253),0.24168534044599382,0.7044546734905628,0.8958810068649885,0.9724446188010343,1.0,5/61,7.11%,TTYH3;LRRC8D;GABRB2;CLIC4;VDAC2
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.28837367946967696,-0.7005061728320201,0.8494318181818182,0.9641582349159081,1.0,4/11,27.12%,MAP3K1;MAP3K7;MAP3K5;MAP3K15
prerank,cytokine receptor activity (GO:0004896),0.2389283601000178,0.6992824737571026,0.9152915291529153,0.9763017812358068,1.0,12/83,16.59%,IL1R1;CSF2RA;CMKLR1;IFNAR1;IL17RA;F3;IL27RA;CCR5;IL4R;IL10RB;CSF2RB;IFNAR2
prerank,cytochrome-c oxidase activity (GO:0004129),0.30437825990598066,0.6981048283526734,0.8290854572713643,0.9753925636130797,1.0,2/15,10.62%,COX5A;COX7A2L
prerank,GTPase inhibitor activity (GO:0005095),0.3195025233027726,0.6980153357042331,0.8217665615141956,0.9733005889974853,1.0,1/13,1.32%,IPO5
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",-0.25994615198841015,-0.6979011198621156,0.874251497005988,0.9615982055236226,1.0,7/14,37.85%,MTHFD1;BLVRB;DHFR;ALDH1L1;ALDH4A1;PYCR3;NOXRED1
prerank,phosphatidic acid binding (GO:0070300),0.2934270904694973,0.6908636482106701,0.8406432748538012,0.9788398181814825,1.0,3/19,8.03%,ATP13A2;SMPD3;PACSIN2
prerank,protein kinase inhibitor activity (GO:0004860),0.2556183865273462,0.6897866024838452,0.8833535844471446,0.9777721775220386,1.0,10/42,19.99%,NCK1;DUSP19;GMFB;SH3BP5L;MBIP;CIT;RPTOR;IBTK;TRIB1;SNCA
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.28820315292729204,0.6896333623898054,0.861731843575419,0.9757518048296093,1.0,3/20,10.71%,AGPAT4;GPAT4;LPCAT1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.32519865693330063,0.681848101607989,0.834920634920635,0.9818792460679302,1.0,3/10,12.46%,CASP4;CASP9;CFLAR
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.29360275393574853,-0.6797638338383871,0.8695652173913043,0.9748568114907664,1.0,4/10,27.92%,DPYSL5;OPLAH;CRMP1;DPYSL2
prerank,disordered domain specific binding (GO:0097718),0.2757603787534356,0.6788471100413137,0.8774104683195593,0.9826341449551873,1.0,5/23,14.79%,HSP90AB1;BCL2L2;CLTC;NCOA3;FKBP8
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.24810025177591988,0.6780087513011815,0.8944246737841044,0.9813173668645219,1.0,8/46,14.74%,PIGQ;MGAT5;POMGNT1;MGAT5B;MGAT4A;GCNT2;LFNG;PIGP
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.32817789364449995,0.677157158595241,0.8530805687203792,0.9800709379857964,1.0,2/11,11.71%,PRMT2;PRMT3
prerank,cardiolipin binding (GO:1901612),-0.27919548240583447,-0.6763373546147009,0.8863049095607235,0.9727742386187854,1.0,4/10,22.75%,PLEKHN1;MME;OPA1;STOML2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.290390651857373,0.6752429682444118,0.843108504398827,0.9798198903412527,1.0,1/15,6.62%,SLC39A8
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.2897255000082037,0.6739254834244501,0.8564954682779456,0.9789785779504869,1.0,3/17,14.67%,AK8;CMPK1;NME6
prerank,cAMP binding (GO:0030552),0.3180327727599951,0.6728788254327257,0.8504823151125402,0.9779079036383999,1.0,1/11,4.44%,POPDC3
prerank,phosphatidylglycerol binding (GO:1901611),-0.2526187557173414,-0.6674236374794409,0.9258160237388724,0.9752224586783695,1.0,5/13,22.75%,PITPNC1;PLEKHN1;MME;OPA1;STOML2
prerank,deoxyribonuclease activity (GO:0004536),0.2960105020131075,0.6643211193684451,0.8569206842923794,0.9839286675371915,1.0,3/14,16.29%,MAP1S;MBD4;DNASE1L1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.30945262415665103,0.6640722220367371,0.8611544461778471,0.9820515158132642,1.0,1/11,2.04%,NEIL2
prerank,O-methyltransferase activity (GO:0008171),-0.2776230094219908,-0.663269666161768,0.900804289544236,0.973226243277175,1.0,6/10,33.60%,COQ3;CMTR1;MEPCE;FTSJ3;BCDIN3D;ASMT
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.24441620283095294,-0.6622171527033498,0.8982035928143712,0.9687320902845927,1.0,1/15,0.59%,P2RY12
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.28330734313603356,0.65913878209921,0.8869309838472834,0.9845346454366621,1.0,3/18,12.12%,BAIAP2L1;BAIAP2;ANXA2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.2539753194825389,-0.6564877778107804,0.8997214484679665,0.9678185199442634,1.0,9/13,42.95%,DNA2;FAN1;ZGRF1;SLX4;GEN1;DICER1;DNASE1L2;EXO1;FEN1
prerank,ATP hydrolysis activity (GO:0140603),0.24041519401693445,0.6563488788531416,0.9274092615769712,0.9849151456466032,1.0,6/41,14.08%,MYO1E;DHX9;TOR3A;CHD1L;CLU;ABCB10
prerank,NF-kappaB binding (GO:0051059),0.2597219286451038,0.6486363177070068,0.9125168236877523,0.9896421440037174,1.0,5/24,14.50%,RELA;RNF25;HDAC1;COMMD6;MTDH
prerank,voltage-gated sodium channel activity (GO:0005248),0.2664232571874179,0.6443579200321563,0.9076704545454546,0.9911474467086933,1.0,3/22,9.70%,SCN8A;CACNA1G;SCN1B
prerank,telomerase RNA binding (GO:0070034),0.2664231204634404,0.6413920451309191,0.9121813031161473,0.9916060301465379,1.0,3/22,11.07%,HNRNPU;SMG7;EXOSC10
prerank,FMN binding (GO:0010181),0.29998099320764904,0.640088462738713,0.886326194398682,0.9905812712125306,1.0,1/11,7.11%,POR
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.3008525617933984,0.6373442620421689,0.8762376237623762,0.9909153953697746,1.0,1/11,4.36%,NUDT5
prerank,sodium channel regulator activity (GO:0017080),-0.1822804020231434,-0.6352965477145167,0.9855769230769231,0.9777989625683444,1.0,19/37,40.16%,FGF12;YWHAH;SNTA1;GPD1L;FXYD5;COMMD1;PTPN3;PKP2;GPLD1;SCN3B;FXYD7;NEDD4;SCN4B;FXYD1;FGF11;SGK2;SGK3;NOS1;SCN2B
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.25384670745906146,0.632012122009297,0.91,0.9930495278035143,1.0,6/21,20.69%,CHRAC1;POLB;POLD4;POLD3;POLG;POLI
prerank,wide pore channel activity (GO:0022829),0.2560623193868576,0.6309085511506244,0.9132176234979973,0.991717163924368,1.0,23/23,74.43%,GJC3;GJA1;GJB5;GJB4;GJA3;GJA8;GJA10;GJA9;GJD4;GJE1;PANX3;GJA4;GJA5;PRF1;GJD2;GJB2;PANX2;GJC1;GJD3;GJB6;GJB1;GJC2;PANX1
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.1914045963581871,-0.6303581798545841,0.9806201550387597,0.9758091346385882,1.0,11/26,33.76%,BOD1L1;PPP1R14C;PPP1R2;PPP1R8;PPP1R11;LMTK2;PPP1R14A;PPP1R14B;BOD1;SAG;PABIR1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.30527306967984935,0.6290152997525136,0.8915094339622641,0.9911008944532692,1.0,11/11,69.49%,DDAH2;DDAH1;PADI3;PADI6;ALLC;PADI1;AGMAT;ARG1;ARG2;PADI4;PADI2
prerank,voltage-gated potassium channel activity (GO:0005249),0.2149549738945615,0.6272821975795269,0.9600443951165372,0.990404084483813,1.0,2/80,1.03%,KCNH2;KCNJ6
prerank,retinoid X receptor binding (GO:0046965),0.29683086881475784,0.6253830611707047,0.8913738019169329,0.9897828356253713,1.0,3/11,15.12%,ARID5A;MED25;TACC1
prerank,phospholipase inhibitor activity (GO:0004859),0.3018088533278547,0.6246600134928698,0.912621359223301,0.9882409296428558,1.0,2/10,12.12%,APOC1;ANXA2
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.258085939764113,0.624566223544046,0.923728813559322,0.9862427957603855,1.0,7/20,19.26%,SENP3;USP25;USP21;EIF3H;OTUB1;SENP5;COPS5
prerank,gap junction channel activity (GO:0005243),0.25604623405992843,0.6235038885390289,0.9260273972602739,0.9849663288273837,1.0,22/22,74.43%,GJC3;GJA1;GJB5;GJB4;GJA3;GJA8;GJA10;GJA9;GJD4;GJE1;PANX3;GJA4;GJA5;GJD2;GJB2;PANX2;GJC1;GJD3;GJB6;GJB1;GJC2;PANX1
prerank,BMP binding (GO:0036122),0.29399491472513106,0.6228783434683789,0.9117647058823529,0.9833804894659868,1.0,1/11,8.66%,ENG
prerank,DNA polymerase activity (GO:0034061),0.24789936772998988,0.622043567851369,0.9358974358974359,0.981959363673845,1.0,6/22,20.69%,CHRAC1;POLB;POLD4;POLD3;POLG;POLI
prerank,Hsp90 protein binding (GO:0051879),0.23847236244872322,0.6218456927751085,0.94148244473342,0.9800484496262425,1.0,7/33,19.27%,HDAC6;PTGES3;USP19;STUB1;STIP1;PPP5C;TSC2
prerank,cell-cell adhesion mediator activity (GO:0098632),0.22792224833656263,0.6160258351253024,0.9547738693467337,0.9823177522864284,1.0,9/42,17.35%,SIRPA;BAIAP2L1;DSCAM;BAIAP2;CD200;ANXA2;NPTN;CNTN4;PALLD
prerank,O-acyltransferase activity (GO:0008374),0.23626203009706861,0.6159356342818132,0.9408740359897172,0.9803263357227613,1.0,3/30,10.71%,PLA2G4A;GPAT4;LPCAT1
prerank,solute:anion antiporter activity (GO:0140323),0.2749154015055336,0.6129508625423896,0.9104704097116844,0.9804053765120717,1.0,1/14,5.41%,SLC4A2
prerank,Toll-like receptor binding (GO:0035325),-0.25443300781884676,-0.6124450100359322,0.9152046783625731,0.9812138925630414,1.0,3/11,23.30%,UNC93B1;CD36;MYD88
prerank,phosphatase inhibitor activity (GO:0019212),0.251275498205645,0.6090032485126906,0.952112676056338,0.981059000802681,1.0,5/20,21.62%,MGAT5;SET;CABIN1;PTN;STYX
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.21126944957747767,0.6085800825422545,0.9772209567198178,0.979317724261402,1.0,10/75,17.92%,CBR1;CBR3;DHRS4;MDH1;ADH5;HADHA;AKR1B10;PHGDH;PGD;HIBADH
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.21763261852381582,0.5917100667741164,0.9659367396593674,0.9875109688407143,1.0,7/40,15.86%,CARNMT1;THUMPD3;THUMPD2;COMT;DNMT3A;PCMTD2;LCMT1
prerank,tRNA methyltransferase activity (GO:0008175),0.2538571243432668,0.5875927157039192,0.9292168674698795,0.9878289284172013,1.0,3/16,14.03%,THUMPD3;THUMPD2;TRMT44
prerank,metal ion transmembrane transporter activity (GO:0046873),0.2285922873919669,0.5869089557983597,0.9483443708609272,0.9862174453729641,1.0,3/27,9.74%,SLC23A1;TUSC3;CNNM2
prerank,U6 snRNA binding (GO:0017070),0.2632542179819294,0.5827221497377248,0.9366715758468336,0.9863477558471795,1.0,4/14,17.65%,LARP7;TUT1;SART3;PRPF4
prerank,anion:anion antiporter activity (GO:0015301),0.24590177808081182,0.5759833671736576,0.9430199430199431,0.9879141948331117,1.0,2/17,12.90%,SLC4A2;SLC25A5
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.20199263523523178,-0.5706842425140581,0.9683544303797469,0.9949875606715647,1.0,8/16,30.50%,SLC25A30;SLC25A12;SLC1A5;SLC25A11;SLC38A7;SLC25A22;SLC1A4;SLC13A3
prerank,low-density lipoprotein particle binding (GO:0030169),0.2493825427796668,0.568139095172079,0.9472913616398243,0.9897145161565362,1.0,2/16,8.32%,COLEC12;SORL1
prerank,receptor antagonist activity (GO:0048019),0.24064305450891738,0.5604972280457463,0.9591240875912409,0.9911537862133686,1.0,17/17,75.96%,DKK2;ADH7;DKK1;LRPAP1;IL1RN;WFIKKN2;DKK4;DKKL1;AGTR2;WFIKKN1;IGSF1;FST;ESR2;CCL5;IL18BP;PXDN;DKK3
prerank,retinoid binding (GO:0005501),0.23249563960246916,0.5579166639282686,0.9713114754098361,0.9901601887071099,1.0,2/22,16.45%,PTGDS;RXRA
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.20828212127491272,0.5546385906821402,0.9806451612903225,0.9896064837665981,1.0,6/35,18.76%,ABL2;PTK2B;PEAK1;DYRK1A;TEC;HCK
prerank,cyclic nucleotide binding (GO:0030551),0.2283442482279743,0.5539056613701397,0.9643874643874644,0.9878673002470536,1.0,1/21,4.44%,POPDC3
prerank,microtubule minus-end binding (GO:0051011),0.2516660499969119,0.551353436585189,0.943683409436834,0.9868923359634875,1.0,3/13,14.88%,TUBGCP5;TUBGCP6;TUBGCP4
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",-0.198259223369916,-0.5264033925688869,0.9815384615384616,1.0,1.0,8/14,36.11%,ACO1;ISCU;ETFDH;RSAD1;ISCA2;RSAD2;NUBPL;NDUFS1
prerank,monocarboxylic acid binding (GO:0033293),-0.17998979395340017,-0.5251916437941638,0.9893617021276596,0.9974440706784989,1.0,4/18,26.65%,PYGL;NAPEPLD;RARA;NR2F2
prerank,ion channel inhibitor activity (GO:0008200),0.1986616219708779,0.525185331030022,0.9836888331242158,0.9939307878610555,1.0,3/35,9.70%,FKBP1B;KCNMB2;SCN1B
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.20285322168878828,0.5182763278443048,0.9880478087649402,0.9938497161472793,1.0,3/29,12.37%,SLC25A13;SLC25A21;SLC1A1
prerank,cGMP binding (GO:0030553),-0.20721092365963587,-0.5131894818649086,0.979002624671916,0.9945119328503123,1.0,1/11,10.56%,PDE10A
prerank,death receptor activity (GO:0005035),-0.2051131705981761,-0.5062234542895183,0.9919137466307277,0.9905677835412869,1.0,7/11,50.18%,TNFRSF1A;TNFRSF19;FAS;TNFRSF14;TNFRSF11A;TNFRSF25;TNFRSF4
prerank,lysine N-methyltransferase activity (GO:0016278),0.21285725297762048,0.5021584247668929,0.9840116279069767,0.995946015979821,1.0,3/20,16.36%,KMT5A;SETD7;EEF1AKMT1
prerank,retinoic acid binding (GO:0001972),0.22594010923472918,0.4854728613296945,0.9824561403508771,0.997436165885564,1.0,12/12,77.42%,RXRA;CYP26A1;UGT1A10;UGT1A1;UGT1A8;UGT1A4;UGT1A6;UGT1A7;CYP26C1;CYP26B1;NR2F2;RARA
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.1765326108152983,0.48058201235168757,0.9974905897114178,0.9962437929938973,1.0,3/42,8.51%,INCA1;CCNL1;CCNK
prerank,fibroblast growth factor receptor binding (GO:0005104),0.1923994974874369,0.46064846785472047,0.9972144846796658,0.9971496718193787,1.0,21/21,80.79%,NPTN;FGF9;FGF1;FGF17;FGF6;FGF8;FGF4;FGF3;KLB;FGF23;FGF16;FGF20;KL;FGF22;FGF5;FGF18;FGF7;FRS3;FRS2;FGF2;FGF10
prerank,acyl-CoA hydrolase activity (GO:0047617),0.1793519216277319,0.41657080195909507,0.9940652818991098,0.9993633681581101,1.0,17/17,82.08%,PPT1;ACOT13;PLA2G6;ACSBG2;BAAT;ACOT12;ABCD1;ACOT4;ACOT1;ACOT7;ACOT2;ACOT6;ACAA2;ACOT9;THEM4;ACOT8;ACOT11
prerank,steroid hydroxylase activity (GO:0008395),0.17356357927786495,0.40520730924857806,0.9929971988795518,0.9980982103671917,1.0,16/16,82.66%,CYP2A6;CYP27A1;CYP11A1;CYP17A1;CYP11B1;CYP2E1;CYP21A2;CYP7B1;CYP2S1;CYP1B1;CYP46A1;CYP1A1;CYP2U1;CYP39A1;CYP2R1;CH25H
